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I. Samenvatting 
Het DFNA5 gen werd in 1997 gekarakteriseerd als een gen verantwoordelijk 
voor autosomaal, dominant, niet-syndromaal gehoorverlies (GV). Tot op 
heden zijn er reeds acht verschillende families geïdentificeerd met GV 
gerelateerd aan mutaties in DFNA5. Op genomisch niveau verschillen vier 
van de acht gevonden mutaties, maar ze resulteren telkens in skipping van 
exon 8 met een prematuur getrunceerd proteïne als gevolg. Skipping van 
exon 8 leidt tot een verschuiving van het open reading frame, resulterend in 
een verkorte versie van het wild-type niet-gemuteerde DFNA5-proteïne 
(wtDFNA5), genaamd mutant DFNA5 (mutDFNA5). 
Behalve GV is wtDFNA5 ook geassocieerd met verschillende vormen van 
kanker, zoals borst-, colorectaal-, maag- en melanoma kanker. In deze 
tumoren is wtDFNA5 epigenetisch geïnactiveerd door hypermethylatie. 
Overexpressie van DFNA5 in verschillende tumor cellijnen leidde echter tot 
een reductie in tumorvorming en koloniegrootte. Deze resultaten wijzen in 
de richting dat DFNA5 een potentieel tumor suppressor gen is. 
Gregan et al. waren de eerste die aantoonde dat mutant DFNA5 
(mutDFNA5) een groeidefect induceerde in gist, maar de exacte rol van 
DFNA5 bleef voor lange tijd ongekend. Recent functioneel onderzoek in 
humane cellijnen echter, identificeerde DFNA5 als een apoptose-inducerend 
eiwit. Omdat reeds was aangetoond door Gregan et al. dat de DFNA5-
celdood-gerelateerde mechanismen minstens gedeeltelijk zijn 
geconserveerd tussen humane cellijnen en gist, werd er in het eerste deel 
van deze thesis een nieuw Saccharomyces cerevisiae gistmodel ontwikkeld 
en gevalideerd door verschillende celdood assays om de waarde van het gist 
DFNA5-model te bepalen.  
Vervolgens screenden we een collectie van achttien deletiemutanten, 
giststammen die een specifieke apoptotische component missen, met het 
oog op het identificeren van DFNA5-modulatoren. Van elke gist deletiestam 
werd er een groeiprofiel opgesteld, aangevuld met verschillende 
apoptotische kleuringen, en dit werd vervolgens vergeleken met de 
achtergrond stam. Deze screening resulteerde in de identificatie van 
verschillende mitochondriële proteïnen betrokken bij DFNA5-geïnduceerde 
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celdood, namelijk Fis1 en Por1, en Aac1 en Aac3, zijnde respectievelijk 
inhibitoren en activatoren van DFNA5-gemedieerde celdood. Aangezien 
deze vier proteïnen allen betrokken zijn bij mitochondriële processen was 
dit een eerste aanwijzing voor een mogelijke mitochondriële rol in het 
DFNA5-mechanisme. Bovendien, demonstreerden we dat het 
proteïnedegradatiemechanisme in gist ontoereikend bleek voor de afbraak 
van mutDFNA5 in tegenstelling tot wtDFNA5.  
De rol van de mitochondriën werd verder aangetoond door een Agilent-
microarraystudie uitgevoerd in gist. Transformatie van mutDFNA5 leidde tot 
de opregulatie van verschillende mitochondriële processen, zoals het ATP-
gekoppelde elektronentransport en het respiratieproces, en de 
neerregulatie van proteïnevouwing en processen gerelateerd aan het 
endoplasmatisch reticulum (ER). Deze resultaten bevestigen inderdaad de 
bovengenoemde resultaten en wijzen een belangrijke rol aan van de 
mitochondriën en mogelijks ook  van het ER in mutDFNA5-geassocieerde 
celdood in Saccharomyces cerevisiae.  
In het tweede deel van deze thesis maakten we gebruik van humane 
HEK293T-cellen. Een eerder uitgevoerd Illumina-microarrayexperiment werd 
opnieuw geëvalueerd en aangevuld met een additionele gene ontology-
analyse voor de identificatie van DFNA5-gerelateerde pathways. Twee 
belangrijke processen werden hierbij geïdentificeerd. Allereerst zagen we 
een opregulatie van de MAPK-pathways, welke was gekenmerkt door 
fosforylatie van het ERK- en het JNK- proteïne. Specifieke inhibitie van het 
JNK-proteïne reduceerde het celdood-inducerend effect van mutDFNA5, wat 
aantoonde dat de MAPK-pathway betrokken is bij de inductie van het 
DFNA5-mechanisme. Voorts zagen we ook een neerregulatie van processen 
geassocieerd aan proteïnevouwing wat kan wijzen op een potentiële rol van 
het ER in humane HEK293T-cellen.  
Om de rol van de mitochondriën verder te onderzoeken in humane cellijnen, 
voerden we verschillende mitochondriële assays uit. Deze assays 
demonstreerden een gedeeltelijke reductie van de mitochondriële 
membraanpotentiaal aangevuld met een verhoogde ROS-productie, 
vrijstelling van zowel cytochroom c en het matrix citraatsynthase. Deze 
mitochondriële veranderingen waren bovendien caspase-onafhankelijk. 
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Onderzoek van het mitochondriële netwerk, gebruik makend van 
fluorescentiemicroscopie, toonde bovendien desintegratie van het 
mitochondriële netwerk aan. Dit werd gekenmerkt door sferische 
aggregaten en de afwezigheid van een tubulair, intact netwerk zoals 
geobserveerd in de controle stalen.  
Deze data demonstreren dat expressie van mutDFNA5 in humane HEK293T-
cellen resulteert in mitochondriële beschadiging gevolgd door celdood. De 
connectie tussen de mitochondriën, de MAPK-pathway en het ER in DFNA5-
geassocieerde celdood blijft echter onduidelijk op dit moment. Verder 
onderzoek naar DFNA5-gemedieerde processen zal leiden tot een beter 
inzicht in DFNA5-geassocieerd GV en tot GV gerelateerd aan mitochondriële 
celdood in het algemeen.  
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II. Abstract 
In 1997, DFNA5 was originally identified as a gene responsible for an 
autosomal dominant non-syndromic form of hearing loss (HL). Today, 
already eight families with HL have been reported with mutations in DFNA5. 
Four of these mutations differ at genomic level, but they all result in 
skipping of exon 8 leading to a truncated immature protein. Skipping of exon 
8 causes a frameshift of the open reading frame, leading to a shortened 
version of the unmutated wild-type DFNA5 protein (wtDFNA5), namely 
mutant DFNA5 (mutDFNA5). 
In addition to HL, wtDFNA5 has also been correlated with different forms of 
cancer, such as breast, colorectal, gastric and melanoma cancer. In these 
tumours, DFNA5 is epigenetically inactivated by hypermethylation. 
Furthermore, overexpression of DFNA5 in tumour cell lines resulted in 
reduced tumour growth and colony size which led to the hypothesis that 
DFNA5 is a tumour suppressor gene.  
 
Gregan et al. (2003) were the first to demonstrate that mutDFNA5 induced a 
growth defect in fission yeast, but the exact function of DFNA5 remained 
unknown for a long time. Recently however, functional studies on DFNA5 
identified the gene as an apoptosis-inducing gene in human cell lines. As 
already demonstrated by Gregan et al., the DFNA5-induced cell death 
mechanism seems to be at least partially conserved between yeast and 
human cell lines. Therefore, the first part of this thesis was performed using 
Saccharomyces cerevisiae as a model organism. A DFNA5-humanised yeast 
model was developed in the BY4741 background strain, transformed with 
either wtDFNA5 or mutDFNA5, and validated by several cell death assays to 
determine the value of yeast as a model organism for DFNA5.  
Next, an apoptosis deletion strain collection, a collection of eighteen yeast 
strains deleted in one particular gene related to apoptosis, was screened to 
identify modulators of the DFNA5 cell death mechanisms in yeast. Growth 
profiles of every yeast strain and several apoptotic stainings were 
performed and compared to the background strain. This identified several 
mitochondrial proteins related to DFNA5-induced cell death. The Fis1, Por1, 
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and, Aac1 and Aac3 proteins were characterised as respectively inhibitors 
and inducers of DFNA5-related cell death. These proteins were related to 
either the mitochondrial dynamics or the permeabilisation process, 
revealing for the first time an important role for the mitochondria.  
Additionally, wtDFNA5 was subject to normal protein degradation in yeast, 
whereas mutDFNA5 seemed to escape this protein quality control. As the 
endoplasmic reticulum (ER) is involved in protein folding and degradation, 
these results could suggest an additional role for the ER. As both organelles, 
the mitochondria and the ER, are tightly correlated, interplay between the 
ER and the mitochondria could be important for DFNA5-induced cell death 
in yeast.  
Later on, an Agilent microarray study performed in yeast confirmed the role 
of the mitochondria as several gene ontology mitochondria-related 
processes, such as ATP-coupled electron transport and respiration, were up-
regulated upon mutDFNA5 transformation in yeast. Additionally, processes 
related to protein folding and the endoplasmic reticulum (ER) were down-
regulated upon mutDFNA5 transformation. These data validated the former 
results indicating a role for the mitochondria and a potential role for the ER.  
 
The second part of this thesis was performed in human HEK293T cells. A 
former Illumina microarray experiment was re-evaluated by an additional 
analysis investigating the gene ontology-enriched annotations. This 
microarray experiment identified two main features, namely the up-
regulation of the MAPK pathways and the down-regulation of the protein 
folding process upon mutDFNA5 transfection. The up-regulation of the 
MAPK pathway was characterised by phosphorylation of JNK and ERK. 
Specific inhibition of JNK partially abolished the mutDFNA5-induced cell 
death, indicating the importance of this pathway in the DFNA5-associated 
cell death mechanism. Down-regulation of gene ontology processes related 
to protein folding again revealed a potential role for the ER in DFNA5-
associated mechanisms.  
 
Because the prior research in yeast identified several mitochondrial 
proteins, several mitochondrial aspects were additionally investigated in 
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human HEK293T cells. This revealed partial loss of the mitochondrial 
membrane potential, increased ROS production, release of both cytochrome 
c and the matrix citrate synthase. These events were independent on 
caspases. The mitochondrial network was further investigated by 
fluorescence microscopy and revealed the accumulation of damaged 
mitochondria in mutDFNA5-transfected HEK293T cells. This was 
demonstrated by the presence of spherical aggregates and the absence of a 
tubular integer mitochondrial structure which was observed in the control 
samples. These results indicate the presence of dysfunctional mitochondria 
upon expression of mutDFNA5 leading to mitochondrial collapse and 
eventually cell death. The link between the mitochondria, the MAPK 
pathway and the ER in DFNA5-related cell death, however, remains 
unknown at this moment. Additional research is needed to further 
investigate DFNA5-related processes, which will lead to new insights for 
DFNA5-associated HL and, more in general, for HL related to mitochondrial 
cell death.  
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III. Abbreviations 
∆Ψ Mitochondrial membrane potential 
3-MA 
Aac1/3 
3-methyladenine 
ADT/ATP carriers 
Adh2 Alcohol dehydrogenase 
AFG3L1  ATPase family gene-3 
AIF Apoptosis-inducing factor 
ANT Adenine nucleotide translocase  
Apaf-1 Apoptosis protease-activating factor 1 
ARHI Age-related hearing impairment 
ATG Autophagy-related genes  
ATP Adenosine triphosphate 
AV AnnexinV 
BCL2 B-cell lympfoma 2 
Beclin BCL2-interacting protein  
BH BCL2 homology  
BIR Baculovirus IAP repeats 
Caf4 CCR4-associated factor 
CARD Caspase recruitment domain  
CDC19 Pyruvate kinase CDC19 
CF Cytosolic fraction 
COX Cytochrome c oxidase 
CsA Cyclosporine A 
Cy3/5 Cyanine 3/5-CTP  
CypD Cyclophilin-D 
DAPI 4',6-diamidino-2-phenylindole 
DDP Diadenosine and Diphosphoinositol Polyphosphate phosphohydrolase 
DFNA5 Deafness, autosomal dominant 5 
DHE Dihydroethidium 
DIABLO Direct IAP-binding protein with low pI 
DISC Death-inducing signalling complex 
DMEM Dulbecco’s modified eagle’s medium 
DNAJB 1 DnaJ (Hsp40) homolog, subfamily B, member 1 
Dnm1p Dynamin-related  
DRP1 Dynamin-related protein 
EGFP Enhanced green fluorescent protein 
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EGR1 Early growth response 1 
EndoG Endonuclease G 
ER Endoplasmic reticulum 
ERAD ER-associated degradation 
ERK Extracellular signal-related kinase 
FADD Fas-associated death domain 
FITC Fluorescein isothiocyanate 
FM-4-64 
N-(3-triethylammoniumpropyl)-4-(p-diethylamino phenylhexa-trienyl) 
pyridinium dibromide 
Fzo1 Fuzzy onion 1 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GDAP Ganglioside-induced differentiation-associated protein 1 
GO Gene ontology 
GSDM Gasdermin 
H2O2 Hydrogen peroxide  
HA Hemaglutinin 
HCA Hydrophobic cluster analysis 
HEK293T Human embryonic kidney  
hFIS/Fis1 (Human) fission protein 
HK Hexokinase  
HL Hearing loss 
HMBG 1 High mobility group Box 1 protein 
HRP Horse radish peroxidase 
Hsp90 Heat shock protein 90 
HSPA6 Heat shock 70kDa protein 6 
HTRA2 High temperature requirement serine protease 
IAP Inhibitor of apoptosis 
IMM Inner mitochondrial membrane 
IPOD Insoluble protein deposit 
JNK c-Jun N-terminal kinase 
JUNQ Juxtanuclear quality control 
kD Kilo Dalton 
LC3 Microtubule-associated process 1 light chain 3 
MAPK Mitogen-activated protein kinase 
Mdm30/36 Mitochondrial distribution and morphology 
Mdv1 Mitochondrial division 
ME Mid-exponential 
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Mca Metacaspase (yeast caspase) 
MF Mitochondrial fraction 
MFF Mitochondrial fission factor 
MFN1/2 Mitofusin 1and 2 
Mgm1 Mitochondrial genome maintenance 
Mgr2 Mitochondrial genome required 2 
MIB Mitofusin-binding protein 
MIEF/Mid49/51 Mitochondrial elongation factor 1 
mitoPLD Mitochondria-associated phospholipase D 
MLKL Mixed lineage kinase domain-like 
MOMP Mitochondrial outer membrane permeabilisation 
MPT Mitochondrial permeability transition 
mPTP Mammalian mitochondrial transition pore 
MSBR3 Methionine sulfoxide reductase B3 
MTGM Mitochondrial targeting GxxxG motif protein 
MTP18 Mitochondrial protein 
MTS Mitochondrial targeting signal 
mutDFNA5 Mutant DFNA5 
NIHL Noise-induced hearing loss 
Nma111 Nuclear mediator of apoptosis 
Nuc1 Endonuclease G 
Num1p Nuclear migration protein 
OD Optical density 
OMA1/MPRP-1, Metalloprotease-related protein-1 
OMM Outer mitochondrial membrane 
OPA1 Optic atrophy 1 
PARL Presenilin-associated rhomboid-like 
PCD Programmed cell death 
Pcp1p Processing of cytochrome c peroxidase 
PD Post-diauxic 
PGK1 Phosphoglycerate kinase 
PI Propidium iodide 
PMAIP1 Phorbol-12-myristate-13-acetate-induced protein 1 
Por Porin 
PPP Pentose phosphate pathway 
PTPC Permeability transition pore complex  
RIPK1/3 Receptor-Interacting serine/threonine protein kinases 
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ROS Reactive oxygen species 
rtPCR Reverse transcriptase PCR 
S. cerevisiae Saccharomyces cerevisiae 
siRNA Short interfering RNA 
SMAC Second mitochondria-derived activator of caspase 
t-BHP Tert-butylhydroperoxide 
TDH2/3 Triose-phosphate Dehydrogenase 
Timm8a Translocase of the inner mitochondrial membrane 
TM7SF2 Transmembrane 7 superfamily member 2 
TMRM Tetramethyl rhodamine methylester 
TNF Tumour necrosis factor  
TOR Target of rapamycin 
TPI Triose phosphate isomerase 
TRAF2 TNF receptor-associated factor 2 
TSG Tumour suppressor gene 
UCP 2 Uncoupling protein 2 
Ugo1 Means fusion in Japanese 
UPR Unfolded protein response 
Ups1 Unprocessed  
VDAC Voltage-dependent anion channel  
VPS33B Vacuolar protein-sorting 33 homolog B (yeast) 
wtDFNA5 Wild-type DFNA5 
Ybh3p Yeast BH3-only protein 
Yca/Mca Yeast caspase/Metacaspase 
YME1L Yeast mitochondrial escape 
yPTP Yeast mitochondrial transition pore 
Ysp2 Yeast suicide protein 
zVAD-fmk N-benzyl-oxycarbonyl-Val-Ala-Asp -fluoromethylketone 
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1 Introduction 
DFNA5 was originally identified as a gene responsible for a dominant 
autosomal non-syndromic form of hearing loss (HL) in a Dutch family [1]. 
Today, already eight families have been identified with mutations in DFNA5 
associated with HL [2-7]. HL is a very diverse and complex disorder reflected 
by the many different genes that have been identified [8, 9]. The past 
decades, genetic research on HL has identified many different loci and 
causative genes. Today, more than 30 genes responsible for an autosomal 
dominant non-syndromic form of HL have been identified. Additionally, 55 
autosomal recessive non-syndromic genes and 4 non-syndromic X-linked 
genes were found to be associated with hereditary hearing problems 
(http://hereditaryhearingloss.org). It is estimated that around 1 in 1000 
children are born deaf or will develop hearing problems in early childhood 
and most of the time this is attributable to genetic factors [10-12]. In 
addition, about half of the people over age 75 will develop severe hearing 
problems during aging, which makes it one of the most common sensory 
deficits in the elderly [13]. Furthermore, in the last decade, an increase of 
the prevalence of HL among young adults has been recorded due to 
excessive use of music devices [14-16]. HL is hence a very common and 
underestimated health problem which leads to social isolation, 
stigmatisation and reduced quality of life. 
 
The function of DFNA5 remained unknown for a long time, but recently 
DFNA5 has been associated with apoptosis, a specific form of programmed 
cell death (PCD) [17]. Apoptosis is a very complex and highly regulated 
mechanism. It is one of the major routes of cell death associated with 
numerous physiological processes and major implications upon 
deregulation. It is therefore essential to maintain the apoptotic process in 
balance and disturbance of this delicate task leads to a variety of 
pathologies, such as cancer and neurodegeneration but also HL [18-20]. 
 
The role of apoptosis in the pathology of HL has been well studied and plays 
a prominent role, especially in the development of the vertebrate inner ear 
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and in the morphogenesis of the semicircular canals [21]. Due to its 
prominent role in hearing impairment, several types of HL, such as age-
related hearing impairment (ARHI), noise-induced hearing loss (NIHL) and 
monogenic forms of HL, like DFNA5-induced HL, are linked to apoptosis. 
Genetic research on HL has identified many different genes and some of 
them were involved in apoptotic pathways, such as DFNA5, TJP2 and 
Smac/DIABLO [16, 22, 23]. Additionally, a clear link between ARHI and 
apoptosis has been established as demonstrated by several mouse models 
used to study ARHI. Commonly used mouse strains for ARHI are CBA/J and 
C57BL/6, which both showed increased oxidative stress and enhanced 
apoptotic activation in the aged cochleas of these mouse models [24, 25]. 
Finally, apoptotic damage was reported in several animal models following 
acoustic overstimulation demonstrating a link between NIHL and apoptosis 
[26, 27]. 
 
As DFNA5 was recently identified as a gene related to apoptosis [17] this 
introduction will highlight some important aspects of apoptosis and other 
forms of PCD. The emphasis will lie on the mitochondria as these are key 
players in the regulation of PCD. Mitochondria serve as docking sites for 
several PCD proteins and play a decisive role for either survival or cell death. 
After a short summary about the current knowledge of DFNA5, two specific 
aspects of the mitochondria, namely their dynamics and the mitochondrial 
permeabilisation process, will be discussed.  
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1.1 DFNA5 
1.1.1 DFNA5 and hearing loss 
In 1966, Huizing et al. described for the first time a Dutch family with severe 
hearing problems [28]. Until 1985, this family was followed up and genetic 
research in 1995 localised the candidate gene to chromosome 7p15 [29]. 
Further refinement of this region led to the identification of a complex 
mutation in a gene expressed in the cochlea which co-segregated with HL in 
this family. The gene was termed DFNA5 as no function could be assigned 
[16]. The HL was inherited in an autosomal dominant way with a penetrance 
of 100% and no other phenotypic abnormalities were seen, classifying the 
HL as non-syndromic.  
 
Nowadays, eight families have already been identified with mutations in 
DFNA5-associated with HL. Comparison of a Korean, a Chinese and two 
Japanese DFNA5 families resulted in the identification of a putative founder 
mutation in East-Asians [2, 6]. Four of these eight mutations differ at the 
genomic level but they all result in the skipping of exon 8 leading to an 
immature truncated protein (Table 1) [3-6].  
 
The phenotype of DFNA5-related HL is very similar in all these families with 
the exception of the age-of-onset (Table 1). HL related to DFNA5 is 
symmetric, meaning that both the right and the left ear are similarly 
affected. The age-of-onset of DFNA5-related HL varies between 15 year and 
50 year and no vestibular problems are observed. The HL starts at the higher 
frequencies but eventually spreads to the lower frequencies. Due to the 
relative slow speech recognition deterioration, it is assumed that DFNA5-
related HL is associated to cochlear dysfunction and is not an auditory 
neuropathy.  
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1.1.2 DFNA5 and cancer 
Additionally to hearing impairment, DFNA5 has also been linked to several 
forms of cancer. The first indication that DFNA5 was not only related to HL 
but also to cancer was established in 1998 by Thompson et al. [30]. This 
study searched for differentially expressed genes between hormone-
responsive and hormone-unresponsive breast carcinomas. Hormone-
responsive breast cancer is associated with the expression of the oestrogen 
receptor and is clinically less aggressive compared to oestrogen receptor 
negative tumours. Thompson et al. identified an inverse correlation 
between the expression of DFNA5 and oestrogen receptor. Since then, 
DFNA5 has been associated with breast, colorectal, melanoma, gastric and 
hepatocellular cancer [30-35].  
In several different forms of cancer, such as breast, colorectal and gastric 
cancer, wild-type DFNA5 (wtDFNA5) is epigenetically inactivated by 
methylation resulting in a reduced amount of DFNA5 expression. Because 
the percentages of DFNA5 methylation in these tumour cells are very high, 
ranging from 52% to 65% in respectively gastric and colorectal tumour 
tissue, it was hypothesised that DFNA5 is a tumour suppressor gene (TSG). 
Enhancement of full-length DFNA5 expression decreased cell growth and 
resulted in a reduction in colony number. Whereas DFNA5 down-regulation 
increased cell growth and colony size of the cancer cell lines, which further 
confirmed this hypothesis [31-33]. 
Additionally, DFNA5 expression is also regulated by p53, one of the most 
frequent genetic altered TSG [36-38]. A screen for p53-regulated genes in 
responses to cellular stress revealed the transcriptional activation of DFNA5 
by a p53-responsive sequence in the gene. Furthermore, a p53-mediated 
apoptotic response was enhanced by DFNA5 expression [36]. 
 
The physiological relevance of DFNA5 in cancer is unclear at this moment, 
but a link of DFNA5 and apoptosis, a mechanism frequently disturbed in 
several forms of cancer, has been demonstrated several times. Enhanced 
caspase-3-mediated apoptosis was seen in DFNA5-transfected melanoma 
cell lines, which was the first time that DFNA5 was associated with 
apoptosis. Furthermore, expression of apoptosis-related proteins, such as 
10 
 
caspase-8 and Fas, was also significantly increased in hepatocellular 
carcinoma upon DFNA5 expression [34, 35]. Finally, DFNA5 expression has 
been associated with lymph node metastasis in breast cancer [32]. The high 
methylation percentages and the correlation with cellular invasiveness 
support the DFNA5 properties as a TSG and underlie the potential of DFNA5 
as a biomarker for certain forms of cancer. 
1.1.3 Functional studies on DFNA5 
The function of DFNA5 remained unknown for a long time due to the fact 
that DFNA5 has no clear structural or functional similarities with other 
genes. Gregan et al. (2003) were the first who demonstrated a toxic effect of 
mutant DFNA5 (mutDFNA5) upon transformation in fission yeast [39]. They 
also identified a conserved zinc-finger-like motif, a CCCH domain, which has 
sequence similarity with the fusion yeast gene Mcm10, a gene related to 
DNA replication. It is however, very unlikely that they share functional 
similarity because DFNA5 was not able to complement the fission yeast 
Mcm10 homologue, the cdc23 mutant [39].  
Besides Mcm10, one other closely related gene to DFNA5 was identified 
through phylogenetic analysis, namely Pejvakin [40]. Pejvakin is associated 
with an autosomal recessive non-syndromic form of HL and shares a 250 
amino acid N-terminal stretch with DFNA5 revealing a common ancestor 
[41, 42]. DFNA5 and Pejvakin both belong to the gasdermin family, a group 
of genes with a high tissue-specific expression pattern in the gastrointestinal 
tract. They all share this N-terminal conserved region. Despite this, DFNA5 
and Pejvakin are phylogenetically distant from other gasdermin members 
and form a distinct clade in this family. Additionally, due to the 
gastrointestinal specific expression profile of the gasdermin family, it is very 
unlikely that they have similar molecular functions. Until today, the current 
function of Pejvakin remains unknown revealing no further information on 
DFNA5, until a few years ago.  
 
A few years ago, functional studies on DFNA5 in human cell lines revealed a 
direct link with apoptosis [17]. Transfection of mutDFNA5 in human 
HEK293T cells resulted in enhanced apoptotic cell death. This was 
demonstrated by the externalisation of phosphatidylserines and the 
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presence of DNA fragmentation, two hallmarks of apoptosis. This was the 
first indication about the function DFNA5 and the starting point for this 
thesis.  
The same functional study also gave a first indication about the structure of 
DFNA5. This was established by a hydrophobic cluster analysis (HCA), a 
structural prediction analysis based on the hydrophobicity of the amino acid 
sequence. The HCA analysis revealed that DFNA5 contains two globular 
domains (exon 2-6 and exon 7-10) connected by a hinge region (exon 6-7) 
(Fig. 1).  
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Fig. 1: DFNA5 protein structure aligned with the coding exons. The upper part shows the structure of the wtDFNA5 protein aligned with the 
coding exons in relation to the two globular domains, domain A and B, separated by a hinge region, as defined by the HCA analysis [17]. The 
lower part demonstrates the splicing mutation of the wtDFNA5 protein, namely mutDFNA5. Skipping of exon 8 results in an ORF shift. This leads 
to a truncated protein due to a premature stop codon in exon 10, lacking a part of domain B. The predicted β-sheets and α-helices are shown by 
respectively arrows and helices. AA, amino acid; ORF, open reading frame. 
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This structure is shared by all gasdermin members, although the length of 
the hinge region and the form of the second globular domain can differ. The 
mutations in DFNA5 described in the different HL families, led to exon 8 
skipping resulting in an immature, truncated protein lacking the second 
globular part of this protein (Fig. 1 and 2). Furthermore, it was 
demonstrated that the first part of this protein, exon 2-6, was the apoptosis-
inducing part, the part shared between wtDFNA5 and mutDFNA5. This 
observation led to the hypothesis that the second, non-apoptotic part of 
DFNA5 shields the first, apoptotic, part inhibiting its activation (Fig. 2, [17]). 
 
 
 
Fig. 2: Hypothetical model of the structure of DFNA5 showing wtDFNA5 and mutDFNA5. 
The genomic mutations, present in the different families with HL, result in the skipping of 
exon 8 leading to an immature truncated protein. It was demonstrated that the first part 
(exon 2-6) is the apoptosis-inducing part. It is hypothesised that the second part shields the 
first activating part and that due to the partial lack of this second part (exon 7-10), 
mutDFNA5 is constitutively active. 
 
Despite our limited knowledge about the function of DFNA5, the association 
with apoptotic cell death and the structural elucidations enabled us to make 
an assumption on the link between DFNA5-mediated HL and cancer. In HL, 
genomic mutations in DFNA5 result in a truncated protein lacking the 
second globular part. We hypothesised that this prevents the shielding of 
the first apoptotic region leading to a constitutively activated protein. Over 
activation, meaning excessive apoptotic cell death, will probably cause 
degeneration of the inner hair cells and eventually lead to HL. In cancer, 
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hypermethylation of DFNA5 results in decreased activation of DFNA5 and 
inadequate cell death, probably enabling tumour formation. This again 
demonstrates the importance to maintain the delicate apoptotic balance, 
essential for cellular homeostasis.  
1.1.4 Yeast as a model organism 
As already shown by Gregan et al. (2003), transformation of mutDFNA5 in 
fission yeast induced a growth defect suggesting that the DFNA5-induced 
cell death mechanism seems to be at least partially conserved in yeast [39]. 
Therefore, a yeast model organism was used to further investigate the 
DFNA5-related mechanisms. The use of yeast as a model organism has 
several advantages, but the question remains whether yeast could be used 
as a model organism for a gene related to PCD. 
1.1.4.1 Advantages of yeast as a model organism  
Since the elucidation of the yeast genome in 1996, this model has been a 
pioneer organism in functional genomics and system biology for several 
reasons [43]. Much of the newest cellular techniques, such as high 
throughput arrays, are often pioneered and validated in yeast. The genetic 
tractability and the existence of a genome wide collection of deletion strains 
make yeast a very attractive model organism [44, 45]. Since the unravelling 
of the yeast genome, a deletion collection of every non-essential gene has 
been produced. This created a lot of opportunities where yeast can be used 
to study protein and/or gene interactions on high throughput level [46].  
In addition to the high throughput applications and the genetic tractability, 
the high degree of conservation between yeast and human makes the 
model organism very valuable. Up to 30% of known genes involved in 
human diseases have an orthologue in yeast and nearly 1000 yeast genes 
(~17% of the yeast genome which has 6000 genes) are orthologues of gene 
families correlated with human diseases [47]. Comparison of the human 
genome with the yeast genome does not always reveal this homology, but 
yeast can often give a first clue about the functional annotation of a gene. 
The speed of growth, the price and the relatively easy control of cell division 
and cell growth are additional reasons making yeast a valuable tool to the 
knowledge of the eukaryote biology.  
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1.1.4.2 Physiological role of programmed cell death in yeast 
It has been a debate for a long time whether PCD does exist in yeast, a 
unicellular organism. What would be the purpose and the benefit for a 
unicellular organism to have a suicide program? Since the publication of the 
yeast genome, numerous studies were performed on this topic and revealed 
that yeast cannot solely be seen as a unicellular organism being an isolated 
cell without any communication. In fact, yeast behaves like a multicellular 
community where cell death can be beneficial for the whole colony. In this 
point of view, cell death can be seen as an altruistic mechanism to serve the 
fitness of the population [48]. There are several reasons for yeast to commit 
suicide. During chronological aging of a yeast population, the older, more 
damaged cells die by PCD [49]. The older yeast cells thereby release 
nutrients which can be reused by the younger and fitter cells. In addition, 
they also secrete certain pro-survival factors stimulating the proliferation of 
the colony. During mating, yeast cells also act like a community where PCD 
serves the benefit of the colony. In the absence of a suitable mating partner, 
yeast cells die, eliminating damaged or infertile cells. This promotes a 
diploid state which enhances genetic diversity and adaptive regrowth 
capacity, ensuring overall survival of the population [48, 50].  
Some yeast strains, known as virus-encoded killer yeast, produce certain 
toxins encoded by cytosolic double-stranded RNA viruses. Killer yeast 
themselves are immune for those toxins but they can induce apoptosis in 
susceptible yeast strains under competing circumstances such as nutrient 
depletion. Here, apoptosis is misused by some yeast strains which use this 
mechanism as a competitive benefit for survival [51, 52].   
1.1.5 Conclusion 
DFNA5 is a gene associated with a dominant autosomal non-syndromic form 
of HL and is correlated with several forms of cancer. In human cell lines, 
DFNA5 was shown to induce cell death related to apoptosis. Additionally, 
DFNA5 was also shown to induce a growth defect in a fission yeast model, 
suggesting that the DFNA5 PCD mechanism is at least partially conserved 
between yeast and metazoan. As PCD was the main research field 
throughout this thesis, the next part of the introduction will highlight some 
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important aspects about PCD in general, and on mitochondria in particular. 
As yeast was initially used as a model organism to study the DFNA5-related 
mechanisms, a comparison will be made between the yeast and mammalian 
apoptotic pathway discussing the resemblances and the differences. 
1.2 Programmed cell death 
Cell death is a fundamental aspect of life and is closely related to health and 
disease. Many different forms of cell death have been identified over the 
past few decades. Therefore, cell death is a very complex and highly 
regulated cellular mechanism important during development, 
organogenesis, the function of the immune system and tissue homeostasis 
[21, 82] . Many different types of cell death co-exist and an orchestrated 
interplay between them is highly important. Deregulation has many 
implications in different pathologies, such as auto-immune diseases [18] and 
cancer [19, 53]. Autophagy, apoptosis and necrosis are the main cell death 
pathways in mammalian cell lines. For a long time, only apoptosis and 
autophagy were considered as programmed forms of cell death contrasting 
necrosis which was regarded as an accidental process. However, research of 
the last few decades challenged this idea by the identification of several 
regulators of necrosis, creating a new type of cell death, namely regulated 
necrosis or necroptosis. 
1.2.1 Introduction to programmed cell death: Autophagy and Necrosis 
Initially, autophagy was classified to have a pro-survival and protective role 
in cells. Its main function is to remove damaged organelles during starvation 
by a self-digestion process providing metabolites which can be reused. 
Formation of autophagosomes, double membrane vesicles, is a key step in 
this process which is essential for sequestering of components to be 
degraded and for delivering them to lysosomes [54, 55]. Different steps are 
involved in the autophagic process starting from initiation, recognition and 
engulfment of components to be degraded, nucleation, expansion and 
eventually fusion of the vesicle with the lysosome [55-57]. Already 31 
autophagy-related genes (ATG) have been identified which can be classified 
into groups depending on their functional role in one of the autophagic 
steps. Most of these ATG genes have been identified in yeast and they have 
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similar roles in higher eukaryotes. TORC1 or the RAS/cAMP PKA pathway for 
example, regulate autophagy both in yeast and in mammals [58-62]. Despite 
its role in survival, autophagy is also correlated with cell death and 
implicated in a wide range of diseases [56, 63, 64]. The close relation 
between autophagy and different forms of cell death, such as apoptosis and 
necrosis, has been well studied. A variety of stimuli can activate different 
forms of cell death, including autophagy. Depending on the trigger or cell 
type, autophagy can either stimulate or block cell death [65].  
 
For a long time, necrosis was regarded as a passive, unregulated form of cell 
death. Necrosis can be distinguished from other forms of cell death by the 
presence of swollen organelles, rupture of the plasma membrane, no 
caspase activation and the largely intact nucleus. Necrosis is often related to 
inflammatory responses triggered by spoilage of cytoplasmic content due to 
rupture of the plasma membrane [66, 67]. Later on, it became clear that 
necrosis is more than just an accidental form of cell death and some even 
claim that all forms of necrosis should be considered as potentially regulated 
[68, 69]. This consideration would have major implications at the 
therapeutic level which should be carefully investigated. Programmed 
necrosis or necroptosis can be triggered either by activating the death 
receptors present at the plasma membrane, similar to apoptosis, or by 
pathogen recognition receptors present at cells of the innate immune 
system [70, 71]. The main regulators of necroptosis are the receptor 
interacting serine/threonine protein kinases (RIPK1/3) and mixed lineage 
kinase domain-like (MLKL) protein [72, 73]. 
 
Similar to metazoan, evidence of necrotic cell death under normal 
physiological circumstances in yeast is mounting, suggesting the existence of 
regulated necrosis. One of the most prominent examples of necrosis under 
normal conditions is the exhibition of morphological necrotic features 
during chronological aging while lacking apoptotic markers. Nuclear release 
of Nhp6Ap, the HMGB1 (high mobility group Box 1 protein) yeast 
homologue and the marker for necrotic cell death, was demonstrated in 
aged yeast cells [74, 75]. Furthermore, different organelles and genetic 
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factors have been identified in yeast to mediate necrosis. The yeast Hsp90p 
for example, is one of the factors which have been associated with necrotic 
regulation harbouring a pro-death role [76, 77]. Additionally, the vacuoles 
are closely connected to necrotic cell death being responsible for 
maintaining the intracellular pH. Dysfunctional vacuoles induce necrosis due 
to a collapse in intracellular pH hereby releasing pro-necrotic proteases 
resembling the induction of necrotic cell death by high concentrations of 
acetic acid [78, 79]. 
1.2.2 Apoptosis, a specialised form of PCD 
1.2.2.1 Metazoan 
Apoptosis is a complex and highly regulated mechanism. Typical apoptotic 
hallmarks are nuclear condensation and fragmentation, DNA cleavage, 
externalisation of phosphatidylserine providing an ‘eat-me signal’ and 
formation of apoptotic bodies. Apoptosis is an active, energy-consuming 
suicidal process contrasting necrosis and necroptosis which will occur under 
low energy conditions [80, 81]. 
Two major apoptotic pathways are present in mammalian cell lines, the 
extrinsic or death receptor-mediated pathway and the intrinsic or 
mitochondria-related pathway [82]. Despite different activation triggers, a 
similar pattern is followed once activated. Triggering one of the cell death 
pathways activates different initiator caspases by cleavage followed by 
cleavage of effector caspases [83, 84] (Fig. 3). 
The receptor-mediated pathway is activated by extracellular binding of 
different ligands, such as FasL, TNF and TRAIL, to their transmembrane 
death receptors [85-87]. Upon binding to its receptors, a Death-Inducing 
Signalling Complex (DISC) is formed by recruitment of the adaptor death 
domain (FADD or TRADD dependent on the ligand) and procaspase-8 [86, 
88, 89]. Proteolytic activation of procaspase-8 initiates the caspase cascade 
leading to apoptosis [90] (Fig. 3).  
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Fig. 3: The apoptotic pathway in metazoan. The extrinsic pathway is activated by binding of 
different death ligands on their receptor. An activating death domain is recruited, which in 
turn activates the initiator procaspase-8 by cleavage. The intrinsic pathway is induced by 
either exo- or endogenous triggers. The mitochondria are the key players in this pathway 
which are regulated by different pro- and anti- apoptotic BCL2 proteins (dark green). Pro-
apoptotic BCL2 proteins translocate to the mitochondria upon apoptosis induction and 
mediate mitochondrial permeabilisation. This results in the release of several apoptotic 
factors indicated by red circles. The initiator procaspase-9 is activated by the release of 
cytochrome c. Both the extrinsic and intrinsic pathway will result in activation of the 
effector procaspase-3 where both pathways converge. Cleavage of BID by caspase-8 
demonstrates the interplay between the two pathways [91, 92]. Other released factors are 
AIF and EndoG, which are translocated to the nucleus to cleave DNA, and Smac/DIABLO and 
HtrA2/Omi which can mediate apoptosis by inhibiting IAP proteins. IAP, inhibitor of 
apoptosis; tBID, truncated BID; AIF, apoptosis-inducing factor; EndoG, endonucleaseG; 
Apaf-1, apoptosis protease-activating factor; SMAC, second mitochondria-derived activator 
of caspase; DIABLO, direct IAP-binding protein with low pI; Cyt.c, cytochrome c; HtrA2, high 
temperature requirement serine protease; BCL2-2; B-cell lympfoma 2. 
 
The intrinsic apoptotic pathway is mediated by the mitochondria. 
Mitochondria are activated by different stimuli, both extra- and intracellular, 
such as DNA damage, oxidative stress or radiation [93, 94]. Triggering the 
mitochondrial pathway releases several pro-apoptotic proteins, such as 
cytochrome c, Smac/DIABLO (second mitochondria-derived activator of 
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caspase/direct IAP-binding protein with low pI) and HtrA2/Omi (high 
temperature requirement serine protease), thereby activating the caspase 
cascade [92, 95, 96]. Once released from the mitochondria, cytochrome c 
will initiate the formation of a protein complex, named the apoptosome [97, 
98]. This complex is formed by the recruitment of several Apaf-1 proteins 
(apoptosis protease-activating factor) and procaspase-9 (Fig.3). Monomeric 
Apaf-1 contains an N-terminal caspase recruitment domain (CARD) which 
will be displaced by binding to cytochrome c. Following cytochrome c 
binding, monomeric Apaf-1 will assemble with six others Apaf-1 to generate 
a heptametrical wheel-shaped structure which will provide a platform to 
increase the local concentration of procaspase-9. Through this 
displacement, the CARD domain is now freely available to recruit several 
inactive procaspase-9 proteins [99-101]. By recruiting several pro-caspases, 
different catalytic domains are brought in close proximity inducing 
dimerisation and hence activation of the caspases [102-104]. Procaspase-9 
has a long prodomain which facilitates the selective recruitment by the 
Apaf-1 adaptor molecules [105]. Once recruited, activation of procaspase-9 
will initiate the caspase cascade. Caspase-9 will cleave other effector 
caspases as long as it is bound to the apoptosome. Due to the length of the 
activation loop of caspase-9, the region between the large and the small 
subunits is much longer compared to other caspases, autocatalytic cleavage 
is not necessary. This linker is free to move and can access the active site of 
the effector caspases without cleavage. Autocatalytic cleavage is not 
essential for their function and would release caspase-9 from the 
apoptosome, and thereby its capacity to activate procaspase-3 [103, 106-
108]. Due to the autocatalytic cleavage within the apoptosome, the initial 
intracellular concentration of procaspase-9 and the rate of this dissociation 
event will eventually determine the duration of the apoptosome activity 
[107, 109]. This branch of the mitochondria-related pathway is called the 
caspase-dependent pathway (Fig. 3).  
 
 
The caspase-independent pathway is mediated by either EndoG 
(endonuclease G) or AIF (apoptosis-inducing factor), two factors which are 
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also released from the mitochondria upon apoptotic stimuli [110-112]. Once 
released from the mitochondria, they are translocated to the nucleus which 
results in DNA fragmentation, one of the typical apoptotic hallmarks (Fig. 3).  
This intrinsic apoptotic pathway can be regulated by two major proteins 
families: the BCL2 (B-cell lympfoma) and the IAP (inhibitor of apoptosis) 
family. The IAPs inhibit the caspase-dependent pathway and contain one to 
three BIR domains (baculovirus IAP repeat) by which they bind and inhibit 
the caspases [113, 114]. Eight distinct IAPs have been characterised in 
metazoan and most of them can inhibit the proteolytic activity of caspases 
either directly or indirectly by ubiquitination. Some of them reside in the 
cytosol, nucleus or are released from the mitochondria to the cytosol upon 
apoptotic induction [115-117]. Upon induction of apoptosis, the IAPs can be 
inhibited in turn by Smac/DIABLO or Omi/HtrA2, which are both released by 
the mitochondria together with cytochrome c [118-121] (Fig. 3).  
The other major group of proteins mediating the intrinsic pathway is the 
BCL2 family which can be divided in three main groups: the pro-apoptotic 
proteins, the anti-apoptotic proteins and the pro-apoptotic mediators, also 
called the BH3-only proteins [122, 123]. They all share up to four BCL2 
homology (BH) domains of which the BH3-domain is the most crucial one 
[123]. The final stoichiometry of the pro- and anti-BCL2 proteins will 
eventually determine whether the apoptotic pathway will be activated 
[124]. Once the delicate balance is shifted towards apoptosis, some of the 
BCL2 proteins will translocate to the mitochondria and induce the release of 
several apoptotic factors (Fig. 3).  
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1.2.2.2 Yeast 
Similar to metazoan, different forms of PCD exist in unicellular organisms, 
although often in a simplified version. In yeast for example, only the intrinsic 
apoptotic pathway is present contrasting the higher eukaryotes where both 
an extrinsic and an intrinsic pathway exist (Fig. 4).  
 
Comparison of the intrinsic, mitochondrial apoptotic pathways of yeast and 
metazoan reveals a high degree of similarity. Besides the presence of the 
typical apoptotic hallmarks, such as phosphatidylserine externalisation, DNA 
fragmentation, ROS production and chromatin condensation, several 
important apoptotic regulators have been identified [125, 126]. The 
identification of yeast homologues of the apoptosis-inducing factor 
(AIF/Aif1) [127], the endonuclease G (EndoG/Nuc1) [128], HTRA2-like serine 
protease (HtrA2 or OMI/Nma111) [129, 130] and cytochrome c [131, 132], 
further demonstrates the resemblances between yeast and higher 
eukaryotes (Fig. 4). These factors are, with the exception of Nma111, 
released from the mitochondria to the cytosol upon induction of apoptosis 
and play a role in cell death in yeast. When released from the mitochondria, 
Nuc1 and Aif1 are, similar to metazoan, translocated to the nucleus where 
they function as nuclear mediators of cell death and cleave DNA, resembling 
the caspase-independent pathway [127-130].  
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Fig. 4: Yeast apoptotic pathway. Release of several apoptotic factors, indicated by red 
circles, can be mediated by either exo- or endogenous triggers. Pro-apoptotic Ybh3p 
translocates to the mitochondria upon apoptosis induction. Release of Aif1 and Nuc1 
induces DNA fragmentation preceded by their nuclear translocation. Meanwhile, the yeast 
caspase Yca1 (Mca) is activated by cleavage. Bir1p belongs to the IAP family and can reduce 
apoptosis by Mca inhibition or can be inhibited by HtrA2/Nma111. Aif1, apoptosis-inducing 
factor; Nuc1, endonucleaseG; Cyt.c, cytochrome c; Mca, metacaspase (yeast caspase); Bir, 
baculovirus IAP repeats; Ybh3p, yeast BH3-only protein; Nma111, nuclear mediator of 
apoptosis. 
 
 
Release of cytochrome c and cleavage of caspases are two hallmarks of the 
apoptotic pathway in higher eukaryotes. Although there is no indication that 
the apoptosome protein complex does exist in yeast, release of cytochrome 
c upon induction of cell death has been demonstrated [131, 132]. 
Additionally, caspase activity has also been reported in yeast cells which 
24 
 
express a metacaspase, known as Yca1/Mca. Yca1 and the other caspases 
have slightly different cleavage capacities [133], but common substrates 
have been identified like GAPDH [134, 135].  
As mentioned before, two protein families, BCL2 and IAPs, are known to 
regulate this apoptotic branch in metazoan. Although these families have a 
much more elaborated role in metazoan, two proteins have been identified 
in yeast to mediate apoptosis, Bir1p and Ybh3p (Fig. 4) [136, 137]. Bir1p, a 
homologue of the IAP family, is a cytosolic and nuclear protein mediating 
the sensitivity of yeast cells to apoptosis. Overexpression of Bir1p in yeast 
prolongs lifespan and reduces apoptotic-like cell death. Similar to metazoan, 
the IAP protein can be inhibited by Htra2/Nma111, which is located in the 
nucleus instead of the mitochondria [129, 136].  
Ybh3p is a homologue of the BCL2 family and only recently identified. Ybh3p 
shows several resemblances with the human equivalents, such as BAX. 
Ybh3p can interact with BCL-xL and is translocated to the mitochondria upon 
lethal stimuli mediating apoptosis (Fig. 4). Deletion of Ybh3p prolongs 
lifespan and displays reduced sensitivity towards apoptosis [137].  
 
Despite the much more sophisticated and large protein family regulating 
apoptosis in metazoan, the basic features are conserved between yeast and 
the higher eukaryotes. The absence of an extensive BCL2 family in yeast, 
does not necessarily implicate the absence of the whole pathway. 
Numerous examples exist which demonstrate that the human BCL2 family 
acts on conserved mitochondrial substrates in yeast corresponding directly 
to their homologues in human cell lines. Transformation of BAX for example, 
induced release of cytochrome c, ROS production and phosphatidylserine 
externalisation in yeast, suggesting the existence of similar pathways [125]. 
 
Whether a cell dies by apoptosis, necroptosis or autophagy depends on a 
variety of factors, such as cell type or the duration of stimuli. Another 
decisive factor is the level of cellular ATP [138, 139]. High levels of ATP will 
enable an apoptotic form of cell death, whereas low levels will stimulate 
cells to undergo necroptosis. Changes in the cellular ATP level will switch the 
cell death mode. Because the mitochondria are the main site of ATP 
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production, they will play a crucial role in the decision of the type of cell 
death. Besides the level of ATP, a variety of other factors will determine the 
cell death mode and a complex relationship exists between necroptosis, 
apoptosis and autophagy. Crosstalk between either of those different forms 
has been described and they can cooperate, antagonise or assist each other 
[70, 140, 141].  
In yeast, the different modes of cell death are also highly interconnected 
and a regulated switch in cell death mode from apoptosis to necrosis has 
been described mediated by autophagy. This switch depends on various 
factors, and one determining factor is a concentration dependent shift, as 
described for acetic acid, H2O2 and pheromones. Where low doses trigger 
apoptosis, higher concentrations rather induce necrosis [50, 79, 125, 142]. 
The nature of nutrient deficiency can also determine the type of cell death 
which is additionally associated to the autophagic processes. During nutrient 
starvation, deletion of specific autophagic genes, such as ATG8 or ATG11 
determines whether yeast is more susceptible to respectively necrosis or 
apoptosis [143].  
 
Due to the complex crosstalk between the different cell death modes both 
in yeast and metazoan, it is very difficult to assign a single type of cell death 
to a certain cell death stimulus, such as DFNA5. Because mitochondria are 
central organelles important during different cell death processes, several 
aspects of the mitochondria will be highlighted with the emphasis on their 
role in cell death. Mitochondrial proteins which are released during cell 
death, their dynamics and morphology, and the mitochondrial 
permeabilisation complex essential for the execution of apoptosis, will be 
described in this chapter. As yeast was used in this thesis to study the 
DFNA5-related apoptotic pathway, a comparison is made between 
metazoan and yeast. 
1.3 The central role of mitochondria in cell death 
Mitochondria are the main producers of cellular ATP and this is mediated by 
oxidative phosphorylation. They serve as docking sites for different proteins 
thereby integrating several cellular responses [91, 131, 144-146]. Due to this 
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cooperation, mitochondria are central players in the decision of cell’s fate 
for either survival or cell death. It is therefore essential to maintain intact 
mitochondria as disintegration would have a detrimental effect on the 
cellular energy supply.  
Due to their role as energy power houses in the cell, mitochondria have long 
been considered to be closely related to cell survival. The determination of 
the mitochondrial localisation of many apoptosis-related proteins led to the 
discovery that the mitochondria are not only involved in cell survival but 
also associated with cell death [145-147]. Since then, a lot of research has 
been performed on different mitochondrial aspects related to cell death. 
Especially during apoptosis, the internal apoptotic pathway in particular, 
mitochondria are essential modulators for the proper execution of cell 
death. Several features of the mitochondria, such as the mitochondrial 
dynamics and the mitochondrial permeabilisation process, play a key role in 
programmed cell death [132, 148-151].  
This part of the introduction will first focus on the mitochondrial 
morphology, determined by mitochondrial fusion and fission, and the 
mitochondrial permeabilisation process. Mitochondrial dynamics mediate 
adaptation under various conditions regulating the energy production, 
which is essential for proper mitochondrial functionality. The 
permeabilisation of the mitochondria will release several apoptotic factors 
essential during cell death. It is crucial to keep both processes in balance as 
deregulation of either of them will have detrimental effects on cellular 
health.  
1.3.1 Mitochondrial dynamics: Fission and Fusion 
Mitochondria are very dynamic organelles continually fusing, dividing and 
moving within cells using a microtubule and/or microfilament platform. 
They can either form a long, dynamic interconnected network or distinct 
spherical organelles [152, 153]. Balancing this dynamic behaviour is crucial 
to maintain functional mitochondria and is closely related to cell death [154, 
155]. The heterogeneous morphology of mitochondria depends on various 
conditions, such as their metabolic conditions, the energy status of the cell 
or the cell cycle stage. The major components contributing to mitochondrial 
fusion and fission have been evolutionary conserved between yeast and 
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higher eukaryotes. Although the core machinery of this mechanism might be 
conserved, their regulation is far more sophisticated and different as novel 
regulators have been identified in mammals [156, 157]. Due to this 
conservation, yeast was one of the most important models where the key 
players of this dynamic process were characterised.  
The biological objective behind this dynamics is the same for yeast as for any 
other organism. The main purpose is to maintain mitochondrial quality by 
distributing and removing damaged mitochondrial components providing a 
defence mechanism [158]. Mitochondrial dynamics and cell death are 
strongly connected and reveal the state of health of the population [159]. 
Enhanced fusion for example, is related to metabolic active cells mediating 
efficient energy transfer in the cell [160, 161]. Fission on the contrary, 
contributes to mitophagy and plays a role during cytokinesis and apoptosis 
[10, 162-165].  
1.3.1.1 Fission machinery 
The core machinery of fission contains two proteins: a dynamin-related 
protein (DRP1) and the (human) fission protein (hFIS1). Upon induction of 
apoptosis, DRP1 is recruited to the outer mitochondrial membrane (OMM) 
by hFIS1 which functions as a membrane receptor for DRP1 (Fig. 5) [166-
170]. It has been shown that DRP1 can self-assemble into large multimeric 
ring-like structures in vitro, probably reflecting the constriction and fission of 
the mitochondrial membrane in vivo (shown at the bottom of Fig. 5) [167, 
169-171]. 
 
In yeast, fission of the mitochondrial outer membrane is mediated by two 
additional proteins with no functional or structural homologues in 
multicellular eukaryotes, namely Mdv1 (Mitochondrial division) and Caf4 
(CCR4-associated factor). They function as adaptor proteins mediating the 
recruitment of Dnm1 (the yeast homologue of DRP1) by Fis1 (the yeast 
homologue of hFIS1) (Fig. 5) [172-175]. Dnm1 and Fis1 share high functional 
similarity with their human equivalents as they both depend on GTP for 
energy supply during fission. Dnm1 is also able to form spirals around the 
mitochondria mediating their constriction and eventually scission upon GTP 
hydrolysis (shown at the bottom of Fig. 5) [171, 176]. Mdv1 and Caf4 are 
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cytosolic proteins associated with the OMM sharing structural similarity. In 
the presence of both Fis1 and Dnm1, they form a punctuate structure at the 
membrane mediating fission. Cooperation between Fis1, Dnm1 and Mdv1 or 
Caf4 is essential in order to drive correct mitochondrial fission, although 
Caf4 is dispensable for this process [172, 177]. 
  
 
Fig. 5: Comparison of the fission core machinery in yeast and human. ‘?’ indicates 
currently unknown regulators or processes related to fission. Once DRP1/Dnm1 is recruited 
to the mitochondrial outer membrane, DRP1/Dnm1 (red dots) will self-assemble into large 
multimeric ring-like structures, as shown below, mediating fission. OMM, outer 
mitochondrial membrane; IMM, inner mitochondrial membrane; Mdm30/36, mitochondrial 
distribution and morphology; Mdv1, mitochondrial division; MFF, mitochondrial fission 
factor; MIEF, mitochondrial elongation factor 1; Caf4, CCR4-associated factor; hFIS/Fis1, 
human fission protein; Num1p, nuclear migration protein; DRP1/Dnm1, dynamin-related 
protein; MTP18, mitochondrial protein. 
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Many studies have shown a correlation between apoptosis and 
mitochondrial dynamics. Mitochondrial fragmentation is a common 
hallmark of apoptosis, although it is not always present and does not 
necessary lead to apoptosis. Down-regulation of DRP1 by either siRNA or a 
selective inhibitor mdivi-1, inhibits mitochondrial fragmentation and inhibits 
cytochrome c release [150, 178]. Down-regulation of hFIS1 induces 
mitochondrial fusion and produces increased resistance to apoptosis. 
Furthermore, hFIS1-related apoptosis was characterised by release of 
cytochrome c and BAX recruitment [150, 179]. Also in yeast, a mutual 
relation exists between lifespan and the dynamics of the mitochondria. 
Dysfunctional mitochondria can lead to decreased lifespan, whereas 
elongated mitochondria enhance longevity [180, 181]. The same outcome as 
in mammalian cell lines was seen upon deletion of several yeast fusion and 
fission genes. Deletion of either Dnm1 or Mdv1, two fission genes, increased 
resistance to apoptotic stimuli, such as acetic acid. Deletion of Fis1 however, 
reduced viability in yeast cells and it was suggested that during cell death 
Fis1 inhibits the Dnm1-mediated fragmentation [149]. Furthermore, down-
regulation of several fission proteins, such as Mdv1, Fis1 and Caf4, was seen 
upon calorie restriction, a mechanism known to prolong lifespan in yeast 
[182]. 
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1.3.1.2 Fusion machinery 
In mammalian cell lines, mitochondrial fusion is mediated by three large 
GTPases, Mitofusin 1 and 2 (MFN1/2), and Optic Atrophy 1 (OPA1) (Fig. 6) 
[183, 184]. Two outer and two inner membranes of adjacent mitochondria 
need to be tethered to achieve mitochondrial fusion. Alternative splicing of 
OPA1 generates transcripts of different length necessary to mediate 
efficient mitochondrial fusion of the inner membrane [185-187]. MFN1 and 
MFN2 mediate mitochondrial outer membrane fusion, although they have a 
slightly different function. Only MFN1 is essential for the initiation of 
membrane tethering [183, 188, 189], while MFN2 acts more downstream of 
the initial process [190]. MFN2 has a broader spectrum of functions, one of 
them is related to the tethering of the ER to the mitochondria [190]. 
Recently a novel mitofusin-binding protein (MIB) was identified, which 
interacts with MFN1, thereby negatively regulating its function (Fig. 6) [191].  
 
The core machinery for fusion in yeast exists of three proteins: Mgm1 (the 
yeast homologue of OPA1), Fzo1 (the yeast homologue of MFN1/2) and 
Ugo1 (Fig. 6) [192-194]. The function and localisation of these proteins are 
similar in yeast and human. Mgm1 plays a key role in the inner 
mitochondrial membrane (IMM) fusion. In contrast to OPA1, Mgm1 has only 
two splice isoforms, a short isoform present in the intermembrane space 
and a longer form located at the IMM. Fzo1, located in the OMM, is 
responsible for the formation of transcomplexes enabling tethering of 
adjacent mitochondria [193, 195]. Ugo1 is the third component of the yeast 
fission machinery and does not have a homologue in higher organisms. 
Ugo1 binds directly to Fzo1, by its cytosolic part, and to Mgm1, via its 
intermembrane domain, creating a bridge coordinating efficient fusion (Fig. 
6) [192, 196]. 
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Fig. 6: Comparison of the fusion core machinery in yeast and human. Interaction of 
Fzo1/MFN1 of adjacent mitochondria leads to fusion of the OMM of opposing 
mitochondria. Fusion of the IMM is mediated by Mgm1/OPA. Ups1p, Pcp1p, AFG3L1, OMA 
and YME1L are regulators of Mgm1/OPA cleavage. OMM, outer mitochondrial membrane; 
IMM, inner mitochondrial membrane; Fzo1, fuzzy onion 1; OPA1, optic atrophy 1; Pcp1p, 
processing of cytochrome c peroxidase; MFN1/2, mitofusin 1 and 2; Mgm1, mitochondrial 
genome maintenance; MIB, mitofusin-binding protein; Mdm30, mitochondrial distribution 
and morphology; Ugo1, means fusion in Japanese; Ups1, unprocessed; OMA1/MPRP-1, 
metalloprotease-related protein-1; YME1L, yeast mitochondrial escape; AFG3L1, ATPase 
family gene-3 yeast-like-1. 
 
 
The association between mitochondrial fusion and cell apoptosis has also 
been extensively described. Overexpression of one of the fusion proteins, 
MFN1 or MFN2, reduced the sensitivity to apoptosis by inhibiting 
cytochrome c release, whereas silencing enhanced the sensitivity to 
apoptotic triggers [197, 198]. A direct link between fusion and apoptosis was 
also shown for OPA1. Loss of OPA1 or mutations in functional domains of 
OPA1 both induced apoptotic cell death, whereas OPA1 expression 
protected cells from apoptosis [199, 200]. Overall, the balance between 
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fusion and fission is shifted during apoptosis, resulting in either excessive 
fission or insufficient fusion. 
Besides modulating mitochondrial fragmentation, OPA1 also mediates 
cristae remodelling in the IMM enabling cytochrome c release [201, 202]. 
Under normal circumstances, OPA1 stabilises the cristae junctions by 
wrapping OPA1 oligomers around the junctions. Disruption of OPA1, by tBID 
or PARL (Presenilin-associated rhomboid-like) cleavage, mediates fusion of 
the cristae and opens these junctions, releasing cytochrome c [200, 201, 
203].  
 
1.3.1.3 Regulation of mitochondrial dynamics: yeast versus human 
Fission  
Although the two central components of fission are evolutionary conserved 
between yeast and human, the interaction partners assisting the core 
elements are functionally very different. Besides co-factors regulating the 
dynamics in vertebrates, post-translation modifications, including 
phosphorylation ubiquitination, phosphorylation and sumoylation, 
regulating either DRP1 or hFIS1, have been described. They can inhibit, 
activate or give regulatory feedback controlling mitochondrial fission [166, 
204-206]. 
 
Additionally, multiple receptors have been identified regulating the 
recruitment of DRP1 to the mitochondria. Besides hFIS1, a mitochondrial 
elongation factor 1 (MIEF1) [207, 208] and a fission factor 1 (MFF) [209], two 
proteins with no yeast homologue, regulate fission (Fig. 5). MIEF1 prevents 
fission by sequestering DRP1 inhibiting their binding to GTP. In contrast to 
MIEF1, the interaction of MFF1 with DRP1 stimulates mitochondrial fission. 
MFF1 mediates DRP1 recruitment to the mitochondria through interaction 
by its N-terminus. Nine isoforms of MFF1 have been identified, supporting 
the more complex regulation of fission in human compared to yeast [210-
213]. Besides these two main regulators, a variety of other smaller players 
could influence mammalian fission, including endophilin B1 [214], GDAP1 
(ganglioside-induced differentiation-associated protein 1) [215] and 
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DDP/TIMM8a [216]. In order to achieve correct mitochondrial fission, 
coordination between the IMM and the OMM is needed. Two co-factors 
mediating this interplay have been proposed, namely MTP18 (mitochondrial 
protein) [217, 218] and MTGM (mitochondrial targeting GxxxG motif 
protein) [219] located in respectively the intermitochondrial space and at 
the IMM (Fig. 5). Reduction of either MTP18 or MTGM expression resulted 
in a highly interconnected mitochondrial network. Although a yeast 
homologue of MTGM has been identified, namely Mgr2 (mitochondrial 
genome required 2), its contribution to the mitochondrial dynamics in yeast 
is unknown [220].  
 
For yeast, no post-translational modifications have been identified to 
influence fission, but a genome-wide screen on yeast deletion mutants did 
reveal three proteins to be involved in the regulation of mitochondrial 
fission. Although not essential for fission in yeast, Num1p interacts with 
Dnm1 stabilizing or recruiting Dnm1 to the mitochondria (Fig. 5) [221]. 
Mdm36p (mitochondrial distribution and morphology) is an extra factor 
contributing to this complex as this interaction is abolished in yeast cells 
lacking Mdm36p (Fig. 5) [222]. Inner membrane fission is regulated by 
Mdm33p, an integral mitochondrial inner membrane protein (Fig. 5). 
Deletion of Mdm33p led to the formation of interconnected mitochondria, 
whereas overexpression led to the aggregation of mitochondria [223].  
Fusion  
Similar to fission, differences regarding the regulation of the fusion process 
do exist. Regulators of the human mitochondrial dynamics can either 
mediate the processing of OPA1 or MFN1/2 degradation. Various proteases 
have been characterised to enable OPA1 cleavage, either residing in the 
inner membrane (OMA1/MPRP1) [224, 225], the matrix (AFG3L1 and 
AFG3L2) or the intermitochondrial space (YME1L) (Fig. 6) [186, 187, 226]. 
Although some of them do have yeast homologues, such as Oma1p and 
Yme1p, their contribution to the processing of yeast Mgm1p is largely 
unknown [227, 228] (Fig. 6). The activity of MFN1/2 is regulated by a variety 
of different proteins that mediate their degradation. Some proteins know to 
be involved are stomatin like protein-2 (Stoml2), mitochondria-associated 
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phospholipase D (mitoPLD), Mfn-binding protein (MIB) (Fig. 6) and many 
others, although their exact role in mediating fusion remains obscure [191, 
229, 230].  
 
In yeast, three major regulators of fusion have been identified mediating 
either Fzo1 or Mgm1 similar to the mammalian regulation. Mdm30p, of 
which no homologue has been identified in mammals, helps to maintain 
fusion competent yeast cells by regulating the Fzo1 level (Fig. 6) [231]. It is 
part of an ubiquitination and degradation complex which controls the 
turnover of Fzo1 after GTP hydrolysis. Two others mediate the processing of 
Mgm1. Pcp1p, located at the IMM, generates the short isoform of Mgm1 
and Ups1p mediates this Pcp1p-dependent cleavage of Mgm1 (Fig. 6) [232, 
233]. Both proteins are essential for maintenance of the mitochondrial 
morphology and have functional equivalents in mammals being respectively 
PARL and PREL1, although PARL seems to have only a minor role in the 
human fusion process in contrast to Pcp1p [203] (Fig. 6). 
 
Conclusion 
This pool of regulators reflects the complexity of mitochondrial dynamics. 
Although comparison of the core machinery of mitochondrial dynamics 
points to the conservation of this fundamental process, it is not unexpected 
that the fine-tuning has diverged over time. As mitochondrial dynamics have 
a major impact on numerous cellular processes, more sophisticated 
machinery is required in certain specialised cell types and this needed some 
adaptation in higher eukaryotes. Although most of the players have a 
homologue (Dnm1/DRP1, Fis1/hFIS1, Fzo1p/MFNs and Mgm1p/OPA1), the 
amino acid sequence revealed some major differences implying functional 
diversity. Not all homologues are functionally interchangeable; some require 
certain co-factors which are not conserved, such as Caf4, Mdv1 or MFF1, 
which further increases the complexity of the mitochondrial dynamics. The 
preservation of the fundamental elements however, supports the value of 
yeast to reveal the essential components of cellular processes.  
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1.3.2 Mitochondrial permeability transition 
One of the hallmarks of apoptotic cell death is the permeabilisation of the 
mitochondria, a highly complex and tightly regulated mechanism. Several 
models have been proposed but there is no consensus and the exact 
mechanism still needs to be clarified. Permeabilisation is a critical event 
during apoptosis, mediating the release of several mitochondrial apoptotic 
proteins crucial for the execution of apoptosis [234, 235].  
Mitochondria consist of two compartments: the matrix, enclosed by the 
IMM, and the intermitochondrial space enclosed by the OMM. Both the 
IMM and OMM show signs of permeabilisation during apoptosis due to the 
formation of a scaffold structure at the contact sides of both membranes, 
called the permeability transition pore complex (PTPC) [236]. The PTPC is a 
large, high conductance protein complex comprising two main components, 
the voltage-dependent anion channel (VDAC) located at the OMM, and the 
adenine nucleotide translocase (ANT) present at the IMM, with the addition 
of smaller modulators, such as cyclophilin-D (CypD) and hexokinase (HK) 
(Fig. 7) [235, 237-239]. 
Several models have been proposed to explain the mitochondrial 
permeabilisation. Some concern the PTPC, others consider the rupture of 
OMM due to the increase of the IMM permeability and yet some even 
declare the existence of an unknown channel formed by aggregation of 
membrane proteins. Until now, there is no consensus and recently the F1-F0 
ATP synthase is even suggested to be a main player [240, 241]. A key event, 
where most of the investigators seem to agree on, is that mitochondrial 
permeabilisation is stimulated by an elevated Ca2+ concentration leading to 
several physiological cellular modifications [242-244]. The mitochondrial 
permeabilisation is characterised by mitochondrial swelling, loss of the 
mitochondrial membrane potential (∆Ψ), increased permeability of the IMM 
with a cut-off of 1500 kDa and the release of several apoptotic factors. The 
following part will describe the components known to be related to 
mitochondrial permeabilisation, their regulators, recent advances and the 
conflicting results.  
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Fig. 7: Comparison of the mitochondrial membrane permeabilisation process in yeast and 
human. Several protein complexes, present at both the OMM and the IMM, are responsible 
for the permeability process. This can be mediated by several components, such as ROS, 
ADP, Mg
2+
 and Ca
2+
. VDAC/Por, voltage-dependent anion channel; ANT/Aac, adenine-
nucleotide translocase; CypD/Cpr, cyclophilin-D; Pi, phosphate; CsA, cyclosporine A; OMM, 
outer mitochondrial membrane; IMM, inner mitochondrial membrane; ROS, reactive 
oxygen species; HK, hexokinase. Apoptotic factors are indicated by red circles. 
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1.3.2.1 Metazoan 
Mitochondrial outer membrane permeabilisation (MOMP) leads to the 
release of several apoptotic factors stimulating cell death. The VDAC is a 
mitochondrial membrane protein, present at the OMM, responsible for an 
efficient exchange of metabolites between the mitochondria and the cytosol 
(Fig. 7) [245-247]. The role of VDAC in the permeabilisation of the 
mitochondria, has been established by several studies. Whereas silencing of 
the VDAC channel resulted in reduced cytochrome c release from the 
mitochondria and inhibition of caspase-3 activation [248], overexpression of 
VDAC was associated with Δψ collapse [249].  
The opening of the VDAC channel, formed by oligomerisation of the 
transmembrane protein [250], is regulated either directly or indirectly by 
various components such as HK [251], Ca2+ [252] and BCL2 family proteins 
(Fig. 7) [147, 253]. Binding of HK-I and HK-II to VDAC, both catalysts of the 
glycolysis, results in closure of the VDAC channel. HK interaction would 
prevent the formation of the VDAC-BAX complex and hence protects the cell 
from mitochondrial apoptotic cell death [251, 254].  
 
Permeabilisation of the mitochondria during cell death is characterised by 
the collapse of the ∆Ψ, which is maintained over the IMM. The electron 
transport chain complex in the IMM transfers protons from the IMM to the 
intermitochondrial space, resulting in the proton gradient used for oxidative 
phosphorylation. Dissipation of this potential is a result of the sudden 
increase in the permeability of the IMM to small ions and water, known as 
mitochondrial permeability transition (MPT) [255, 256]. ANTs are considered 
to be important for this permeabilisation over the IMM as they transport 
metabolites across the IMM and contribute to the exchange of ATP for ADP 
(Fig. 7). ANT proteins are transmembrane proteins capable of forming 
channels [236, 257, 258] (Fig. 7). The role of ANT in apoptosis was supported 
by the finding that binding of ANT inhibitors, such as bongkrekic acid, 
mediated the induction of apoptosis [259].  
Despite the evidence for both protein complexes in mitochondrial 
permeabilisation [236, 239, 260, 261], the necessity of these complexes has 
been controversial as they seem to be dispensable for mitochondrial 
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transition. Deletion of two ANT isoforms in mice for example, still resulted in 
mitochondrial permeabilisation, despite an increased resistance to cell 
death [262]. Similar to ANT, VDAC null mice displayed no differences in 
cytochrome c release and caspase cleavage compared to wild-type mice 
[263, 264]. It is clear that both complexes do play a role in the mitochondrial 
permeabilisation. Their necessity for efficient transition however, is still a 
matter of debate and is uncertain at this moment. In addition to VDAC and 
ANT, another player of the mitochondrial permeabilisation complex, CypD, 
has been accepted as an important regulator in pore opening. 
Role of Cyclophilin-D 
CypD belongs to the cyclophilin family and is, besides its role in cell death, 
crucial for protein folding [265]. The recognition of CypD as a key regulator 
of mitochondrial transition was determined by binding of cyclosporine A 
(CsA), a specific inhibitor of the cyclophilin family, which inhibited pore 
opening (Fig. 7) [266]. CypD resides in the matrix and binds to the IMM 
during mitochondrial transition. It has been shown that CypD can interact 
with either ANT or VDAC [267]. Similar to VDAC and ANT, there is some 
controversy about the role of CypD in MPT. Although no MPT was noted in a 
CypD knock-out mouse model stimulated by Ca2+, it has been reported that 
even without CypD there is still some level of mitochondrial transition 
provided that a higher Ca2+ concentration is used to stimulate such as 
permeabilisation [268-270]. Although the exact role remains to be clarified, 
it is certain that CypD at least sensitises pore permeabilisation for Ca2+-
induced MPT. 
1.3.2.2 Yeast 
Besides the mammalian mitochondrial transition pore, several 
mitochondrial pores have been identified in other eukaryotes including 
yeast. The physiological role and the regulation of these channels are still a 
matter of debate and conflicting results were reported [271, 272]. Despite 
the discrepancies, several studies have shown that the yeast mitochondrial 
transition pore (yPTP) is indeed related to the mammalian permeability 
transition pore (mPTP). Yeast displays several characteristics that suggest 
the existence of an yPTP. Isolated mitochondria show signs of mitochondrial 
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swelling, similar to mammalian mitochondria, and the release of solutes was 
demonstrated [272, 273]. Additionally, the release of cytochrome c was 
observed in response to a variety of cell death triggers, such as H2O2, acetic 
acid and BAX [131, 132, 271]. 
Analogous to human mitochondrial permeabilisation, similar protein 
complexes have been identified in yeast. Shimizu et al. demonstrated the 
role of the yeast homologue of VDAC, Porin (Por), in MPT as VDAC deficient 
yeast strains were resistant to cytochrome c release stimulated by BAX (Fig. 
7) [253]. Since the unravelling of the Por sequence in yeast [274], several 
researchers already investigated the structural and functional homology 
between Por and VDAC. Despite the low degree of conservation of the 
primary sequence, the yeast and human VDAC show clear structural and 
functional similarities illustrated by comparable gating properties such as, 
the conductance of the pore and the pore size [273, 275, 276]. Additionally, 
the Aac proteins, the yeast homologues of the ANT genes, appear to be 
essential for the release cytochrome c, in yeast (Fig. 7) [128, 132].  
 
Despite the conservation of the main players, some differences between the 
yPTP and mPTP were also observed. The main difference is the sensitivity of 
the pore to CsA. As mentioned before, CsA is an inhibitor of the mPTP by 
interaction with CypD [266, 277]. Although a yeast homologue of CypD does 
exist, Crp1, there is no apparent relationship to the yPTP [267, 272]. 
Recently however, it was discovered that not CsA, but inorganic phosphate 
(Pi) is the actual pore inhibitor and that binding of CsA to CypD unmasks an 
inhibitory site to Pi. CsA has been shown to indeed inhibit PT but only in the 
presence of Pi, suggesting that Pi and not CsA is the actual inhibitor [278, 
279]. It should be noted that even in the presence of CsA, pore opening is 
still possible although higher concentrations of Ca2+ are needed. As such, 
CsA is not a true blocker but rather desensitise pore opening. As yPTP is 
indeed sensitive for Pi, this could explain the interspecies discrepancy seen 
between mPTP and yPTP [272, 280]. Based on these observations, Pi could 
be the common feature of PT in all organisms (Fig. 7). The role of Pi in PT 
regulation is however not certain as independence of CsA on Pi has been 
described recently [281, 282].  
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As already mentioned above, a feature of pore opening where most of the 
researchers seem to agree on is the susceptibility to Ca2+ concentration 
[242-244]. Elevated Ca2+ concentration stimulates pore opening, which is 
the second unifying feature between yPTP and mPTP. Although contrasting 
results in yeast do exist and yeast cells lack a mitochondrial Ca2+ uniporter 
necessary for rapid Ca2+ uptake, yPTP can be induced by Ca2+ on condition of 
low Pi concentration [242, 272]. A last important common feature is the 
recent elucidated role of the ATP synthase in PTP. Recently, it was shown 
that the F0-F1 ATP synthase is able to form channel-like dimers in lipid 
bilayers (Fig. 7) [240]. This ATP synthase dimer has properties matching 
those of PTP, being Ca2+-sensitive, and has similar channel conductances. 
Additionally, it was found that CypD binds to the F0-F1 ATP synthase hereby 
stimulating pore opening. That F0-F1 ATP synthase dimer is the actual pore, is 
further supported by a specific inducer of dimerisation, Bz-423. Bz-423 
shares the same binding site as CypD and can trigger the channel activity of 
this ATP synthase [240]. Additionally, the channel forming capacity of the 
ATP synthase has also been demonstrated in yeast, resembling features of 
the mammalian ATP synthase dimers being activated by Ca2+ and inhibited 
by Mg2+ and ADP (Fig.6) [241]. 
1.3.2.3 Regulation of mitochondrial permeabilisation 
Despite the conservation of different components involved in mitochondrial 
permeabilisation, some discrepancies regarding the regulation do exist. One 
of the main differences between yeast and higher eukaryotes is the 
presence of the BCL2 family. These are one of the most important regulators 
regarding mitochondrial cell death, but seem to be completely absent in 
yeast. Only recently one yeast homologue of this family, namely the yeast 
BH3-only protein, Ybh3p, has been identified [137]. 
 
In higher eukaryotes, the BCL2 family protein, is far more sophisticated and 
can be divided in three main groups as mentioned previously. Although the 
main function of the BH3-only proteins is to modulate both the pro- and the 
anti-BCL2 proteins, they can also interact with either VDAC or ANT 
mitochondrial proteins thereby mediating the release of several 
mitochondrial components (Fig.6) [123, 283]. 
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Evidence exists that either anti- and pro-apoptotic BCL2 proteins can 
regulate the VDAC and the ANT channel conformation [147, 284, 285]. The 
pro-apoptotic BAX protein for example translocates from the cytosol to the 
mitochondria upon induction of apoptosis and binds to VDAC leading to the 
release of cytochrome c [147]. The anti-apoptotic BCL-xL however, reduces 
channel conductivity by binding to VDAC [286-288]. Similarly to the VDAC, 
ANT can be regulated by either pro- and anti-apoptotic BCL2 proteins acting 
respectively as facilitators and inhibitors of channel formation [257, 284, 
285]. Although only one BCL2 member has been identified in yeast, Ybh3p 
shows several resemblances with the human equivalent BAX. Similar to BAX, 
Ybh3p translocates to the mitochondria upon induction of apoptosis [137]. 
Furthermore, Uth1p, a mitochondrial outer membrane protein, was needed 
for Ybh3p-mediated cell death, analogous to BAX-mediated cell death in 
yeast [289]. Additionally, it has been shown that Ybh3p can interact with 
BCL-xL thereby inhibiting its pro-apoptotic role and suppressing its lethal 
effects (Fig. 7) [137, 289, 290].  
 
The BCL2 proteins can also form channels independent of VDAC and ANT. 
Once present in the OMM, large homo- or hetero-oligomer complexes of 
BCL2 proteins will lead to channel formation and cytochrome c release [291, 
292]. This conformational change will generate different channel complexes, 
such as dimers, trimers or tetramers, all contributing to the mitochondrial 
permeabilisation (Fig. 7). Although their exact contribution still remains 
controversial, it was demonstrated that pro-apoptotic BCL2 proteins can 
form higher order oligomer membrane formations in vitro [293]. This 
indicates their capacity to form channels and hence contributes to the 
mitochondrial permeabilisation process and the release of apoptotic factors 
[294-297]. 
 
Despite the absence of an extensive BCL2 family in yeast, the pathways by 
which they exert their function seem to be conserved in yeast. This 
implicates that the human BCL2 family acts on conserved, mitochondrial 
substrates present in yeast, which will be shown by a few examples 
described hereafter. Transformation of BAX in yeast induced release of 
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cytochrome c, ROS production, phosphatidylserine externalisation, DNA 
fragmentation and chromatin condensation, suggesting the existence of 
conserved pathways [125, 298-301]. Similar to human cell lines, BAX was 
closely connected to the mitochondria, which was indeed essential for the 
BAX-induced toxicity in yeast. It was shown that in yeast, BAX has the 
capacity to form channels in the OMM and that either VDAC or Aac proteins 
are essential for the BAX-induced cell toxicity, although conflicting results 
exist [253, 257, 302, 303]. Many of these events can be suppressed by co-
expression of either BCL-xL or BCL2, confirming the conservation of its 
protective role upon cell death in yeast [301, 304]. Finally, it was 
demonstrated that, despite the lack of obvious homologues, some aspects 
of the BCL2 proteins seem to be present in other proteins. A good example 
hereof is Fis1, which was demonstrated to have BCL2-like anti-death activity 
[149]. During normal growth, Fis1 is required for mitochondrial 
fragmentation, but during cell death Fis1 protects cells from Dnm1-
mediated fragmentation and loss of functional mitochondria. In this study, 
Fis1 formed pores in lipid vesicles, similar to BCL-xL, and BCL-xL or BCL2 
could restore viability in Fis1-deficient yeast cells. Based on these data it is 
possible that Fis1 contains two functions, the protective role of BCL2 and a 
fission function of hFIS1 which are carried out by two different proteins in 
higher eukaryotes [149]. This further supports the existence of conserved 
pathways between yeast and higher eukaryotes. 
 
Until today, there is no consensus about mitochondrial permeabilisation and 
alternative models are suggested. One model suggests that BAX would only 
regulate pre-existing mitochondrial membrane channels, such as the PTPC 
as describe above. Another model for OMM permeabilisation is based on 
osmotic swelling due to a sudden increase in the IMM permeability. This 
permeabilisation drives water and small ions into the matrix, leading to 
swelling of the matrix and eventually to rupture of the OMM [305]. 
 
Despite the incomplete understanding of either the yPTP or the mPTP, the 
importance of mitochondrial permeabilisation in cell death has been 
demonstrated. The ability to specifically regulate pore opening in yeast, 
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supports the existence of yPTP. Although discrepancies between yPTP and 
mPTP in pore regulation do exist, the main players and the global 
mechanisms are conserved. Once the mitochondrial permeabilisation 
process is initiated, a variety of mitochondrial intermembrane proteins are 
released into the cytosol all contributing to the cell death process.  
1.3.2.4 Release of mitochondrial proteins upon permeabilisation 
One of the first proteins which is released upon activation of the 
mitochondrial pathway is cytochrome c, initially identified as APAF-2. The 
release of cytochrome c is considered as a point of no return in the 
apoptotic cascade [306, 307]. Cytochrome c resides in the cristae of the 
IMM and was first identified to play a role in the electron transport chain 
complex. Cytochrome c is bound by cardiolipin at the cristae of the IMM. 
Conformational changes in the cardiolipin-cytochrome c interaction and 
remodelling of the cristae are needed prior to its translocation [308]. 
Increase in H2O2 levels, cytosolic Ca
2+ and in ATP level can all modify the 
oxidation status of cardiolipin and will lead to the dissociation of 
cytochrome c from the IMM, a required step for the induction of apoptosis 
[309, 310]. Once mobilised, cytochrome c is translocated to the cytosol. 
 
As the release of cytochrome c is irreversible, this process is controlled at 
several levels. First, the remodelling of the cristae is regulated by different 
proteins that are involved in the mitochondrial morphology. OPA1, as 
mentioned before, is one of the fusion proteins and is known to regulate the 
width of the cristae and to sequester cytochrome c. Under normal 
circumstances, OPA1 stabilises and narrows these junctions by forming 
oligomers around them [200, 201, 311]. In addition to OPA1, DRP1 and 
MFN1/2 have also been linked to cristae remodelling, by respectively 
promoting and blocking cytochrome c release [312-314].  
 
Besides their role of the mitochondrial fusion and fission machinery, the 
BCL2 proteins, especially the pro-apoptotic and BH3-only proteins, also play 
a role in regulating cytochrome c release. As described above, certain BCL2 
proteins have pore-forming capacities, disrupting the OMM. Activated Bid 
(tBid), a BH3-only protein, is known to interact with cardiolipin. Binding of 
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tBid to cardiolipin followed by oligomerisation of BAX/BAK both contribute 
to the release of cytochrome c [315, 316]. Despite the contribution of 
numerous mitochondrial proteins in the release of cytochrome c, recent 
results suggest that cytochrome c can contribute to its own escape by 
inducing discrete pores in the OMM in the absence of other apoptotic 
factors due to the cardiolipin-cytochrome c interaction [317] (Fig. 3).  
In addition to cytochrome c, other mitochondrial proteins are released 
during mitochondrial permeabilisation, such as Smac/DIABLO, HtrA2/OMI, 
EndoG and AIF [92, 95, 96]. The two last are considered to induce apoptosis 
through a caspase-independent pathway. Once released from the 
mitochondria, they are translocated to the nucleus, which results in DNA 
fragmentation [110, 111, 146]. 
 
Until today there is no indication that a yeast apoptosome does exist. Yeast 
homologues of cytochrome c, such as Cyc1 and Cyc7, have been 
characterised but their contribution to the yeast metacaspase is uncertain at 
this moment. Nevertheless, release of cytochrome c upon induction of cell 
death has been demonstrated in yeast [132]. Additionally, as already 
mentioned, other apoptotic factors are also released in yeast from the 
mitochondria upon cell death induction. Translocation of Nuc1 and Aif from 
the mitochondria to the nucleus has been demonstrated, where it has a 
homologous function, namely fragmentation of DNA (Fig. 4) [127, 128]. As 
such, a caspase independent pathway seems to be present in yeast a well. 
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1.4 Objectives of this research 
The general objective of this project was to further elucidate the molecular 
mechanisms induced by mutDFNA5. The function of DFNA5 remained 
unknown for a long time due to the fact that DFNA5 has no clear structural 
or functional similarities with other genes. Gregan et al. (2003) 
demonstrated for the first time the toxic effect of mutDFNA5 in fission yeast 
[39]. Recently, functional studies on DFNA5 revealed a direct link to 
apoptosis in human cell lines [17]. This was the first indication that the 
DFNA5-related mechanisms have some conservation among different 
species. This observation led us to our first specific aim of this thesis. 
1.4.1 Elucidation of the DFNA5-associated apoptotic mechanism in a 
yeast model 
In order to unravel specific apoptotic mediators of the DFNA5 process in 
Saccharomyces cerevisiae, an apoptotic deletion strain collection was 
screened. This collection contained eighteen different deletion strains, 
strains in which one specific component, known to be related to apoptosis, 
is deleted. The first specific objective was to evaluate the growth defect of 
each of these strains upon mutDFNA5 transformation, followed by the 
determination of the type of cell death by specific stainings. This growth 
defect was then compared to the growth defect of the wild-type yeast strain 
to determine the effect of the deleted gene. To further unravel pathways 
related to DFNA5-induced cell death, a transcriptomic analysis was 
performed to compare the expression profiles of wtDFNA5 and mutDFNA5 
transformed yeast cells. 
1.4.2 Investigation of the DFNA5-associated apoptotic mechanism in 
human HEK293T cells 
As DFNA5 is a human gene related to HL and cancer, the results obtained in 
the yeast model were investigated in human cell lines to evaluate whether 
the results obtained in yeast could be confirmed. We wondered whether 
yeast would be a good model to study DFNA-related mechanisms and 
therefore focused on several mitochondria-related aspects. In order to 
unravel specific DFNA5-related pathways, previously obtained 
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transcriptomic data of DFNA5 in HEK293T cells were re-evaluated and 
additional functional studies were performed.  
As mitochondria are central players in different types of cell death, several 
mitochondrial assays were performed to determine the role of this organelle 
in DFNA5-induced cell death. The mitochondrial permeabilisation, the 
mitochondrial structure and different mitochondrial proteins were 
investigated. A role for the mitochondria in DFNA5-associated cell death 
does not necessarily implicate apoptosis, therefore we wondered whether 
other types of cell death would be involved in the DFNA5 mechanism. 
Therefore, extra experiments were performed to study the role of DFNA5 in 
non-apoptotic forms of cell death.  
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2 The splicing mutant of the human tumour suppressor 
protein DFNA5 induces programmed cell death when 
expressed in the yeast Saccharomyces cerevisiae 
2.1 Abstract  
DFNA5 was firstly identified as a gene responsible for autosomal dominant 
deafness. Later, it became clear that the protein also has a tumour 
suppression function and that it can induce apoptosis. Epigenetic silencing 
of the DFNA5 gene is associated with different types of cancers, including 
gastric and colorectal cancers as well as breast tumours. We introduced the 
wild-type and mutant DFNA5 allele in the yeast Saccharomyces cerevisiae. 
The expression of the wild-type protein was well tolerated by the yeast cells, 
although the protein was subject of degradation and often deposited in 
distinct foci when cells entered the diauxic shift. In contrast, cells had 
problems to cope with mutant DFNA5 and despite an apparent 
compensatory reduction in expression levels, the mutant protein still 
triggered a marked growth defect, which in part can be ascribed to its 
interaction with mitochondria. Consistently, cells with mutant DFNA5 
displayed significantly increased levels of ROS and signs of programmed cell 
death. The latter occurred independently of the yeast caspase, Mca1, but 
involved the mitochondrial fission protein, Fis1, the voltage-dependent 
anion channel protein, Por1 and the mitochondrial adenine-nucleotide 
translocators, Aac1 and Aac3. Recent data proposed DFNA5 toxicity to be 
associated to a globular domain encoded by exon 2 to 6. We confirmed 
these data by showing that expression of solely this domain confers a strong 
growth phenotype. In addition, we identified a point mutant in this domain 
that completely abrogated its cytotoxicity in yeast as well as human 
HEK293T cells. Combined, our data underscore that the yeast system offers 
a valuable tool to further dissect the apoptotic properties of DFNA5. 
 
Key words: DFNA5, Saccharomyces cerevisiae, yeast, cell death, apoptosis, 
hearing impairment, tumour suppressor 
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2.2 Introduction 
Evasion of apoptosis is known to be an important factor in tumorigenesis, 
but the underlying mechanisms are often not well understood. Therefore, 
more research is required on the factors that govern cellular decisions 
between malignant outgrowth or programmed cell death, as this may 
eventually lead to the design of more efficient anti-cancer therapies [1-3]. 
Here, we describe our findings on the heterologous expression in yeast of a 
human protein that has an important role in controlling the switch between 
cell survival and cell death, i.e. DFNA5. 
 
Supported by the observation that the exon 8 splicing mutant of DFNA5 
(mutDFNA5), but not the wild-type allele (wtDFNA5), triggers cell cycle 
arrest when expressed in the fission yeast Schizosaccharomyces pombe [4], 
we decided to use yeast as a model to investigate the role of DFNA5 in more 
detail. We expressed wtDFNA5 and mutDFNA5 in the budding yeast 
Saccharomyces cerevisiae and analysed the repercussions on growth, 
oxidative stress and the induction of programmed cell death (PCD). We first 
evaluated the value of Saccharomyces cerevisiae as a model organism to 
unravel the mechanisms related to DFNA5.  
 
Based on these results, we screened a collection of several apoptotic 
deletion strains (these are yeast strains deleted in one specific gene related 
to apoptosis) and compared the growth defect of DFNA5-transformed 
deletion strains to the background strain. Data obtained from the wild-type 
strain and a series of deletion mutants confirmed that mutDFNA5 strongly 
induces PCD, a phenomenon being dependent on mitochondrial integrity, 
but independent of the yeast caspase, Mca1. Several mitochondrial proteins 
were identified, namely the mitochondrial fission protein, Fis1, the voltage-
dependent anion channel protein, Por1 and the mitochondrial adenine-
nucleotide translocators, Aac1 and Aac3.  
 
In addition, the region responsible for the induction of programmed cell 
death was assigned to the first globular domain of DFNA5, similar to which 
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was previously identified in HEK293T cells. Amino acid substitution of the 
second, highly conserved, hydrophobic amino acid reduced this cell death-
inducing capacity, which proves that yeast is an ideal tool to identify point 
mutations. This underscores the feasibility of the yeast model for the 
unravelling of the cellular mechanisms of DFNA5. 
2.3 Materials and methods 
2.3.1 Strains, plasmids and growth analysis 
In this study, we used the BY4741 wild-type strain [5] and isogenic deletion 
strains of the genome-wide collection (EUROSCARF, Frankfurt, Germany) 
lacking proteins involved in PCD as listed in Suppl. Table 2.1 The C-terminally 
HA-tagged full-length wtDFNA5 and mutDFNA5 cDNAs, the C-terminally 
EGFP fusion proteins and the wtDFNA5 first and second globular fragments 
were isolated and amplified as previously described [4, 6] using the primers 
listed in Suppl. Table 2.2. All amplified products were ligated into the 
pYX212 plasmid using either EcoRI and BamHI or EcoRI and SalI restriction 
sites, thereby placing the inserts under expression control of the 
constitutive TPI1 promoter. The mutants HCA-F2R and HCA-A3R at the N-
terminal end of the first globular domain were generated by site-directed 
mutagenesis (Agilent, Santa Clara, USA) in combination with the custom 
designed primers listed in Suppl. Table 2.2. All constructs were verified by 
bidirectional sequencing on an ABI genetic analyser 3130xl (Applied 
Biosystems, Foster City, CA, USA). The construction of the plasmid for Mito-
RFP was previously described [7]. Standard transformation techniques were 
applied [8] and all strains were grown at 30°C in a selective minimal medium 
containing 2% of glucose (SD-Ura). Growth profiles were determined in 96-
well microtiter plates with continuous shaking at 30°C in a Multiskan GO 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, USA). Overnight 
cultures of at least three different transformants were diluted to start new 
cultures for growth analysis. Growth was monitored until the stationary 
phase was reached. Growth curves are depicted with scaled OD units and as 
the mean values of the transformants, with error bars representing standard 
deviations. The growth profiles of the strains expressing HA- or EGFP-tagged 
wtDNFNA5 or mutDFNA5 were compared to that of a control strain 
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transformed with either empty vector or a plasmid allowing for expression 
of EGFP. The differences in time required to reach half maximal optical 
densities (ΔT½) were calculated and used as standards for growth 
quantification. The difference in ΔT½ obtained for wtDFNA5 (∆T½ wtDFNA5-
Control) and mutDFNA5 (∆T½ mutDFNA5-Control) in the BY4741 wild-type 
strain was used as reference and set as 100%. 
Human Embryonic Kidney 293T cells (HEK293T) were subcultured in 60 mm 
dishes at a density of 2 x 106 cells in Dulbecco’s modified Eagle’s medium 
containing 4500 mg/l glucose supplemented with 10% (v/v) fetal calf serum, 
100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine (all 
products from Invitrogen, San Diego, USA). The cells were incubated 
overnight at 37°C in a 5% CO2 humidified environment. The plasmids used 
for wtDFNA5 and mutDFNA5 expression in mammalian HEK293T cells, after 
transfection with lipofectamine, were described before [6]. In addition, we 
used the pEGFP-N1 vector to construct plasmids for the expression of HCA-
F2R and HCA-A3R mutants. 
2.3.2 Western blot analysis 
Yeast samples were grown in 3 ml cultures on selective medium and were 
harvested at an OD600nm between 1.5 and 2.0. An equal amount of cells were 
taken and lysed by boiling for 15 minutes in SDS sample buffer [50 mM Tris 
(pH 8.0), 10 mM β-mercaptoethanol, 2% SDS, 0.1% bromophenol blue, 10% 
glycerol]. Proteins were separated by standard SDS-PAGE and blotted onto 
PVDF membranes (Immobilon-P transfer membranes, Millipore, MA, USA). 
For immunodetection we used the primary rabbit anti-HA or anti-EGFP 
antibodies (Santa Cruz, CA, USA) and a secondary horse radish peroxidase 
(HRP) conjugated goat anti-rabbit antibody (Santa Cruz, CA, USA). The 
endogenous yeast alcohol dehydrogenase Adh2 served as internal standard. 
Membranes were developed using the ECL detection kit (Thermo Scientific, 
IL, USA).  
2.3.3 Flow cytometric analysis of cell death, ROS accumulation and 
caspase activity 
Tests for apoptotic and necrotic markers, using AnnexinV/Propidium Iodide 
(AV/PI) co-staining, as well as ROS-accumulation, using the superoxide-
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driven conversion of non-fluorescent dihydroethidium (DHE) to fluorescent 
ethidium, were performed and quantified using BD Influx flow cytometry 
(BD Biosciences, New Jersey, USA) as described previously [9]. Yeast samples 
were harvested at different time points. Samples were collected at mid-
exponential phase at an OD600nm between 3.5 to 4.0, just after cells had 
traversed the diauxic shift (PD) at an OD600nm between 6.0 to 7.0, and in 
stationary phase (ST) at an OD600nm of 8.5 or higher. Analysis of the BD influx 
flow cytometry data was performed using the software program FlowJo 
(Tree Star Inc., Ashland, USA). Viability tests of the HCA-F2R and HCA-A3R 
mutants in HEK293T cells were performed on a FACScan flow cytometer (BD 
Biosciences, New Jersey, USA) after staining of the cells with PI. Cell viability 
was then determined as the ratio of cells showing no PI fluorescence to the 
total cell population. 
A previously described protocol was used to measure the caspase activity 
[10]. Yeast cells grown on selective medium were harvested at an OD600nm of 
approximately 4.5. A staining solution containing 10 µM FITC-VAD-FMK in 
PBS (CaspACE, Promega, WI, USA) was added to an amount of cells 
corresponding to an OD600nm of 0.5 and incubated for 20 minutes at room 
temperature. After washing and suspension in 200 µl PBS flow cytometric 
analysis was performed using a 530/40 bandpass filter. 
2.3.4 Fluorescence microscopy  
Cells transformed with wtDFNA5 or mutDFNA5 fused to EGFP were grown 
until mid-exponential or post-diauxic phase as indicated and visualised using 
a Leica DM4000B fluorescence microscope (Leica Microsystems GmbH, 
Wetzlar, Germany). Pictures were taken with a Leica DFC420C camera using 
the Leica Application Suite software. The percentages of post-diauxic cells 
with or without inclusions were determined by manual counting of at least 
300 cells per sample.  
Mitochondria were visualised by the expression of a mitochondria-targeted 
red fluorescent protein, Mito-RFP [7]. To stain the vacuolar membrane, cells 
were in the post-diauxic phase and incubated with FM4-64 ([N-(3-
triethylammoniumpropyl)-4-(p-diethylamino phenylhexa-trienyl) pyridinium 
dibromide]; Molecular Probes, Eugene, USA) at room temperature for at 
least 30 minutes in a HEPES buffer containing 1% of glucose to facilitate the 
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uptake of FM4-64. To visualise the nucleus, we performed a 4',6-diamidino-
2-phenylindole (DAPI) staining. The cells were harvested in the post-diauxic 
phase and incubated for 20 minutes in a phosphate buffer (0.04 M K2HPO4, 
0.01 M KH2PO4, 0.15 M NaCl, 0.1 g/100 ml NaN3) containing 50% ethanol. 
After washing with PBS, DAPI was added (1 µg/µl) and samples were 
incubated at room temperature for 15 minutes.  
2.3.5 Statistical analysis 
All experiments included biological replicates and the use of independent 
transformants. Statistical analysis was performed using unpaired t-tests or 
one-way ANOVA. 
2.4 Results 
2.4.1 Mutant DFNA5 induces apoptotic and necrotic cell death in yeast 
To study the properties of human DFNA5 in a well-defined model, we 
expressed the cDNAs of wtDFNA5 and mutDFNA5 in the BY4741 wild-type 
strain. We used high-copy-number plasmids allowing expression of 
wtDFNA5 and mutDFNA5 as C-terminally HA-tagged proteins under the 
control of the strong constitutive TPI1 promoter. For wtDFNA5, this resulted 
in good expression levels of the full-length protein, though we noticed that 
the protein was subject of proteolytic degradation as evidenced by the 
presence of discrete breakdown products upon western blot analysis (Fig. 
1a). A lower expression level was obtained for mutDFNA5 and, interestingly, 
no major proteolytic fragments were observed in this case, even not when 
higher concentrations of protein extracts were loaded or when the exposure 
time of the immunoblots was increased. Growth analysis of the 
transformants revealed that the expression of wtDFNA5 had only a 
moderate effect on growth, while expression of mutDFNA5 triggered a 
significant growth defect. The latter was characterised by a longer doubling 
time and a lower maximal optical density of the cultures (Fig. 1b). Hence, as 
compared to a culture of the BY4741 strain transformed with the empty 
plasmid, a culture of cells expressing wtDFNA5 required on average only an 
additional 3 h (SD ± 0.24) to reach half of the maximal optical density (ΔT½), 
whereas for a culture of cells expressing mutDFNA5 this ΔT½ was extended 
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to about 11.5 h (SD ± 0.32) (Suppl. Data Table 2.3). Combined these data 
suggest that yeast cells tolerated the presence of wtDFNA5 fairly well but 
have problems to cope with mutDFNA5. Notably, since the mutant protein 
seemed to escape the protein breakdown, the cells apparently counter 
selected and reduced the expression of the mutant protein to prevent 
extreme harmful effects. 
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It is known that cytotoxic effects instigated by heterologous proteins are 
often a reflection of a failing protein quality control and clearance system, 
which then leads to enhanced oxidative stress and eventually increased cell 
death (reviewed in [11]). To examine whether this is also the case for 
heterologous expression of DFNA5, we measured the level of reactive 
oxygen species (ROS) using a DHE staining on culture samples taken at 
different time points during growth (Fig. 1c, d). In mid-exponential cultures, 
the ROS levels were only significantly increased in cells expressing 
mutDFNA5 when compared to the control. However, once the cultures 
traversed the diauxic shift and switched their metabolism to respiration, a 
marked increment of the ROS level was observed for both the cells 
expressing wtDFNA5 and those expressing mutDFNA5. In case of wtDFNA5, 
the level of ROS in the early post-diauxic phase was three times higher than 
that of the control cells and it further increased in stationary phase. With 
mutDFNA5, the increment in ROS in the early post-diauxic phase was 
comparable to wtDFNA5, though by the time these cells reached the 
stationary phase the average ROS level was lower than that of cells 
expressing wtDFNA5. 
We also performed a co-staining with AV/PI to detect cells showing signs of 
apoptotic and necrotic cell death (Fig. 1e). This again revealed that only the 
expression of mutDFNA5 significantly enhanced cell death during the mid-
exponential phase, while both expression of wtDFNA5 or mutDFNA5 
enhanced cell death once the cultures were beyond the diauxic shift, albeit 
to a different extent. More in particular, we noticed that in the post-diauxic 
and stationary phase the expression of the wild-type and especially the 
mutant allele triggered an increase in the number of late apoptotic (AV+/ PI+) 
and necrotic cells (AV-/PI+) and that in the stationary phase this was even 
associated with a significant decrease in early apoptotic (AV+/PI-) cells. That 
the increments of late apoptotic and necrotic cells are most pronounced 
upon expression of mutDFNA5 is consistent with the observed enhanced 
growth defect. Furthermore, these results are also in agreement with 
previously reported observations of enhanced apoptotic and necrotic cell 
death in mammalian cells transfected with mutDFNA5 [6, 12].
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2.4.2 Mutant DFNA5 escapes protein quality control deposition and 
interacts with mitochondria 
To analyse the intracellular localisation, we expressed wtDFNA5 and 
mutDFNA5 as a C-terminally tagged EGFP fusion. Their relative expression 
levels were comparable to those of the HA-tagged counterparts. 
Furthermore, similar as for the HA-tagged versions, the wtDFNA5-EGFP 
fusion was subject to proteolytic degradation, while this was by far less 
pronounced for the mutDFNA5-EGFP fusion (Fig. 1a). Despite of these 
similarities, we noticed that the fusion proteins induced slightly enhanced 
growth defects as judged from the ΔT½ values calculated based on the 
growth difference with control cultures expressing native EGFP (ΔT½ 
wtDFNA5-EGFP: 4.60h ± 1.27; ΔT½ mutDFNA5-EGFP: 15.85h ± 1.84; Suppl. 
Data Table 2.3). Nonetheless, since also in this case mutDFNA5-EGFP 
instigated a much higher cytotoxicity than wtDFNA5-EGFP, we reasoned that 
further analysis would still provide important insight in the differential 
properties of the proteins.  
Fluorescence microscopy confirmed the difference in expression level 
between wtDFNA5-EGFP and mutDFNA5-EGFP. It also showed that 
wtDFNA5-EGFP was evenly distributed over the cytoplasm in mid-
exponential growth phase, although we noticed that one fifth of the cells 
(22%) gradually accumulated fluorescent material in more dense inclusions 
(Fig. 2a). This resulted in the formation of one or a few distinct deposits by 
the time these cells reached the post-diauxic phase. Similar as in transfected 
mammalian cells [12], the distribution of mutDFNA5-EGFP in mid-
exponential phase cells appeared to be more granulated and possibly 
confined to intracellular structures, though it was difficult to assign a 
definite pattern due to the low expression level of the fusion protein. In the 
post-diauxic phase, inclusions were present in about one out of seven cells 
that expressed mutDFNA5-EGFP (14%). As compared to the deposits of 
wtDFNA5-EGFP, the inclusions formed by the mutant protein were usually 
less intense and occurring as small foci in the vicinity of the plasma 
membrane (Fig. 2a).  
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It was previously shown that cells protect themselves by sequestering 
breakdown products and damaged or aggregated proteins in different protein 
quality control compartments, referred to as aggresomes or JUNQ and IPOD. 
JUNQ represents a juxta-nuclear quality control compartment that serves as a 
temporary storage site for misfolded proteins, keeping them in an 
ubiquitinated, soluble state for either refolding or degradation by the 
ubiquitin-proteasome system. IPOD, on the other hand, is a perivacuolar 
compartment for the deposit of insoluble, non-ubiquitinated substrates, such 
as amyloidic proteins, that possibly await clearance by means of autophagy 
[13, 14]. To analyse in more detail the localisation of the inclusions formed by 
wtDFNA5-EGFP and mutDFNA5-EGFP, we performed stainings with DAPI and 
FM4-64 to respectively visualise the nucleus and the vacuolar membrane. This 
demonstrated that the larger deposits of wtDFNA5-EGFP did not co-localise 
with the nucleus (Fig. 2b). Instead, these deposits were found at the 
periphery of the vacuole and thus are likely to correspond to IPOD (Fig. 2c). 
The small foci formed by mutDFNA5-EGFP, neither co-localised with the 
nucleus, nor with the vacuolar membrane but, interestingly, seemed to 
partially overlap with DAPI-stained mitochondrial DNA. This led us to visualise 
the mitochondrial network. The strains were therefore co-transformed with a 
plasmid enabling the expression of a mitochondrial red fluorescent marker 
protein, Mito-RFP [7]. Further analysis revealed that, indeed, the small foci of 
mutDFNA5-EGFP often co-localised with punctuated fragmented 
mitochondria and this in contrast to the larger deposits of wtDFNA5-EGFP 
(Fig. 2d). 
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2.4.3 Mutant DFNA5 induces cell death independently of caspase 
Next, we systematically assessed the repercussion of wtDFNA5 and 
mutDFNA5 expression in strains harbouring deletions of key players of the 
PCD machinery. We monitored the expression of the HA-tagged DFNA5 
proteins, compared the growth profiles and measured the levels of ROS and 
cell death during mid-exponential growth. One of the strains analysed was 
the mutant lacking the yeast caspase, Mca1, which allowed us to establish 
whether DFNA5-induced cell death involves the previously described 
caspase-dependent or caspase-independent processes [15]. As compared to 
the corresponding wild-type strains, the mca1Δ strains displayed similar 
expression profiles of wtDFNA5 and mutDFNA5 (Fig. 3a) and albeit the 
mutant strains grew more slowly, they maintained similar DFNA5-
dependent growth defects as determined by calculating the ΔT½ values 
(Suppl. Table 2.3 and Fig. 3b). In addition, the deletion of MCA1 did not 
prevent accumulation of ROS upon expression of mutDFNA5, nor did it 
prevent the mutDFNA5-instigated induction of apoptotic and necrotic cell 
death markers (Fig.  3c, d). Consistently, treatment of BY4741 wild-type cells 
with the FITC-labelled pancaspase inhibitor zVAD-FMK, which binds to the 
active site of caspases in yeast [10], did not provide evidence for enhanced 
caspase activity upon the expression of wtDFNA5 or mutDFNA5 (Fig. 3e). 
When combined, these observations suggest that mutDFNA5-induced cell 
death occurs mainly independent of the caspase Mca1. Likewise, we could 
exclude several of the other known players of the yeast apoptotic machinery 
to have a major impact on the DFNA5-dependent phenotypes. These 
included the mitochondrial cell death effector, Aif1, the mitochondrial 
endonuclease G, Nuc1, the orthologue of the mammalian Omi/HtrA2 serine 
protease, Nma111, as well as the yeast suicide protein, Ysp2 (Suppl. Data 
Table 2.3 and data not shown). 
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2.4.4 Mutant DFNA5 induces cell death through mitochondrial functions  
In contrast to the mutant strains mentioned above, we found increased 
DFNA5-induced cytotoxicity in the strains lacking either the mitochondrial 
outer membrane protein Fis1, or the voltage-dependent anion channel 
protein Por1. The Fis1 protein is involved in mitochondrial fission that 
attracts the dynamin-related GTPase, Dnm1 through the adaptors Mdv1 and 
Caf4. The complex then forms a contractile ring that promotes outer 
membrane division. Interesting is that with the fis1Δ strains, both the 
cultures expressing wtDFNA5 or mutDFNA5 displayed a comparable lower 
maximal optical density (Fig. 4a). This is similar to what we observed for 
cultures of wild-type cells transformed with mutDFNA5 and it probably 
reflects the disturbance of mitochondrial dynamics. The role of Fis1 and 
mitochondrial fission in PCD is still not fully clarified and seems to depend 
on the type of the cell death stimulus [16]. For instance, for ethanol-induced 
apoptosis, Fis1 was shown to mediate mitochondrial fragmentation and cell 
death independently of Dnm1 and Mdv1 [17], whereas for acetic acid-
induced apoptosis, Fis1 was reported to protect cells by inhibition of Dnm1- 
and Mdv1-mediated mitochondrial fission and cell death [18]. Concerning 
the DFNA5-induced cell death, Fis1 obviously exerted a protective function, 
but this appeared to be largely independent of Dnm1 and Mdv1 because 
neither the deletion of Dnm1, nor the deletion of Mdv1 affected the DFNA5-
mediated growth phenotype (Suppl. Data Table 2.3). As was to be expected, 
the levels of ROS were generally higher in the fis1Δ strains than in the wild-
type strains with a minor increment in case of wtDFNA5 expression, but a 
clear augmentation in case of mutDFNA5 expression (Fig. 4b). Likewise, the 
amount of dying cells in mid-exponential cultures were in general higher in 
the fis1Δ strains as compared to the wild-type strains, especially the number 
of early apoptotic cells, and while there was no significant increase in the 
total number of cells showing signs of cell death between the control and 
cultures expressing wtDFNA5 or mutDFNA5, the latter two still showed a 
trend towards enhanced late apoptosis and necrosis (Fig. 4c). Analysis of 
fis1Δ cells with combined expression of Mito-RFP and EGFP-fusions showed 
that most cells contained fragmented and aggregated mitochondria, which 
did not overlap with the deposits formed by wtDFNA5-EGFP but clearly co-
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localised with the foci of mutDFNA5-EGFP (Fig. 4d). Similar as the loss of 
Fis1, also the absence of the channel protein Por1 appeared to sensitise cells 
for DFNA5-mediated cell death. However, with this por1Δ deletion strain it 
was difficult to correctly assess the repercussions on ROS accumulation or 
cell death due to the very slow growth of the cells transformed with 
mutDFNA5 (Fig. 4e). 
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In two other mitochondrial mutants, i.e. the aac1Δ and aac3Δ deletion 
strains (Fig. 5a, b), the growth differences between the control cultures and 
the cultures expressing wtDFNA5 or mutDFNA5 were almost annihilated, 
indicative that the lack of Aac1 or Aac3 abrogated the mutDFNA5-associated 
cytotoxicity.  Aac1 and Aac3 encode for two of the three ADP/ATP carriers of 
the inner mitochondrial membrane. Previously reported studies implicated 
these proteins as effectors of acetic acid-induced apoptosis, a role which 
apparently does not depend on their ADP/ATP translocase activity but 
rather on their impact on the mitochondrial outer membrane 
permeabilisation and mitochondrial degradation [19, 20]. As documented 
for the aac3Δ mutant, the deletion of the ADP/ATP carrier did not prevent 
the accumulation of ROS during the post-diauxic phase in cells expressing 
wtDFNA5 or mutDFNA5 (Fig. 5c). However, the lack of Aac3 clearly 
interfered with the appearance of cell death markers. In the aac3Δ control 
cultures, the levels of dying cells were markedly higher as compared to 
control culture of wild-type cells, which is consistent with the fact that the 
aac3Δ mutant grows slower. The cultures with cells expressing wtDFNA5 or 
mutDFNA5 still displayed altered ratios between early or late apoptotic and 
necrotic cells, but the total number of cells with signs of cell death did not 
alter in the different growth phases. Furthermore, the total number of dying 
cells was comparable for the control culture and the culture of cells 
expressing wtDFNA5 and it was consistently lower for the culture of cells 
expressing mutDFNA5 (Fig. 5d). Similar data were obtained for the aac1Δ 
mutant (data not shown). These observations confirm that mutDFNA5 
requires the ADP/ATP carriers to instigate cytotoxicity and cell death. 
Furthermore, while ROS production has been described as an event 
common to most of the yeast apoptosis scenarios, our data demonstrate 
that in the ADP/ATP carrier mutants the correlation between ROS 
accumulation and viability does not hold. As such, our data are completely 
in line with previously reported results obtained with a triple aac1-3Δ 
mutant for acetic acid-induced apoptosis [19]. 
 
Analysis of aac3Δ cells co-transformed with Mito-RFP and the EGFP-fusions 
revealed that these cells contain a well-developed mitochondrial tubular 
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network. Even in cells expressing mutDFNA5-EGFP such a tubular network 
was present, but there were still punctuated mitochondria co-localising with 
the foci of the EGFP fusion (Fig. 5e). This led us to conclude that the absence 
of the ADP/ATP carriers did not prevent mutDFNA5 to interfere with 
mitochondrial fission and fusion dynamics or the clearance of fragmented 
mitochondria, which both are aspects that remain to be studied in more 
detail. 
Finally, it should be noted that we did not observe significant differences in 
expression or degradation of the HA-tagged wtDFNA5 or mutDFNA5 
proteins between the wild-type strain and the different mutant strains (Fig. 
5f). This indicates that the observed changes in DFNA5-instigated 
cytotoxicity in the mutant strains are related to their deleted functions and 
not to alterations in DFNA5 expression. 
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Fig. 5: MutDFNA5 cytotoxicity depends on the mitochondrial ADP/ATP carriers. a, b. Growth 
profiles of (A) aac1Δ cells or (B) aac3Δ cells expressing C-terminally HA-tagged wtDFNA5 (dark 
grey squares) or mutDFNA5 (black triangles) or transformed with an empty plasmid (light grey 
circles). c, d. Quantification of  ROS accumulation using DHE staining (panel C) or AV/PI 
positive cells (panel D) in mid-exponential (ME) and post-diauxic (PD) phase in aac3Δ cultures 
without (contr.) or with expression of HA-tagged wtDFNA5 or mutDFNA5. e. Fluorescence 
microscopy pictures of aac3Δ cells expressing EGFP or displaying inclusions of wtDFNA5-EGFP 
or mutDFNA5-EGFP and co-transformed with Mito-RFP to visualise mitochondria. f. Western 
blot analysis of protein extracts of the aac1Δ, aac3Δ, fis1Δ, por1Δ mutant strains transformed 
with constructs allowing for the expression of C-terminally HA-tagged wtDFNA5 or mutDFNA5 
as indicated. Immunodetection was performed using primary antibodies directed against the 
HA-tag or Adh2, which was used as loading control. Significances were assayed using unpaired 
t-tests.  For the AV/PI co-staining the following significances were obtained when compared to 
the control: for wtDFNA5 in PD: AV
+
/PI
+
 *, AV
-
/PI
+
 *. (*=p<0.05; ***=p<0.001) 
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2.4.5 DFNA5 toxicity is confined to its first globular domain 
We recently proposed that wtDFNA5 is composed of two globular domains, 
which are separated by a hinge region (Fig. 6a). In that study, we also 
demonstrated that the first domain induces apoptotic cell death in 
transfected HEK293T cells, which led to a model where the second domain 
can fold back to mask and regulate the apoptotic activity of the first domain 
[6]. Here, we expressed the two domains separately in yeast. As shown, the 
expression of the first domain, designated domain A and corresponding to 
the amino acid residues 1 to 256, triggered a very pronounced growth 
defect that by far surpassed the defect observed for mutDFNA5 (Fig. 6b). 
Expression of the second domain, referred to as domain B and 
corresponding to residues 282 to 496, did not affect growth and the growth 
curve almost perfectly overlapped with the one obtained for the empty 
vector control. 
 
DFNA5 belongs to the gasdermin protein family, named after the founder 
protein GSDMA, which is involved in gastric cancer and also contains pro-
apoptotic activities [21]. Sequence alignment of the different gasdermin 
family members show a high degree of conservation, especially in the first 
domain, which based on hydrophobic cluster analysis contains short α-
helical folds interspaced by β-sheets [6]. To document the importance of 
these structures for the apoptotic-inducing activity of the domain, we used 
PCR-based site-directed mutagenesis and phenotypically tested two of the 
mutants generated in domain A (Fig. 6a). The first mutant, designated HCA-
F2R, contained the substitution of a highly conserved hydrophobic 
phenylalanine into a basic arginine, thereby disrupting the first α-helical 
fold. When expressed in yeast, this mutant only triggered a small growth 
defect (ΔT½: 3.33h ± 0.93) and thus lost most of the apoptotic-inducing 
activity (Fig. 6B).  In the second mutant, i.e. HCA-A3R, a non-conserved 
alanine residue was changed into arginine. Although this mutation also 
affected the first α-helical fold, its repercussions on the apoptotic-inducing 
activity were less pronounced as evidenced by the observation that the 
expression of this mutant in yeast resulted in an intermediate growth defect 
(ΔT½: 20.50h ± 5.96; Fig. 6b).  
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Next to the experiments in yeast, we also assessed the cell viability of 
human HEK293T cells transiently expressing the generated DFNA5 mutants. 
The expression of the HCA-A3R construct led to a significant decrease of cell 
viability (mean viability: 38.28% ± 9.37), whereas expression of HCA-F2R did 
not (mean viability: 78.60% ± 4.03), as it gave a similar cell viability as that 
observed for cells transfected with an empty EGFP vector (mean viability: 
77.59% ± 5.58; Fig. 6c). In fact, the cell viability of cells expressing HCA-A3R 
is highly comparable to those expressing mutDFNA5, while cell viability of 
cells expressing HCA-F2R is comparable to cells expressing wtDFNA5. As 
such, the results obtained in HEK293T cells confirm those obtained in yeast. 
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Fig.6: DFNA5 cytotoxicity is confined to its first globular domain. a. Schematic 
representation of wtDFNA5 with the two globular domains connected by the hinge region 
and the indication of the mutants HCA-F2R and HCA-A3R (boxed) in the first domain. b. 
Growth profiles of BY4741 cells expressing the first (grey triangles) or the second (greys 
squares) globular domain of wtDFNA5 or expressing point mutants in the first globular 
domain, i.e. mutants HCA-F2R (open squares) or HCA-A3R (open triangles). The dashed line 
is given as reference and depicts the growth of BY4741 cells transformed with an empty 
plasmid. c. Cell viability of HEK293T cells transiently expressing the HCA-F2R and HCA-A3R 
mutants, wtDFNA5 and mutDFNA5 as indicated. Significances were assayed using One-Way 
ANOVA (***= p < 0.001). Cells expressing EGFP served as control.  
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2.5 Discussion 
In this study we analysed the repercussion of heterologous expression of 
human wtDFNA5 or mutDFNA5 in Saccharomyces cerevisiae. Our data 
clearly demonstrate that mutDFNA5 causes a significant growth defect, 
which is associated with an increased number of late apoptotic and necrotic 
cells especially when the culture entered the stationary phase and this in 
contrast to wtDFNA5. These findings confirm previous reported results 
showing that mutDFNA5 induces apoptotic and necrotic cell death when 
expressed in mammalian cells [6,12].  
Detailed analysis of the expression of wtDFNA5 and mutDFNA5 in the yeast 
system revealed that both proteins form inclusions. For wtDFNA5, these 
inclusions most likely correspond to IPOD as they are found at the periphery 
of the vacuole. The IPOD is a protein quality control compartment where 
proteins are deposited that presumably await autophagic clearance [13,14]. 
This suggests that wtDFNA5 is subjected to the normal cellular repertoire of 
protein quality control and clearance mechanisms. MutDFNA5 seems to 
escape these quality control systems. It does not form large IPOD-like 
deposits but rather smaller and more numerous foci, which are less intense 
and occurring mostly in the vicinity of the plasma membrane. Previous 
studies already suggested an association of mutDFNA5 with the plasma 
membrane and/or a membrane protein in mammalian cells, but the exact 
location remained unclear [12,22]. We now show that in yeast the foci 
formed by mutDFNA5 often co-localise with fragmented mitochondria, 
suggesting that the mutant proteins may interact either with the 
mitochondrial membrane or one of the mitochondrial membrane proteins, 
which in turn may lead to mitochondrial impairment. The latter is further 
evidenced by the fact that mutDFNA5 is even more toxic in the fis1Δ and 
por1Δ mutants, while it lost its specific toxicity-inducing capacity in mutant 
strains lacking the ADP/ATP carriers Aac1 and Aac3. It is remarkable that the 
same mitochondrial proteins have previously been identified as key players 
with similar contributions for acetic acid-induced apoptosis in yeast [18,19]. 
This underscores that mutDFNA5-instigated cytotoxicity and acetic acid-
induced apoptosis build on common molecular mechanisms. Note that we 
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did not analyse the third ADP/ATP carrier Aac2 in our studies for the simple 
reason that its deletion is lethal in the BY4741 background [23].  
 
The studies on acetic-acid-induced apoptosis demonstrated a protective 
function of Fis1 that relates to inhibition of Dnm1-mediated mitochondrial 
fission and possible additional pro-apoptotic Dnm1 functions [18]. Also for 
mutDFNA5-induced cell death we found that Fis1 fulfils a protective role but 
this apparently does not involve Dnm1 or its adaptor Mdv1.  Indeed, our 
observation that neither the deletion of DNM1 nor of MDV1 prevented 
mutDFNA5-induced cell death excludes these fission proteins as 
downstream effectors. That Fis1 could have a specific function not shared by 
the other fission factors Dnm1 and Mdv1 was already noted before in 
studies dealing with ethanol-induced apoptosis. These studies suggested 
that Fis1 has a specific role for the maintenance of mitochondrial 
fragmentation in response to ethanol [17]. However, most recent studies 
revealed that fis1Δ mutants accumulate secondary loss-of-function 
mutations in the WHI2 gene [24, 25], which encodes a protein involved in 
cell cycle regulation [26], the general stress response, actin dynamics and 
Ras-cAMP-PKA signalling [27, 28] as well as the selective degradation of 
dysfunctional mitochondria via autophagy, a process known as mitophagy 
[29]. In fact, the studies on cell death and mitophagy showed that the 
enhanced sensitivity of the fis1Δ mutants towards cell death stimuli is solely 
due to the loss of the Whi2 function and not to the lack of Fis1 [24, 25]. Also 
the fis1Δ mutant strain of the yeast deletion collection that was used in our 
study appears to contain such a secondary loss-of-function mutation in 
WHI2 [24]. Hence, it is feasible that the enhanced mutDFNA5-instigated 
cytotoxicity in the fis1Δ mutant strain relates to the WHI2 mutation and the 
consequent diminished stress resistance and lower rate of mitophagy, 
rather than to a deficiency in mitochondrial fission. At least, it would explain 
the observed accumulation of fragmented and aggregated mitochondria co-
localising with the foci of mutDFNA5-EGFP in the fis1Δ mutant, and as such 
provide an additional confirmation that mutDFNA5 triggers cell death 
through mitochondrial damage. 
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Another aspect of Fis1 is that the protein has similar cellular properties as 
the mammalian BCL2 and BCL-xL and although these anti-apoptotic proteins 
cannot replace the mitochondrial fission function of Fis1, they do substitute 
for Fis1 in cell viability assays [18]. BCL2 and BCL-xL have important roles as 
regulators of mitochondrial membrane permeabilisation, since they inhibit 
non-specific pore formation by the adenine nucleotide translocator, ANT, 
the mammalian orthologue of the Aac1/2/3 ADP/ATP carriers [30, 31].  
Previous studies in yeast identified Fis1 as a potential regulator together 
with the mitochondrial permeability transition pore components Aac1/3 and 
the VDAC protein Por1 for acetic acid-induced cell death [18-20]. Our data 
now demonstrate that mutDFNA5 cytotoxicity is enhanced in the absence of 
Por1, while this toxicity is basically abrogated in the absence of Aac1 or 
Aac3. Whether this means that mutDFNA5 directly targets the ADP/ATP 
carriers to alter mitochondrial membrane permeability remains to be 
clarified. In humans, mutations in the ANT1 gene are associated with 
progressive external ophthalmoplegia [32] and to our knowledge there are 
no reports that link DFNA5 to this disorder or, conversely, that link ANT1 to 
autosomal dominant deafness. 
 
DFNA5 belongs to the gasdermin family. Although the members of this 
family appear to have different molecular functions, they share conserved 
structural features, such as the presence of a globular domain in their N-
terminal half [6, 21, 33]. Intriguingly, this domain harbors the DFNA5 
capacity to induce cell death as confirmed in previous studies [6] and ours. It 
is not known whether this capacity to induce cell death is a common 
physiological property of all gasdermin family members, but at least for one 
other member, i.e. GSDMA, this seems to be the case since the protein was 
reported to induce apoptosis in a gastric epithelial cell line [21]. The 
apoptosis-inducing globular domain was proposed to be shielded in 
wtDFNA5 by a second C-terminal regulatory domain. In mutDFNA5 a large 
part of this regulatory domain is missing and therefore the apoptosis-
inducing domain is presumably more exposed [6, 22]. Structurally, the 
apoptosis-inducing domain is composed of short α-helical folds interspaced 
by β-sheets. Here, we show that mutations disrupting the first α-helical fold 
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strongly reduce the cell death-inducing capacity of the N-terminal domain in 
yeast and human HEK293T cells. This demonstrates the feasibility to use the 
yeast system to further dissect the structural requirements of DFNA5 
associated with its apoptosis-inducing property. 
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3 Mutant DFNA5 induces cell death by mitochondria and 
MAPK-related pathways 
3.1 Abstract 
Cell death exists in many different forms. Some are accidental, but most of 
them encounter some kind of regulation and are called programmed cell 
death. This study investigated programmed cell death induced by DFNA5, a 
gene responsible for autosomal dominant hearing loss and a tumour 
suppressor gene involved in frequent forms of cancer. Recently, functional 
analysis of mutant DFNA5 linked expression to programmed cell death both 
in human cell lines and in Saccharomyces cerevisiae. To further investigate 
the cell death mechanism induced by mutant DFNA5, we performed a 
microarray study in both models using respectively an Illumina human 
HT12v3 bead chip and an Agilent Quick Amp 2 colour 8x15K slide. 
When using wild-type DFNA5 as reference, which in contrast to mutant 
DFNA5 does not induce cell death, our data show that the yeast pathways 
related to mitochondrial ATP-coupled electron transport chain, oxidative 
phosphorylation and energy metabolism are up-regulated, while in human 
cell lines, MAP kinase-related activity is up-regulated. Inhibition of this 
pathway is able to partially attenuate the resulting cell death induced by 
mutant DFNA5 in human cell lines. In yeast, the association with the 
mitochondria was demonstrated by the up-regulation of several cytochrome 
c oxidase genes involved in the cellular oxidative stress production. The link 
between the mitochondria and the MAPK pathway is however unknown at 
this moment but could be mediated by oxidative stress.  
Both models show a down-regulation of protein sorting- and folding-related 
mechanisms (related to the endoplasmic reticulum (ER) in yeast) which 
could indicate a role for the ER. The exact relationship between the ER and 
the mitochondria in DFNA5-induced cell death remains unknown at this 
moment, but these results suggest a potential relation between those 
organelles, triggering a proper cellular response in mutDFNA5-induced cell 
death. Further elucidation of the DFNA5-related cell death mechanism can 
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lead to new insights and therapies related to HL and may yield possible 
therapeutic targets for DFNA5-induced HL. 
3.2 Introduction 
DFNA5 was originally identified as a gene responsible for an autosomal 
dominant form of hearing loss (HL) in a Dutch family [1]. In addition to HL, 
DFNA5 has also been correlated with several forms of cancer, such as 
breast, colorectal, hepatocellular and gastric cancer. Endogenous DFNA5 is 
epigenetically silenced by hypermethylation in cancer cells resulting in a 
decreased DFNA5 expression level [2-5]. 
 
Recently, functional studies in human cell lines revealed that DFNA5 is 
correlated with programmed cell death (PCD). Human HEK293T cells were 
used to study the function of DFNA5 and transfection of mutant DFNA5 
resulted in an apoptotic growth defect compared to wild-type DFNA5  [6, 7]. 
Additionally, experiments in fission yeast revealed a cell cycle arrest upon 
expression of mutDFNA5 [8]. In chapter II we demonstrated the presence of 
this growth defect in the budding yeast Saccharomyces cerevisiae 
confirming the value of this model organism to unravel the mechanisms 
related to DFNA5. Moreover, we also demonstrated a role of mitochondria 
in DFNA5-related cell death in Saccharomyces cerevisiae (described in 
chapter two). Several mitochondrial proteins, such as Fis1, Por1, Aac1 and 
Aac3, were identified to be involved in mutDFNA5-induced cellular toxicity. 
All these proteins are functionally related to mitochondrial fission or 
permeabilisation. Moreover, mutDFNA5 was found to co-localise with a 
mitochondria-targeted red fluorescent protein, Mito-RFP [9]. These former 
observations confirmed the role of mitochondria in cell death mechanisms 
in yeast, more in particular for DFNA5-related processes. Due to the high 
degree of conservation of cell death mechanisms between yeast and 
human, we decided to further investigate DFNA5-related mechanisms both 
in Saccharomyces cerevisiae and in human HEK293T cells.  
 
In order to further elucidate cell death-related to DFNA5, a transcriptomic 
analysis was performed in Saccharomyces cerevisiae and in human HEK293T 
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cells transfected with either wild-type DFNA5 (wtDFNA5) or mutant DFNA5 
(mutDFNA5). In the current study, we confirmed the significance of the 
mitochondria, more specific the cellular ATP-related processes and oxidative 
phosphorylation, in DFNA5-induced cell death in Saccharomyces cerevisiae. 
Additionally, a potential role could also be assigned to the endoplasmic 
reticulum (ER) as a gene ontology analysis identified a correlation of 
mutDFNA5 with processes related to the ER and protein folding. The latter 
observation was not only present in Saccharomyces cerevisiae, but could 
also be confirmed in human cell lines. Furthermore, we show that the MAPK 
pathways, namely the induction of the extracellular signal-regulated kinases 
(ERK) and c-Jun N-terminal kinase (JNK), are activated upon mutDFNA5 
transfection in human cell lines. 
 
At this specific moment the exact role of the mitochondria and ER remains 
unclear. These two organelles do not exist as separate entities, but 
physically interact by mitochondria-associated membranes [10]. Thereby 
our data suggest the presence of a cellular adaptive response related to 
mitochondrial bio-energetics which could be associated with the ER. The 
exact correlation between these two processes and DFNA5 is still a matter 
of debate but further elucidation will lead to a better understanding of 
DFNA5-induced cell death mechanisms. 
3.3 Material and methods 
3.3.1 Yeast 
3.3.1.1 Yeast strains and growth conditions 
In this study, we used the BY4741 (MATa his3∆1 leu2∆0 met15∆0 ura3∆0) 
wild-type strain [11]. Full-length cDNA of either wtDFNA5 or mutDFNA5 was 
isolated and amplified as previously described [8]. Amplified products were 
ligated into yeast pYX212 plasmid containing a HA-marker (Clontech, 
Mountain View, CA, USA) using EcoRI and BamHI restriction sites. All 
constructs were verified by bidirectional sequencing on an ABI genetic 
analyser 3130xl (AppliedBiosystems, FosterCity, CA, USA). 
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Yeast strains were grown at 30°C in selective medium containing 2% glucose 
(SD-URA). 50 ml yeast cultures, transformed with either wtDFNA5 or 
mutDFNA5 were harvested in mid-exponential phase (OD600nm=3.5-4.2) and 
at the post-diauxic shift (OD600nm=7.4-8.4). Standard transformation 
techniques were applied for these transformations [12]. 
3.3.1.2 RNA extraction yeast 
RNA was collected from yeast at mid-exponential phase and just after the 
post-diauxic shift using RNA pure kit following the manufactures instructions 
(GenHunter® Corporation, Nashville, TN, USA). All steps were performed in 
duplo at 4°C to avoid RNA degradation. This resulted eventually in eight 
different RNA samples: mid-exponential wtDFNA5, (WT_E1 and WT_E2), 
mid-exponential mutDFNA5 (Mut_E1 and Mut_E2), post-diauxic wtDFNA5 
(WT_S1 and WT_S2) and post-diauxic mutDFNA5 (Mut_S1 and Mut_S2). 
3.3.1.3 Microarray design and analysis 
Microarray experiments were performed at the VIB Nucleomics Core 
(www.nucleomics.be). Before labelling, RNA concentration and purity were 
determined spectrophotometrically using the Nanodrop ND-1000 
(Nanodrop Technologies) and RNA integrity was assessed using a 
Bioanalyser 2100 (Agilent). Per sample, an amount of 1 µg of total RNA 
spiked with 10 viral polyA transcript controls (Agilent, Santa Clara, CA, USA) 
was converted to double stranded cDNA in a reverse transcription reaction. 
Subsequently the samples were converted to antisense cRNA, amplified and 
labelled with Cyanine 3-CTP (Cy3) or Cyanine 5-CTP (Cy5) in an in vitro 
transcription reaction according to the manufacturer’s protocol (Agilent, 
Santa Clara, CA, USA). A mixture of purified and labelled cRNA (Cy3 label: 5 
pmol; Cy5 label: 3.5 pmol) was hybridised on Agilent Yeastv2 arrays followed 
by washing, according to the manufacturer’s procedures. To assess the raw 
probe signal intensities, arrays were scanned using the Agilent DNA 
MicroArray Scanner and probe signals were quantified using Agilent’s 
Feature Extractor software (version 10.5.1.1). 
In total four different comparisons were made, and each comparison was 
done in duplo by a colour flip. The different comparisons are shown in Fig. 1. 
Gene expressions of strains transformed with wtDFNA5 were compared to 
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strains transformed with mutDFNA5, both in mid-exponential phase 
(comparison 1a) and at the post-diauxic shift (comparison 1b). Additionally, 
comparisons were made between the mid-exponential and the post-diauxic 
shift of either wtDFNA5- (comparison 2b) or mutDFNA5- (comparison 2a) 
transformed cells.  
Analysis of the microarray data was performed using the R package LIMMA 
(http://www.bioconductor.org) [13]. Fold changes were computed using 
raw Cy3 and Cy5 intensities values provided by Agilent’s Feature Extractor 
software (version 10.5.1.1) and loess normalisation and background 
correction were performed to determine the log2-ratios per array. 
Differential expression was assessed via the moderated t-statistic, described 
in Smyth et al. [14]. To control the false discovery rate, multiple testing 
correction was performed. This eventually generated four differentially 
expressed gene lists.  
3.3.2 HEK293T cells  
3.3.2.1 Cell culture and growth conditions 
The microarray experiments in human cell lines were performed using 
Human Embryonic Kidney 293T cells (HEK293T). HEK293T cells were 
subcultured in 60 mm dishes at a density of 2x106 cells in Dulbecco’s 
modified Eagle’s medium containing 4500 mg/L glucose supplemented with 
10% (v/v) fetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 
2 mM L-glutamine. Overnight cultures were transfected with either 
wtDFNA5 or mutDFNA5 using lipofectamine. Six hours post-transfection 
cells were harvested using Triple-x reagent for RNA extraction. All products 
for human cell line cultures were obtained from Invitrogen (San Diego, CA, 
USA). Full-length cDNA of either wtDFNA5 or mutDFNA5 was isolated and 
amplified as previously described [8]. 
3.3.2.2 RNA extraction 
Qiagens RNeasy mini kit was used for RNA extraction from transfected 
HEK293T cells (Qiagen, Hilden, Germany) at different time-points. For the 
microarray experiment RNA was extracted twelve hours post-transfection, 
for the gene analysis by real-time rtPCR, RNA was extracted at either 3, 6, 
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12, 15, 18, 20 or 24 hours post-transfection. For the microarray experiment, 
the integrity of the resulting RNA was checked on an automated Experion 
electrophoresis system (Biorad, Hercules, CA, USA). 
3.3.2.3 Microarray design and analysis 
The ‘Totalprep RNA Amplification’ kit was used to amplify the RNA samples 
(Illumina, Ambion, Austin, TX, USA). Doublestranded-cDNA was generated 
from the mRNA fractions followed by an in vitro transcription reaction which 
produced cRNA strands containing biotin-UTP nucleotides. 750 ng of the 
resulting cRNA samples were hybridised to an Illumina human HT12v3 
beadchip (Illumina, San Diego, CA, USA). 
Six independent biological replicates were used for either wtDFNA5- or 
mutDFNA5-transfected HEK293T cells and loaded on the chip. Overnight 
hybridisation at 58°C was followed by washing and a streptavidin-Cy3 dye 
labelling (Amersham, Buckinghamshire, England). An Illumina Iscan 
equipped with Iscan control software was used to measure the intensity 
values and XY coordinates for every probe on the array. The resulting data 
files were then analysed using the R package “Beadarray v1.14.0” [15] 
followed by a quality control and quantile normalisation. LIMMAv3.2.1 was 
used for the further analysis of the normalised intensity values to determine 
the differentially expressed genes [14].  
3.3.2.4 Real-time rtPCR  
To confirm the results obtained from the microarray data in HEK293T cells, 
gene expression was studied in human HEK293T cell lines using Power SYBR 
Green RNA-to CT 1 Step Kit (Invitrogen, San Diego, CA, USA). Each reaction 
mixture contained 200 nM final primer concentration (primer pairs are 
shown in Suppl Data Table 3.1) and 30 ng RNA template. All reactions were 
performed in triplicate on a LightCycler 480 system (Roche, Basel, 
Switzerland) and resulting data were analysed by Qbase plus (Biogazelle, 
Ghent, Belgium). At least three housekeeping genes were used each time as 
a reference, namely HMBS, GAPDH, RPL13A, UBC and YWHAZ (Suppl. Data 
Table 3.1) [16].  
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3.3.2.5 Western blot analysis 
For western blotting, cells were lysed using RIPA buffer (25 mM Tris-HCl (pH 
7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) (Pierce, 
Rockford, IL, USA) containing a PhosSTOP Phosphatase Inhibitor Cocktail 
Tablet (Roche), an EDTA-free protease tablet and 10 µl (25 units/µl) 
benzonase (70746-4 Novagen®, Merck Millipore, Darmstadt, Germany). 
Transfected HEK293T cells were lysed for 20 minutes at 4°C and centrifuged 
at 2000 g at 4°C to obtain protein lysates. 
 
Proteins were electrophoretically separated and blotted onto a 
nitrocellulose membrane (Whatman, Kent, UK). This membrane was blocked 
for one hour in 5% non-fat dry milk and afterwards incubated overnight 
(4°C) in one of the following primary antibodies: anti-phospho-SAPK/JNK 
(Thr183/Tyr185, #4668), anti-phospho-p44/42 (ERK1/2, #4370), anti-
SAPK/JNK (#9252), anti-p44/42 (ERK1/2, #9102) (Cell Signalling 
Technologies, MA, USA) or anti-β-Actin (A5316, Sigma Aldrich, MO, USA). 
After washing, the membranes were incubated with either a secondary goat 
anti-rabbit (ab6721, Abcam, Cambridge, UK) or sheep anti-mouse (NA931, 
GE Healthcare, Buckingmersham, UK) antibody. Finally, the corresponding 
proteins were visualised using Enhanced ChemiLuminescence Western 
Blotting Substrate (Thermo Scientific, IL, USA). Quantification of the protein 
levels was performed using the ImageQuant TL software (GE Healthcare, 
Buckinghamshire, UK). 
3.3.3 Gene ontology analysis  
In addition to the determination of the differentially expressed genes, gene 
ontology (GO) analysis was performed in order to identify enriched GO 
annotations. GO analysis determines the biologically, cellular and 
molecularly enriched GO terms linked to the differentially expressed genes. 
We used an open-source application, the Ontologizer 
(http://compbio.charite.de/contao/index.php/ontologizer2.html), as a tool 
to statistically analyse the high-throughput data [17]. A standard method for 
statistics, the “Term-for-Term analysis”, was used followed by Benjamini-
Hochberg correction for multiple testing [18, 19]. Differentially expressed 
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genes with a corrected p-value below 0.05 and a log2 (fold change) of 1.5 
and 0.5, in respectively yeast and human cell lines, were selected for this 
analysis. 
3.4 Results 
To study the biological differences of cell death induced by DFNA5 in 
Saccharomyces cerevisiae, we performed a transcriptomic study. RNA 
samples were collected in duplo in the mid-exponential phase and at the 
post-diauxic shift of yeast cells transformed with either wtDFNA5 of 
mutDFNA5. Figure 1 shows all the comparisons studied between the 
different RNA samples (comparisons are labelled 1a, 1b, 2a and 2b). Analysis 
of the microarray data generated four lists of differentially expressed genes.  
Investigation of the differentially expressed genes in mid-exponential phase 
(comparison 1a) revealed no significantly up- or down-regulated genes. 
Therefore this comparison was excluded and only comparisons 1b, 2a and 
2b (shown in Fig. 1) will be taken into account and described.  
Fig. 1: Yeast microarray 
design. a. Illustration of the 
different comparisons that 
were studied between the 
RNA samples. RNA was 
collected from yeast strains 
transformed with either 
wtDFNA5 or mutDFNA5 at two 
different time-points. The red 
and green lines represent the 
colour flip. b. Growth profile 
of the Saccharomyces 
cerevisiae BY4741 background 
strain transformed with either 
wtDFNA5 (grey squares) or 
mutDFNA5 (black squares). 
The blue and red ellipse 
illustrate respectively the mid-
exponential and post-diauxic 
time-points when RNA was 
collected.  
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3.4.1 Mitochondria-related processes are up-regulated in mutDFNA5 in 
post-diauxic shift  
Comparison of the differentially expressed genes in the post-diauxic shift 
(1b) resulted in 451 significantly up-regulated genes between yeast 
expressing mutDFNA5 and using yeast expressing wtDFNA5 as a reference. 
The top 34 of the highest differentially up-regulated genes at the post-
diauxic shift and their association with a specific GO term is shown in Table 
1. Differentially expressed genes with a log2 (fold change) equal or higher 
than 1.5 were selected for GO-enriched annotations, generating 85 
significantly up-regulated genes, which resulted in 65 significantly up-
regulated enriched GO terms.  
 
Analysis of the biological, cellular and molecular GO annotations confirmed 
the role of the mitochondria in mutDFNA5-induced cell death (Suppl. Data 
Table 3.2, indicated in red). Analysis of the GO annotations revealed that the 
molecular cytochrome c oxidase activity-related process (GO: 0004129) was 
the most significantly mitochondrial associated process. Further down the 
list, several biological, molecular and cellular GO processes related to 
mitochondrial mechanisms, such as mitochondrial ATP synthesis-coupled 
electron transport (GO:0042775), aerobic respiration (GO:0009060), the 
mitochondrial respiratory chain (GO:0005746), mitochondrial respiratory 
chain complex IV (GO:0005751) and oxidative phosphorylation 
(GO:0006119) were significantly associated suggesting mitochondrial 
dysfunction (Suppl. Data Table 3.2).  
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Table 1: Top 34 of the highest differentially up-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic shift 
Gene name  logFC AveExpr adj.P.Val GO Term  
     
MAL12 4.16 9.08 0.04 maltose metabolic process 
COX3 4.13 7.46 0.00 respiratory electron transport chain 
MAL32 3.91 8.19 0.04 maltose metabolic process 
ANB1 3.60 9.59 0.01 positive regulation of translational elongation 
SLZ1 3.08 6.38 0.00 - 
PRM7 3.07 11.62 0.01 - 
YPR077C 3.05 9.44 0.00 - 
PRM7 3.04 11.01 0.01 - 
HXT7 3.02 14.80 0.03 transmembrane transport 
YDR374C 2.94 6.69 0.02 - 
YPL014W 2.89 8.59 0.02 protein phosphorylation 
AI5_ALPHA 2.89 10.49 0.04 movement of group I intron (COXI gene) 
RTA1 2.83 7.90 0.00 response to stress 
YPR078C 2.65 7.06 0.00 - 
YLR194C 2.45 13.79 0.01 fungal-type cell wall organization 
SUC2 2.44 11.79 0.04 carbohydrate metabolic process 
SPO20 2.43 9.06 0.01 protein binding 
YOL047C 2.39 10.40 0.01 integral component of membrane 
Q0297 2.38 7.24 0.01 - 
MND1 2.27 7.03 0.01 reciprocal meiotic recombination 
VAR1 2.23 4.18 0.02 mitochondrial translation 
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Table 1 continued: Top 34 of the highest differentially up-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic shift 
Gene name  logFC AveExpr adj.P.Val GO Term  
     
YPL141C 2.22 9.49 0.01 protein phosphorylation 
HXT4 2.22 13.42 0.05 substrate-specific transmembrane transporter activity 
YNR034W-A 2.20 13.88 0.02 - 
YDR034W-B 2.17 9.17 0.02 cell cortex 
COX2 2.16 6.19 0.01 mitochondrial electron transport, cytochrome c to oxygen 
OLI1 2.15 15.96 0.00 ATP synthesis-coupled proton transport 
YBL065W 2.15 6.87 0.01 - 
SPR28 2.13 7.20 0.00 cell cycle 
COX1 2.12 7.77 0.01 mitochondrial electron transport, cytochrome c to oxygen 
DRE2 2.05 12.58 0.01 iron-sulfur cluster assembly 
YKR075C 2.01 13.64 0.00 fungal-type cell wall organization 
YJL218W 2.00 6.92 0.04 - 
YLR338W 1.95 7.52 0.01 - 
YGR287C 1.92 8.55 0.01 carbohydrate metabolic process 
LogFC, logarithm of fold change, up-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for 
multiple hypothesis testing. Genes involved in processes related to the COX activity or energy processes are indicated in bold. ‘-‘ denotes a gene 
with an unknown function. ‘Go Term’ denotes the biological process annotated to the gene or the molecular process/cellular component if the 
biological process was unknown. G.O., gene ontology.  
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Next we compared the identified GO terms with the list containing the 
highest differentially up-regulated genes generated by the R package 
LIMMA to evaluate the resemblances (Table 1). As shown in Table 1, several 
mitochondrial genes related to these GO processes were indeed present in 
the list, including COX/1/2/3 and AI5_ ALPHA (Table 1, indicated in bold). 
COX1/2/3 are the three main subunits of the cytochrome c oxidase, the 
terminal enzyme of the mitochondrial electron transport chain, encoded by 
the mitochondrial genome. The electron transport chain is part of the 
mitochondrial oxidative phosphorylation pathway providing most of the 
cellular ATP [20]. AI5_ALPHA is an endonuclease encoding a mobile intron of 
the COXI gene [21, 22]. Up-regulation of the main COX genes suggests 
enhanced COX activity, which has been associated with increased oxidative 
stress [20, 23].  
In addition, two other groups of significantly enriched GO annotations could 
be distinguished, namely GO annotations related to catabolic and metabolic 
energy processes, such as oligosaccharide catabolic process (GO:0009313) 
or maltose catabolic processes (GO:0000025), and mechanisms related to 
transporter activity, such as cation (GO:0008324) and several sugar 
(GO:0005353 for example) transmembrane activities (Suppl. Data Table 3.2, 
indicated in respectively green and blue). Consistent with the previous 
results, comparison of these processes with the highest differentially up-
regulated genes in Table 1 confirmed these identified GO terms (Table 1). 
Different maltose and sucrose genes like MAL12, MAL32 and SUC2, and 
transmembrane transporter genes like HXT4/7 were present in the list 
(Table 1).  
These results revealed an important role for mitochondria-related processes 
in mutDFNA5 transformed yeast cells in the post-diauxic shift. Especially 
processes associated with the mitochondrial respiratory chain complex and 
cytochrome c oxidase activity showed significant differences. 
3.4.2 Processes associated with glycolysis are down-regulated in 
mutDFNA5 at post-diauxic shift 
To investigate the significantly down-regulated processes and genes in the 
post-diauxic shift between wtDFNA5 and mutDFNA5, we used the same 
method as in the previous part. This revealed 585 significantly down-
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regulated genes in cells expressing mutDFNA5 as compared to those 
expressing wtDFNA5. The top 34 of the highest differentially down-
regulated genes and their association with a specific GO term is shown in 
Table 2. 
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Table 2: Top 34 of the highest differentially down-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic shift. 
Gene name logFC AveExpr adj.P.Val GO Term  
     
ENO2 -3.00 16.12  0.01 glycolytic process 
SSA2 -2.68 14.66  0.01 - 
VHT1 -2.54 13.48  0.02 biotin transport 
DET1 -2.44 16.33  0.01 intracellular sterol transport 
RPS22A -2.44 14.70 <0.00 translation 
PGK1 -2.39 16.90  0.01 glycolytic process 
TDH3 -2.30 15.32  0.01 glucose metabolic process 
TPI1 -2.06 17.08  0.01 metabolic process 
PDC1 -2.05 16.95  0.03 thiamine pyrophosphate binding 
TDH2 -2.02 14.26  0.01 glucose metabolic process 
YHR140W -1.95 8.34  0.03 - 
TOS4 -1.94 10.23  0.05 protein binding 
YRO2 -1.91 14.89  0.03 ion channel activity 
FBA1 -1.91 17.14  0.01 glycolytic process 
RPL9A -1.90 14.27  0.03 translation 
RPL22A -1.86 14.33  0.01 translation 
URA7 -1.83 12.90 <0.00 pyrimidine nucleobase biosynthetic process 
ERG25 -1.77 14.05  0.05 sterol biosynthetic process 
YNR021W -1.74 11.30 <0.00 - 
YBT1 -1.73 12.67  0.05 bile acid and bile salt transport 
KAP122 -1.71 9.48 <0.00 protein import into nucleus 
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Table 2 continued: Top 34 of the highest differentially down-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic 
shift. 
Gene name logFC AveExpr adj.P.Val GO Term  
     
 
CDC19 -1.71 16.94 0.02 pyruvate metabolic process 
YDR509W -1.70 6.06 <0.00 - 
RPS9B -1.67 15.08 <0.00 translation 
GNP1 -1.64 12.19  0.01 amino acid transmembrane transport 
FTR1 -1.61 13.04  0.04 high-affinity iron ion transport 
GPD1 -1.61 13.24  0.05 glycerol-3-phosphate dehydrogenase [NAD+] activity 
RPL16B -1.61 15.38  0.01 translation 
YGR266W -1.61 9.17  0.03 - 
RPA43 -1.60 10.54 <0.00 transcription, DNA-templated 
ARC1 -1.59 13.85  0.01 tRNA aminoacylation for protein translation 
PGI1 -1.58 16.09  0.03 glycolytic process 
RPL18B -1.57 9.61  0.01 translation 
SPE3 -1.56 12.70  0.01 catalytic activity 
LogFC, logarithm of fold change, down-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for 
multiple hypothesis testing. ‘-‘ denotes a gene with an unknown function. ‘Go Term’ denotes the biological process annotated to the gene or 
the molecular process/cellular component if the biological process was unknown.  Genes involved in processes related to the glycolysis or the 
pentose phosphate pathway are indicated in bold. G.O., gene ontology.  
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The significantly down-regulated biological GO annotations can be divided in 
two main groups (Suppl. Data Table 3.3). One group is related to ribosomal 
processes and hence translation such as cytosolic ribosome (GO:0022626) 
and the positive regulation of translation fidelity (GO:0045903) (Suppl. Data 
Table 3.3, indicated in red). The second group was correlated with the 
biosynthesis and metabolism of glucose (GO:0006007), monosaccharide 
(GO:0046365) and glycolysis (GO:0006096).  
Again, we compared the identified GO terms with the list containing the 
highest differentially down-regulated genes generated by the R package 
LIMMA to evaluate the resemblances (Table 2). As expected, this list 
contained several components associated with the glycolysis and several 
protein components of the small and large ribosomal subunit.  
Interestingly, the list also contained several genes such as, TPI, TDH2/3, 
PGK1 and CDC19, which are all enzymes playing a role in either the glycolytic 
or the pentose phosphate pathway (PPP) (Table 2, indicated in bold). CDC19 
is the yeast homologue of the human pyruvate kinase (PK) gene. Down-
regulation of PK has been correlated with the activation of the PPP and the 
redirection of the metabolic flux from glycolysis to PPP both in human cell 
lines and in yeast [24-26]. This will enhance the anti-oxidant response and 
hence increases the tolerance for oxidative stress [26-28]. The down-
regulation of genes involved in glycolysis and the PPP could suggest a link 
with oxidative stress providing a protection mechanism for mutDFNA5-
transformed yeast cells 
3.4.3 Induction of ER-related processes upon mutDFNA5 expression in 
yeast 
In addition to the comparison of mutDFNA5 and wtDFNA5 in the post-
diauxic shift, the modifications between mid-exponential phase and at the 
post-diauxic shift were also investigated both in mutDFNA5- (comparison 2a 
Fig. 1) and wtDFNA5- (comparison 2b Fig. 1) transformed yeast cells. As both 
comparisons studied the differentially expressed genes in exponential phase 
versus post-diauxic shift, we expect the presence of many similar 
significantly expressed genes. These genes are probably related to the post-
diauxc shift but not due to mutDFNA5 expression. Therefore, genes which 
were differentially expressed at the post-diauxic shift upon mutDFNA5 
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transformation, but do not show any differences upon wtDFNA5 expression 
in post-diauxic phase, are potentially related to mutDFNA5-associated 
processes. These were assigned as mutDFNA5-related changes not 
associated with the post-diauxic shift in yeast.  
The GO-enriched processes significantly associated with up-regulated genes 
were very similar between wtDFNA5- and in mutDFNA5-transformed yeast 
cells and correlated with translation. GO-enriched terms significantly 
associated with down-regulated genes were related to ribosomes and RNA. 
These processes were probably due to the shift to respiration and not in 
particular related to mutDFNA5 (data not shown). However, three main 
classes could be distinguished at the post-diauxic shift. Two of them were 
more prominent in mutDFNA5-transformed yeast cells. One class was 
related to the biosynthesis and the metabolism of lipids (GO:0008610), such 
as (ergo)sterols (GO:0016126), (phyto)steroids (GO:0006694) and fatty acids 
(GO:0006633) (Suppl. Data Table 3.4, indicated in red). The other group was 
associated with endoplasmic reticulum processes (GO:0005783), such as the 
endoplasmic reticulum membrane (GO:0005789) and the Sec62/63 complex 
(GO:0031207) (Suppl. Data Table 3.4, indicated in green).  
The third group which could be distinguished was related to the 
cytoskeleton (GO:0005856) and more pronounced in wtDFNA5 transformed 
yeast cells. Cellular enriched GO terms such as the microtubule cytoskeleton 
(GO:0015630) and the microtubule organizing centre (GO:0005815) were 
present in this list (Suppl. Data Table 3.5, indicated in red).  
3.4.4 Association of DFNA5 with the MAPK-related mechanisms in 
HEK293T cells 
To evaluate the value of the yeast model and to further elucidate the 
DFNA5-related pathways, a microarray experiment was performed in human 
HEK293T cells. As described previously, mutDFNA5 induced a growth defect 
in transfected HEK293T cells compared to wtDFNA5 and control [7]. These 
cell death events were evident from 9 h post-transfection and peaked at 12 
h (data not shown). Therefore RNA samples of HEK293T cells were collected 
12 h post-transfection. A transcriptomic analysis was performed on HEK293T 
cells transfected with either wtDFNA5 or mutDFNA5. Six biological replicates 
of every RNA sample were collected although one wtDFNA5-transfected 
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sample did not survive quality control. Therefore, subsequent analyses, 
using wtDFNA5 as a reference, were performed on five wtDFNA5- versus six 
mutDFNA5-transfected samples. Analysis using “Beadarray” and “LIMMA” 
packages available in R identified 228 significantly up- and 222 significantly 
down-regulated genes after correction for multiple hypothesis testing 
(p<0.05). Besides individual gene expression, GO analysis was performed to 
determine the biologically, cellular and molecularly enriched GO 
annotations linked to the differentially expressed genes.  
Table 3 shows the top 34 of the highest significantly up-regulated genes and 
their association with a specific GO term. It contains several genes related to 
the MAPK pathway such as EGR1/2, FOSB and JUNB (indicated in bold). 
Interestingly, this list also contained the PMAIP1 gene. PMAIP1 encodes a 
BH3-only protein belonging to the BCL2 protein family, a family of important 
regulators of apoptotic cell death related to the mitochondria. The top 34 of 
the highest down-regulated genes and their association with a specific GO 
term is shown in Table 4 and contains several genes related to protein 
folding such as HSPA6, ATF3 and CTH (indicated in bold, Table 4).  
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Table 3: Top 34 of the highest significantly up-regulated genes in mutDFNA5-transfected HEK293T cell 
Gene name logFC AveExpr adj.P.Val GO term 
     
ZCCHC12 2.63 12.07 <0.00 transcription, DNA-templated 
ETV5 1.88 9.11 <0.00 regulation of transcription, DNA-templated 
LOC387763 1.86 10.00 <0.00 - 
EGR1 1.83 11.82 <0.00 cellular response to growth factor stimulus, response to cAMP 
ARC 1.61 8.76 <0.00 cytoskeleton organization 
FOSB 1.58 8.85 <0.00 response to cAMP 
KCTD12 1.40 10.32 <0.00 protein homo-oligomerisation 
JUNB 1.40 9.09 <0.00 response to cAMP 
ADAMTS1 1.24 9.88 <0.00 proteolysis 
EGR2 1.19 8.12 <0.00 cellular response to growth factor stimulus, response to cAMP 
FOS 1.18 10.17 <0.00 stress-activated MAPK cascade 
CITED1 1.16 11.66 <0.00 melanocyte differentiation 
MAFB 1.12 9.32 <0.00 negative regulation of erythrocyte differentiation 
RPL15 1.11 13.23 <0.08 translation 
GPR3 1.07 8.29 <0.00 G-protein-coupled receptor signalling pathway 
TNFRSF12A 1.06 9.77 <0.00 positive regulation of apoptotic process 
TRIB1 1.04 11.60 <0.00 regulation of MAP kinase activity 
ANXA1 1.03 8.98 <0.00 inflammatory response 
PMAIP1(2750367) 1.00 10.76 <0.00 positive regulation of apoptotic process 
ETV4 0.99 7.71 <0.00 regulation of transcription, DNA-templated 
SPRY2 0.97 9.96 <0.00 positive regulation of protein serine/threonine kinase activity 
PMAIP1(6020598) 0.96 9.30 <0.00 positive regulation of apoptotic process 
CCNA1 0.94 7.60 <0.00 regulation of cell cycle 
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Table 3 continued: Top 34 of the highest significantly up-regulated genes in mutDFNA5-transfected HEK293T cell 
Gene name logFC AveExpr adj.P.Val GO term 
     
TRIM9 0.92 10.00 <0.00 protein ubiquitination 
MAFF 0.90 7.95 <0.00 regulation of transcription, DNA-templated 
FAM84B 0.90 12.04 <0.00 protein binding 
EPHA2 0.89 7.98 <0.00 multicellular organismal development 
CYP1B1 0.88 8.52 <0.00 membrane lipid catabolic process 
NDRG1 0.87 9.54 <0.00 DNA damage response, signal transduction by p53 class mediator 
SERTAD1 0.85 10.14 <0.00 transcription, DNA-templated 
MCL1 0.81 10.20 <0.00 apoptotic mitochondrial changes 
SPRY4 0.81 7.66 <0.00 multicellular organismal development 
VGF 0.79 8.30 <0.00 growth factor activity 
NEFM 0.79 11.58 <0.00 neurofilament cytoskeleton organization 
LogFC, logarithm of fold change, down-regulation in mutDFNA5-transfected HEK293T cells using wtDFNA5 as a reference; adj.p.value, p-value 
adjusted for multiple hypothesis testing. ‘Go Term’ denotes the biological process annotated to the gene or the molecular process/cellular 
component if the biological process was unknown. ‘-‘ denotes a gene with an unknown function. ‘(number)’ denotes the array address of the 
specific splice variant on the microarray chip. Genes involved in processes related to either the MAPK pathway, cAMP response or the 
mitochondria are indicated in bold. G.O., gene ontology. 
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Table 4: Top 34 of the highest significantly down-regulated genes in mutDFNA5-transfected HEK293T cells 
Gene name logFC AveExpr adj.P.Val GO term 
     
HSPA6 (160092) -1.54 10.49 <0.00 response to unfolded protein 
DDIT4 -1.26 10.18 <0.00 intrinsic apoptotic signalling pathway in response to DNA damage by p53 class mediator 
CLEC2D -0.97 9.47 <0.00 cell surface receptor signalling pathway 
ZNF256 -0.91 9.10 <0.00 transcription, DNA-templated 
TDP1 -0.87 10.90 <0.00 DNA repair 
LRP5L -0.84 8.76 <0.00 canonical Wnt signalling pathway 
CTH (60138) -0.80 10.40 <0.00 endoplasmic reticulum-unfolded protein response 
SNORD15B -0.78 8.76 <0.00 - 
C17orf48 -0.76 8.45 <0.00 hydrolase activity 
LOC389816 -0.73 8.57 <0.00 ion transport 
HSPA6 (1710553) -0.71 9.28 <0.00 Response to unfolded protein 
ZMAT3 -0.70 12.59 <0.00 apoptotic process 
PMS2L3 -0.67 8.69 <0.00 - 
PCDHGA9 -0.66 7.61 <0.00 homophilic cell adhesion 
CTH (6220504) -0.65 8.29 <0.00 endoplasmic reticulum-unfolded protein response 
C3orf34 -0.64 12.64 <0.00 centriole 
FANCE -0.64 9.35 <0.00 DNA repair 
HRK -0.64 8.82 <0.00 positive regulation of release of cytochrome c from mitochondria 
C5orf13 -0.64 9.27 <0.00 regulation of neuron differentiation 
LRAP -0.63 13.23 <0.00 proteolysis 
CLEC2D -0.61 14.72 <0.00 cell surface receptor signalling pathway 
GUSBL1 -0.60 10.04 <0.00 - 
DTL -0.60 10.17 <0.00 protein polyubiquitination 
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Table 4 continued: Top 34 of the highest significantly down-regulated genes in mutDFNA5 transfected HEK293T cells 
Gene name logFC AveExpr adj.P.Val GO term 
     
 
ZSCAN16 -0.58 8.66 <0.00 transcription, DNA-templated 
CTH (1470576) -0.58 8.75 <0.00 endoplasmic reticulum-unfolded protein response 
LOC654194 -0.58 13.17 <0.00 - 
SNORD68 -0.58 10.17 <0.00 - 
ZNF205 -0.57 7.83 <0.00 transcription, DNA-templated 
ZNF416 -0.57 8.56 <0.00 transcription, DNA-templated 
LRRC26 -0.57 8.19 <0.00 ion transport 
Hs.537645 -0.57 7.54 <0.00 - 
ATF3 (4780128) -0.56 11.95 <0.00 activation of signalling protein activity involved in unfolded protein response 
ACOT2 -0.55 9.15 <0.00 long-chain fatty acid metabolic process 
PCK2 -0.55 9.22 <0.00 gluconeogenesis 
LRRC20 -0.54 8.67 <0.00 
 LogFC, logarithm of fold change, down-regulation in mutDFNA5-transfected HEK293T cells using wtDFNA5 as a reference; adj.p.value, p-value 
adjusted for multiple hypothesis testing. ‘Go Term’ denotes the biological process annotated to the gene or the molecular process/cellular 
component if the biological process was unknown. ‘-‘ denotes a gene with an unknown function. ‘(number)’ denotes the array address of the 
specific splice variant on the microarray chip. Genes involved in processes related to protein folding are indicated in bold. G.O., gene ontology. 
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Subsequent GO analysis of the biological annotations revealed, in addition 
to the more general development processes, the up-regulation of the MAPK 
pathway (GO:0043407) and the cAMP response (GO:0051591) (Suppl. Data 
Table 3.6, indicated in red). The response to protein folding (GO:0006986) 
and to topologically incorrect protein (GO:0035966) were the only two 
processes associated with the down-regulated genes in human cell lines and 
both were related to protein folding (Suppl. Data Table 3.7). The most 
important genes that are involved in these processes were HSPA6, a heat 
shock protein and several chaperones proteins, such as DNAJB1 and 
DNAJB2.  
These results demonstrate the association of mutDFNA5-induced cell death 
with the MAPK pathways. The identification of processes related to protein 
folding supports the results in yeast where GO terms related to the ER were 
significantly associated with mutDFNA5. 
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3.4.5 Validation of the MAPK role in DFNA5-related cell death in 
HEK293T cells 
The data generated by the transcriptomic analysis in HEK293T cells were 
validated by real-time rtPCR on newly collected RNA samples. EGR1 and 
FOSB gene expression was investigated on different time-points ranging 
from 3 h until 18 h post-transfection. As shown in Fig. 2, significantly up-
regulated EGR1 and FOSB gene expression was observed from 12 h until 18 
h post-transfection (p<0.05) (Fig. 2). Hence the data generated by the 
transcriptomic analyses were indeed confirmed by real-time rtPCR as 
demonstrated by up-regulation of genes related to the MAPK pathway. 
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Fig. 2: Increased EGR1 and FOSB gene expression in mutDFNA5-
transfected HEK293T cells. RNA samples were collected from HEK293T 
cells transfected with either wtDFNA5 or mutDFNA5 and gene 
expression was measured by real-time rtPCR. Significantly increased 
expression was seen in mutDFNA5 at 12 h (p(egr1)=0.000; 
p(fosB)=0.006), 15 h (p(egr1)=0.017; p(fosB)=0.000) and 18 h 
(p(egr1)=0.004; p(fosB)=0.026) post-transfection. *: p<0.05; **: p<0.01; 
***: p<0.001. 
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After confirmation by real-time rtPCR, the significance of the activated 
MAPK pathway was further validated by two independent experiments. It 
was previously shown that mutDFNA5 induced a growth defect in HEK293T 
cells compared to wtDFNA5 and control [7]. To investigate the significance 
of the MAPK pathway, we wondered whether inhibition of the MAPK 
pathway would attenuate this mutDFNA5-induced growth defect. 
Therefore, a specific JNK inhibitor, namely SP600125, was added followed by 
a viability assay to determine the effect on cell survival. Different 
concentrations of the JNK inhibitor SP600125 were used to measure viability 
by flow cytometry and these results were compared to untreated 
mutDFNA5-transfected HEK293T cells. Overnight treatment of the cells with 
different concentrations of SP600125 did not have any major effect on 
transfection efficiency, but significantly increased the viability of mutDFNA5-
transfected cells. Although addition of both 12.5 µM and 25 µM SP600125 
both significantly increased the viability with a p-value of respectively 0.020 
and 0.004, SP600125 had the greatest effect with a concentration of 25 µM 
SP600125 where the viability was raised from 31.93% to 51.00% (Fig. 3). 
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Fig. 3: MAPK inhibitor effect on mutDFNA5-transfected HEK293T cells. MutDFNA5-
transfected HEK293T cells were pretreated with different amounts of SP600125 (JNK 
inhibitor). Cell viability was measured and compared to untreated mutDFNA5-transfected 
HEK293T cells. *: p<0.05; **: p<0.01. 
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Next, to evaluate the effect of MAPK up-regulation on protein level, 
different MAPK proteins were studied by western blotting. There are three 
main MAPK pathways in human cell lines represented by the ERK, JNK and 
p38 MAPK branch. Consistent with the results obtained by RT-PCR and the 
viability assay, activation of the MAPK pathway proteins was also 
demonstrated by western blotting. Total protein lysates were collected from 
HEK293T cells 12 h post-transfection. Three phosphorylated (activated) and 
non-phosphorylated (not activated) proteins of the MAPK pathway were 
studied using six different antibodies. Activation of ERK (p42/p44) and JNK 
was seen upon mutDFNA5 transfection compared to control and wtDFNA5 
(Fig. 4a). No differences were seen in the expression level of non-
phosphorylated ERK and JNK (Fig. 4a). The expression of p38 was also 
evaluated but no difference in protein expression was observed between 
mutDFNA5 compared to wtDFNA5 and control (data not shown). β-Actin 
was used as a loading control and quantification of the protein expression 
was performed in relation to β-actin using ImageQuantTL software (GE 
Healthcare), although this increase was not significant as determined by one 
way Anova (p<0.05, Fig. 4b).  
 
These results suggest that DFNA5 induces cell death mediated through 
activation of the MAPK pathways. Addition of a MAPK inhibitor partially 
attenuated the mutDFNA5-induced growth defect identifying the MAPK 
pathway as an early event in mutDFNA5-associated cell death.
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3.4.6 Comparison of the yeast microarray results with the gene 
expression in human cell lines 
In order to study the significance of the yeast results, a comparison was 
made between the two microarray experiments. Human homologues of the 
significantly up- and down-regulated yeast genes at the post-diauxic shift 
(comparison 1b) were identified using Ensemble Biomart. Of the 451 
significantly up- and 585 significantly down-regulated yeast genes, 
respectively 296 and 647 human homologues were identified. These specific 
human homologues were analysed by the R package LIMMA generating a 
new list of human genes. The FC cut-off of the resulting gene list was set to 
FC 1.2, resulting in 16 up- and 14 down-regulated human genes. TM7SF2, 
UCP2 and VPS33B, three down-regulated human genes, were selected to 
verify the yeast results in human cell lines using RT-PCR. UCP2 and VPS33B 
were the two highest down-regulated genes present in the list and therefore 
selected. UCP2, an uncoupling protein, is a mitochondrial carrier located at 
the mitochondrial inner membrane. Suppression of UCP2 has been linked to 
increased ROS production [29, 30] and lifespan regulation [31, 32]. The 
Vacuolar protein sorting 33 homologue (VPS33B) gene is involved in 
intracellular vesicle Golgi-to-lysosome transport [33, 34]. TM7SF2 was 
selected based on its function which showed some resemblances with the 
yeast results. TM7SF2 is a transmembrane protein present in the 
endoplasmic reticulum and associated with biosynthesis of cholesterol. In 
addition to its role in cholesterol synthesis, TM7SF2 appears to be involved 
in the inflammatory response upon cellular stress [35-38].  
To verify the yeast results in human cell lines, RNA was collected from 
HEK293T cells transfected with either wtDFNA5 or mutDFNA5 at different 
time-points starting at 12 h after transfection as this was the time-point of 
the human microarray experiment. The TM7SF2, UCP2 and VPS33B genes 
had a fold change of respectively 1.23, 1.31 and 1.27 on the microarray. RT-
PCR on RNA samples 12 h post-transfection confirmed these microarray 
results as all three genes were down-regulated in mutDFNA5 compared to 
wtDFNA5 (Fig. 5a) with fold changes comparable to the microarray 
(respectively 1.35, 1.48 and 1.59). Although not significantly, these three 
genes were down-regulated in HEK293T cells 12 h after transfection (Fig. 
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5a). The down-regulation was still present at 20h, peaked at 24h after 
transfection and was even significant for TM7SF2 (p:0.01) and UCP2 (p:0.07) 
at respectively 20 h and 24 h post-transfection (Fig. 5b). Due to this down-
regulation, we can conclude that there are some similarities between the 
yeast and the HEK293T microarray. Discrepancies are seen when looking at 
the individual genes, but upon study of the different pathways a role for 
processes related to protein folding were seen in both model systems. 
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3.5 Discussion 
This study further investigated the biological differences induced by DFNA5 
in Saccharomyces cerevisiae and in human HEK293T cells. A previous study 
in human cell lines revealed that mutDFNA5 is a cell death inducing gene [7]. 
As described in chapter II, transformation of mutDFNA5 in yeast resulted in 
a growth defect associated with four different mitochondria-related 
proteins. This was the first time that a possible link between the 
mitochondria and DFNA5 was established. In addition, we observed that the 
protein quality control system, responsible for correct protein folding and 
degradation, had problems to cope with mutDFNA5.  
This study confirmed the involvement of mitochondria-related processes 
upon expression of mutDFNA5 in Saccharomyces cerevisiae, especially the 
ATP-coupled electron transport. Several genes related to either the 
glycolysis and the PPP were significantly down-regulated upon mutDFNA5 
transformation in yeast. Furthermore, we show that the JNK and ERK MAPK 
pathways are activated in vitro after transfection of mutDFNA5 in HEK293T 
cells and that inhibition of this pathway is able to partially attenuate the 
resulting cell death. Additionally, this study also revealed an association of 
GO annotations related to the endoplasmic reticulum and protein folding in 
both model organisms.  
3.5.1 Link to oxidative stress 
The up-regulation of different cytochrome c oxidase (COX) genes in yeast 
revealed a potential association of the mutDFNA5-related cell death 
mechanisms with oxidative stress as enhanced COX activity has been 
associated with increased oxidative stress [20, 23]. Previous data indeed 
demonstrated a change in redox homeostasis due to mutDFNA5 expression 
in yeast as described in chapter II. Here we showed increased oxidative 
stress measured by a dihydroethidium bromide staining (DHE). Moreover, 
preliminary experiments in human cell lines confirmed this and also 
revealed enhanced oxidative stress measured by a DHE staining (chapter IV). 
COX is the rate limiting enzyme of respiration which regulates the bio-
energetic status of the cell. Dependent on the cellular energetic 
requirements, COX activity can be rapidly adapted. The ratio of ATP/ADP is 
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one of the regulators of the COX activity. High ADP levels or ATP utilisation 
will increase the enzyme activity and stimulate respiration [39, 40]. 
Activation of the cytochrome c oxidase activity could result in higher 
oxidative stress generated at the mitochondria and elicit mitochondria-
related cell death.  
Additionally, the correlation of mutDFNA5 with several genes of the PPP can 
also be linked to oxidative stress in yeast as the PPP plays a major role in the 
anti-oxidant response. Reduced expression of CDC19, the yeast homologue 
of PK, and of TPI has been correlated with the activation of the PPP and the 
redirection of the metabolic flux from glycolysis to PPP both in human cell 
lines and in yeast [24, 27, 41]. This study revealed both reduced gene 
expression of TPI and CDC19 indicating a shift in redox sensing in eukaryotes 
mediating a fast response to oxidative stress. Activation of the PPP is 
correlated with the inhibition of ROS accumulation and enhancement of the 
anti-oxidant response upon shift from fermentation to respiration. PPP 
activation will enhance the anti-oxidant response and hence increase the 
tolerance for oxidative stress [26-28]. These data demonstrate a change in 
redox homeostasis due to mutDFNA5 expression which was shown 
previously in yeast (chapter II). 
 
Furthermore, enhanced oxidative stress is often related to a failing protein 
quality control system [42-46]. This possibility was already suggested by the 
proteolytic degradation previously seen upon wtDFNA5 transformation in 
yeast, but which was absent in mutDFNA5-transformed yeast cells. 
MutDFNA5 seemed to escape this quality control system, in contrast to 
wtDFNA5 which was subject to the normal clearance system (see chapter II). 
This study thus already suggested a possible link between protein 
degradation and the mitochondria in mutDFNA5-induced cell death as yeast 
seemed to have problems with proper mutDFNA5 protein turnover and this 
link was confirmed in the current study.  
3.5.2 Contribution of the mitochondria in MAPK-related cell death 
In addition to the mitochondria, the MAPK pathways seem to play a 
prominent role in mutDFNA5-induced cell death in HEK293T cells. The link 
between the mitochondria and MAPK in DFNA5-related cell death is 
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unknown at this moment, but several mitochondria-MAPK correlations have 
been described. It is known that MAPK pathways can be induced by ROS 
production generated by the mitochondria [47]. As increased oxidative 
stress has been shown in an earlier study in yeast (see chapter II) and in 
human cell lines (described in chapter IV) this can provide a direct link 
between these two processes. This could suggest that ROS activates the 
MAPK pathway which places ROS up-stream of the MAPK pathway in 
DFNA5-induced cell death. However, a specific MAPK inhibitor was able to 
attenuate the cell death-inducing effects of mutDFNA5, shown in this study, 
and several anti-oxidants (data not shown) did not inhibit this process 
implying that ROS is either a secondary mutDFNA5-related event, or that the 
activation of MAPK is an early event in the cell death process situated up-
stream of ROS production. Furthermore, comparison of yeast and the 
human microarray results identified UCP2, a gene associated with the 
mitochondria, which showed reduced gene expression in mutDFNA5 
transfected cells compared to wtDFNA5 transfected cells. Interestingly, 
mitochondrial stress has been linked to the down-regulation of UCP2 by 
activation of the MAPK pathway and of JNK activation in particular [48, 49]. 
UCP2 reduction was an early event required for the amplification of the 
activated MAPK pathway enabling mitochondrial ROS production [49, 50]. 
This down-regulation enables mitochondrial ROS production providing the 
amplification loop stimulating the MAPK pathway. 
UCP2 can therefore provide the link between MAPK and the mitochondria, 
regulating the ROS production, a feature dysregulated in both model 
organisms. The link between increased ROS, seen in HEK293T cells 
(described in chapter IV) and in yeast (chapter II), and the MAPK pathway is 
however, uncertain at this moment and needs to be further investigated.  
3.5.3 Link ER and mitochondria 
The increase in mitochondrial metabolism seen in this study, namely the 
ATP-coupled electron transport and respiration, and the decrease of protein 
folding processes, can also be explained by the presence of cellular ER stress 
leading to an unfolded protein response. Mitochondria and ER form an 
interconnected network which is important for several biological processes 
mediating an adaptive response under various cellular stress conditions [51, 
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52]. The association between mutDFNA5 and the GO terms related to lipid 
metabolism, protein targeting to ER and the ER membrane, can suggest the 
presence of ER stress [53]. Mitochondria depend on the ER for the import of 
several proteins and lipids and for Ca2+ exchange involved in cell death and 
mitochondrial metabolism [54-57]. Enhanced Ca2+ supply will increase ATP 
production and mitochondrial respiration, processes which were indeed 
both up-regulated at the post-diauxic shift upon mutDFNA5 expression. 
Prolonged enhancement however will eventually have a detrimental effect 
on the mitochondria. 
Despite the limited knowledge about the correlation of mutDFNA5 with ER 
stress, certain forms of HL have already been correlated with the presence 
of ER stress. The Usher syndrome for example, a syndromic form of hearing 
loss, is associated with enhanced ER stress due to protein trafficking defects 
upon mutations [58]. Other forms of HL, such as ototoxicity, were also 
shown to be correlated with ER stress-dependent pathways. Certain 
pharmaceutica lead to tinnitus and progressive bilateral sensorineural HL 
and showed increased ROS production, altered ER morphology and changes 
in ER stress markers, such as CHOP [59].  
Taken together, the previous observation of the importance of the 
mitochondria in mutDFNA5-related cell death and the known correlation 
between the ER and the mitochondria underlines a potential role for the ER 
in DFNA5-induced cell death. The failing of the protein quality control 
system in mutDFNA5, described in chapter II, suggests the involvement of 
the ER, but remains unclear at this moment and needs to be further 
investigated in the future.  
 
In conclusion, this study confirms the role of the mitochondria in 
mutDFNA5-induced toxicity in yeast. Additionally, it showed that 
mutDFNA5-induced cell death is mediated by the MAPK pathway, especially 
through the ERK and the JNK branch. Inhibition of this pathway could 
significantly enhance the cell viability of mutDFNA5-transfected HEK293T 
cells which suggests the importance of this signalling cascade for DFNA5. 
How the MAPK pathways perform their cell death role remains uncertain at 
this moment. The importance of the ER needs to be further investigated in 
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the future. The connection with DFNA5-related mechanism is unclear at this 
moment, but is a good starting point for future studies to unravel the 
DFNA5-induced cell death mechanism which can lead to new therapies and 
to new insights in HL-related to mitochondrial dysfunction.  
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4 Mutant DFNA5-induced cell death is mediated by 
mitochondrial dysfunction 
4.1 Abstract 
Programmed cell death (PCD) is widely present, tightly regulated and 
essential for survival. Several forms of PCD exist side by side and these are 
often highly interconnected. Hearing loss (HL) is one specific pathology 
which has been linked to PCD, especially in the development of the 
vertebrate inner ear and in the morphogenesis of the semicircular canals [1]. 
Apoptosis has been specifically linked to the degeneration of the auditory 
sensory hair cells. Mice deficient in caspase-3, a marker for apoptosis, show 
elevated ABR thresholds and hair cell loss at day 30 [2]. Similarly, oxidative 
stress, another cell death hallmark, can damage the auditory sensory hair 
cells in rats shown by Kopke et al [3]. Due to its prominent role in hearing 
impairment, several types of HL have been linked to PCD, such as age-
related hearing impairment (ARHI), noise-induced hearing loss (NIHL) and 
monogenic HL. Noise-induced damage of hair cells for example could be 
prevented by the inhibition of apoptosis [4]. This study will focus on PCD-
related to DFNA5, a gene responsible for autosomal non-syndromic 
dominant HL. Mutations in DFNA5 leading to exon 8 skipping, result in HL in 
several families. In addition to HL, DFNA5 was identified as a tumour 
suppressor gene involved in different forms of cancer, like breast, colorectal, 
gastric and melanoma cancer.  
We characterised mutant DFNA5 as a cell death-inducing gene both in 
human cell lines [5] and in Saccharomyces cerevisiae. Moreover, several 
mitochondrial proteins, like Fis1, Por1, Aac1 and Aac3, were identified 
contributing to mutant DFNA5-related cell death in yeast (chapter II). These 
four proteins were all related to mitochondrial fragmentation or 
permeabilisation indicating a correlation of mutant DFNA5 with the 
mitochondria.  
In order to further elucidate the cell death mechanisms related to HL, we 
performed several mitochondrial assays to investigate their role in the 
induction of apoptotic cell death in human cell lines. We showed that 
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dysfunctional mitochondria are clearly present in mutant DFNA5-transfected 
HEK293T cells, as demonstrated by the release of cytochrome c and citrate 
synthase, loss of the mitochondrial membrane potential and increased 
oxidative stress. Additionally, accumulation of damaged mitochondria, as 
shown by disintegration of the mitochondrial network, was present upon 
mutant DFNA5 transfection, although their association with mutant DFNA5 
is still unclear.  
4.2 Introduction 
Cell death is inherent to life and essential during numerous cellular 
processes, such as development, organogenesis and the function of the 
immune system. Excessive or scarce cell death however, has major 
implications on tissue homeostasis [1, 4]. It is essential to maintain this 
delicate task in balance and therefore cell death is tightly regulated.  
 
As described in chapter II we characterised mutant DFNA5 as a cell death-
inducing gene in human cell lines and in Saccharomyces cerevisiae. 
Moreover, several mitochondrial proteins, like Fis1, Por1, Aac1 and Aac3, 
were identified in yeast contributing to mutant DFNA5-related cell death. In 
order to further elucidate the cell death mechanisms related to HL, we 
performed several mitochondrial assays to investigate their role in the 
DFNA5-induced cell death in human cell lines. Former results characterised 
DFNA5-induced cell death as apoptotic based on TUNEL positivity and a 
AnnexinV/PI staining [5]. Re-evaluation of the former results obtained in 
human cell lines displayed some uncertainties concerning the role of 
apoptosis. Therefore, we started with the investigation of the role of 
caspases and the release of cytochrome c, typical hallmarks of apoptosis. 
Additionally, two caspase-independent forms of PCD were evaluated, 
namely necroptosis and ferroptosis.  
Besides apoptosis, mitochondria could also play a central role during 
autophagy, more in particular in mitophagy. Therefore, some preliminary 
autophagic experiments were performed in order to unravel the role of this 
survival pathway in DFNA5-induced cell death.  
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Necroptosis, ferroptosis and autophagy were inhibited by respectively Nec-
1s, erastin and 3-methyladenine (3-MA) to determine their role in 
mutDFNA5-transfected HEK293T cells. No specific form of cell death could 
be attributed to mutDFNA5, but transfection of HEK293T cells with 
mutDFNA5 resulted in the disintegration of the mitochondrial network, the 
release of cytochrome c and the matrix citrate synthase suggesting 
mitochondrial collapse. Accumulation of damaged mitochondria is thus 
inherent to mutDFNA5-induced cell death, but the link between the 
mitochondria and mutDFNA5-associated cell death remains unknown.  
4.3 Material and methods 
4.3.1 Reagents 
Ferrostatin-1 (SML0583) and 3-methyladenine (3-MA, M9281) were 
purchased from Sigma-Aldrich (MO, USA). Z-Val-Ala-DL-Asp-
fluoromethylketone (zVAD-fmk, N-1510.0005) was purchased from 
Bioconnect Lifesciences (Huissen, Nederland). Nec-1s was kindly provided by 
Prof. Koen Augustyns (Laboratory of Medicinal Chemistry, University of 
Antwerp). Necrox and t-BHP (tert-butylhydroperoxide) were kindly provided 
by Prof. Wim Martinet (Laboratory of Physiopharmacology, University of 
Antwerp). Erastin was kindly provided by Prof. Peter Vandenabeele (VIB 
Inflammation Research Center, University of Gent). 
4.3.2 Constructs, cell culture and growth conditions 
Human full-length DFNA5 cDNA constructs, previously described by Gregan 
et al., were used as a template to amplify wtDFNA5 and mutDFNA5 [5, 6]. 
pEGFP-N1 was either used as the ligation vector for the constructs or left 
empty to use as a control (EGFP, hereafter referred to as control). All 
constructs were verified by bidirectional sequencing on an ABI genetic 
analyser 3130xl (Applied Biosystems, Foster City, CA, USA).  
Human Embryonic Kidney 293T cells (HEK293T) were subcultured in a 6-well 
plate at a density of 8 x 105 cells in Dulbecco’s modified Eagle’s medium 
containing 4500 mg/l glucose supplemented with 10% (v/v) fetal calf serum, 
100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine 
(DMEM+). Overnight cultures were transfected with control, wtDFNA5 or 
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mutDFNA5 using lipofectamine. Six hour after incubation with serum-free 
Optimem, cells were incubated in DMEM+ medium. Cells were harvested 
using Triple-x reagent. All products for human cell cultures were purchased 
from Invitrogen (San Diego, USA).  
4.3.3 Western Blot analysis 
For western blotting, cells were lysed using RIPA buffer (25 mM Tris-HCl (pH 
7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) (Pierce, 
Rockford, IL, USA) containing a PhosSTOP Phosphatase Inhibitor Cocktail 
Tablet (Roche), an EDTA-free protease tablet and 10 µl (25units/µl) 
benzonase (70746-4 Novagen®, Merck Millipore, Darmstadt, Germany). 
Transfected HEK293T cells were lysed for 20 minutes at 4°C and centrifuged 
at 2000 g at 4°C to obtain protein lysates.  
Proteins were electrophoretically separated and blotted onto a 
nitrocellulose membrane (Whatman, Kent, UK). This membrane was blocked 
for an hour in 5% non-fat dry milk and incubated overnight (4°C) in one of 
the following primary antibodies: anti-LC3 (5F10 clone, NanoTools, 
Teningen, Germany), anti-cleaved caspase-3 (#9661), anti-cleaved caspase-8 
(#9496S), anti-caspase-9 (#9508) (Cell Signalling Technologies, MA, USA), 
anti-citrate synthase (sc-390693), anti-cytochrome c (K265-100, Biovision, 
CA, USA) or anti-β-Actin (A5316, Sigma Aldrich, MO, USA). After washing, 
the membranes were incubated with either a secondary goat anti-rabbit 
(ab6721, Abcam, Cambridge, UK) or sheep anti-mouse (NA931, GE 
Healthcare, Buckingmersham, UK) antibody. Finally, the corresponding 
proteins were visualised using Enhanced ChemiLuminescence Western 
Blotting Substrate (Thermo Scientific, IL, USA). Quantification of the protein 
levels was performed using the ImageQuant TL software (GE Healthcare). 
The LC3 protein expression was visualised by InfraRed (700 nm) detection 
using an Odyssey Sa Infrared imaging system (Li-Cor, NE, USA). 
4.3.4 DNA laddering 
DNA fragmentation was measured using the Apoptotic DNA Ladder Kit from 
Roche (Cat:11 835 246 001, Basel, Switzerland) and performed according to 
the manufactures instructions.  
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4.3.5 Mitochondrial assays 
4.3.5.1 Mitochondrial membrane potential and oxidative stress 
Tetra Methyl Rhodamine Methylester (TMRM, Sigma Aldrich, MO, USA) was 
used to measure the mitochondrial membrane potential (Δψ). TMRM is a 
mitochondrial staining for which uptake is dependent on the presence of the 
Δψ. Twelve hours post-transfection, HEK293T cells were incubated with 200 
nM TMRM for 10 minutes at 37°C.  
Oxidative stress was measured by incubating HEK293T cells, 12 h post-
transfection, for 10 minutes with 2.5 µg/ml dihydroethidium (DHE, Sigma 
Aldrich, MO, USA) at room temperature. After these stainings, cells were 
collected and measured by flow cytometry (CyFlow ML, Partec, Germany). 
4.3.5.2 Cytochrome c and citrate synthase detection 
To measure the release of cytochrome c and citrate synthase to the cytosol, 
transfected HEK293T cells were fractionated to obtain a mitochondrial and a 
cytosolic protein fraction. HEK293T cells were gently lysed for 15’ on ice 
using a HEPES buffer (0.05 nM HEPES, 150 mM NaCl, pH 7.4) containing 25 
µg/ml digitonin (Invitrogen, San Diego, USA). A first centrifugation step 
(200g, 4°C) retrieved the supernatants containing the cytosolic fraction. The 
pellet was further lysed following the protocol described above (4.3.3.). A 
cytosolic (GAPDH, #2118, Cell Signalling, MA, USA) and a mitochondrial 
(VDAC, #4866, Cell Signalling, MA, USA) protein was analysed to determine 
the purity of each fraction by western blotting.  
4.3.5.3 Fluorescence microscopy 
To investigate the integrity of the mitochondrial network, mitochondria 
were stained with a DsRed fluorescent protein fused to a mitochondrial 
targeting signal (MTS). An MTS sequence 
(ATGTCCGTCCTGACGCCGCTGCTGCTGCGGGGCTTGACAGGCTCGGCCCGGCGG
CTCCCAGTGCCGCGCGCCAAGATCCATTCGTTG) was cloned and fused into a 
DsRed ligation vector (DsRed monomer N1 Clontech). This construct was 
verified by bidirectional sequencing on an ABI genetic analyser 3130xl 
(Applied Biosystems, Foster City, CA, USA). HEK293T cells were transfected 
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with either wtDFNA5 or mutDFNA5 and DsRed-MTS plasmid to visualise the 
mitochondria. 
4.3.6 Statistical analysis 
Each experiment was performed in triplicate and statistical analyses were 
performed by the SPSS software (SPPS Statistics 20, Inc. Chicago, IL, USA) 
using either one- or two-way ANOVA. The statistical significance level was 
set to 0.05. 
4.4 Results 
4.4.1 Mutant DFNA5 induces cell death in HEK293T cells 
In order to further investigate the growth defect induced by mutDFNA5, we 
performed a preliminary cell viability experiment by flow cytometry to 
determine the amount of cell death. As shown in Fig. 1a, mutDFNA5 indeed 
induced a significant growth defect (p<0.001) in HEK293T cells compared to 
wtDFNA5 and the control. Cell viability decreased from 89.36% and 86.00%, 
in respectively wtDFNA5 and control cells, to 22.33% in mutDFNA5-
transfected HEK293T cells.  
Previously published research in HEK293T cells specified the type of cell 
death as apoptotic, as determined by a TUNEL and an AnnexinV/PI staining 
[5]. However, re-evaluation of the former results prompted us to investigate 
this further before drawing final conclusions. To further determine the type 
of cell death, we performed a DNA electrophoresis experiment to study the 
DNA laddering pattern, typical for apoptotic cells. DNA was extracted using 
the Apoptotic DNA Ladder Kit (Roche, Basel, Switzerland) and as shown in 
Fig. 1b no DNA laddering pattern was seen in mutDFNA5-transfected 
HEK293T cells when compared to the positive control. A smear of DNA was 
visible when only non-adherent mutDFNA5-transfected HEK293T cells were 
studied indicating random cleavage of DNA contrasting the typical, non-
random DNA laddering pattern of apoptotic cells. This result indicated that 
more research is needed to unravel the true nature of mutDFNA5-induced 
cell death.  
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Fig. 1: MutDFNA5 induces 
cell death in HEK293T 
cells. a. Cell viability of 
HEK293T cells transfected 
with a control plasmid, 
wtDFNA5 or mutDFNA5. 
Viability was measured the 
following day by flow 
cytometry using PI as a cell 
death marker. Only GFP 
positive cells were taken 
into account and at least 
10000 events were 
recorded each time. b. 
DNA laddering pattern of 
control, wtDFNA5-and 
mutDFNA5-transfected 
HEK293T cells. ‘Non-
adherent mutDFNA5’ 
indicates cells which were 
no longer adherent to the 
cell culture dish and 
represent dead cells. * 
denotes a significant 
difference in cell viability of 
mutDFNA5 compared to 
control and wtDFNA5. ***: 
p<0.001. 
 158 
 
4.4.2 MutDFNA5-induced cell death is caspase and RIPK1 independent 
Due to the discrepancies between the former TUNEL staining and the DNA 
laddering experiment, we started with some basic experiments to re-
evaluate the exact type of cell death induced by mutDFNA5. To further 
determine the role of apoptosis, cleavage of several caspases was evaluated 
by western blot as these are the key mediators of apoptosis and can 
differentiate between apoptosis and other forms of PCD. As overexpression 
of RIPK1, a kinase involved in necroptosis and apoptosis, is known to induce 
caspase cleavage through the extrinsic apoptotic pathway in human cell 
lines, RIPK1-transfected HEK293T cells were used as a positive control. 
Overexpression of RIPK1 is able to induce caspase-dependent cell death by 
recruiting caspase-8. MLKL-transfected HEK293T cells, another key player of 
necroptosis, were used as a negative control as MLKL induces cell death that 
is caspase-independent. 
Before protein lysates were taken to study caspase cleavage, the presence 
of cell death was measured by SytoxGreen, a cell impermeable dye, to 
ascertain the induction of cell death (Fig. 2a). MutDFNA5-transfected cells 
indeed showed an increase in the amount of cell death compared to control, 
wtDFNA5- and RIPK1-transfected HEK293T cells. Next, protein lysates were 
taken and caspase cleavage was measured. No cleavage of caspase-3 nor 
caspase-8 was seen in mutDFNA5-transfected HEK293T cells when 
compared to the RIPK1-transfected HEK293T cells (Fig. 2b). No caspase-9 
cleavage was seen in any of the samples (data not shown).  
Due to the lack of caspase cleavage, the classical apoptotic pathway could 
be excluded. These results demonstrate that a clear difference exists 
between the mechanism induced by mutDFNA5 and by RIPK1 in HEK293T 
cells.  
. 
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This was also confirmed when the role of the kinase domain of RIPK1 was 
studied. The kinase domain of RIPK1 and its co-factor RIPK3, a necroptotic 
component is missing in HEK293T cells, are necessary to induce necroptosis. 
This kinase domain can specifically be inhibited by Nec-1s, a stable form of 
necrostatin. Addition of Nec-1s however, does not ameliorate the viability of 
mutDFNA5-transfected HEK293T cells as shown in Fig. 2c. Different 
concentrations of Nec-1s were used and transfected HEK293T cells were 
incubated overnight. Neither 10 μM nor 30 μM Nec-1s could increase the 
cell viability of mutDFNA5-transfected HEK293T cells compared to control 
and wtDFNA5, confirming the independency of RIPK1 for mutDFNA5-
associated cell death. No significant decrease in cell viability could be 
detected when treated and untreated, mutDFNA5-transfected HEK293T 
cells were compared (Fig. 2c).  
The difference in type of cell death between RIPK1 and mutDFNA5 could 
already be assumed by the cell viability experiment shown previously (Fig. 
2a). this demonstrated enhanced cell death in mutDFNA5-transfected 
HEK293T cells, but not in RIPK1-transfected cells indicating a different 
mechanism compared to mutDFNA5. Based on these results, we conclude 
that mutDFNA5-associated cell death is independent of caspases and RIPK1 
which excludes necroptosis and the classical apoptotic pathway. 
4.4.3 Mutant DFNA5 expression leads to accumulation of damaged 
mitochondria 
Research in yeast identified several proteins, such as Fis1, Aac1, Aac3 and 
Por1, related to either mitochondrial fragmentation or permeabilisation (see 
chapter II). Therefore we wondered whether mutDFNA5 induces cell death 
through a mitochondrial pathway in human cell lines. This led us to 
investigate the mitochondrial morphology by fluorescence microscopy to 
determine whether the mitochondrial network is still intact. A mitochondrial 
targeting signal (MTS) was cloned into a DsRed ligation vector and this 
DsRed-MTS construct was transfected in HEK293T cells with wtDFNA5 or 
mutDFNA5. HEK293T cells transfected with DsRed-MTS alone were used as a 
control. As demonstrated in Fig. 3, wtDFNA5-transfected HEK293T cells had 
an intact mitochondrial network. The presence of tubular mitochondrial 
structures under these conditions clearly demonstrates their integrity. In 
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mutDFNA5-transfected HEK293T cells on the other hand, punctuate 
mitochondrial structures were visible and no tubular mitochondria were 
present, suggesting altered mitochondrial morphology. These results 
demonstrate the accumulation of damaged mitochondria induced by 
mutDFNA5. As damaged mitochondria were only seen in mutDFNA5 cells, 
disintegration of the mitochondrial network is probably induced by 
mutDFNA5. How mutDFNA5 regulates this process remains unknown at this 
moment. However, no co-localisation of mutDFNA5 and the mitochondria 
was seen (Fig. 3 overlay) leading us to conclude that this interference is 
probably indirect. 
 
Fig. 3: Visualisation of the mitochondrial network. Fluorescence microscopy of HEK293T 
cells transfected with DsRed plasmid fused to a MTS and wtDFNA5 or mutDFNA5. DsRed-
MTS and wtDFNA5-transfected HEK293T cells show an intact mitochondrial network 
containing tubular structures (filled white arrow), whereas in mutDFNA5 cells 
dysfunctional mitochondria are present as shown by the presence of punctuate 
mitochondria (open white arrow). The expression of DFNA5 is shown in green, the 
mitochondria in red. MTS, mitochondrial targeting signal.  
 
 162 
 
4.4.4 MutDFNA5 induces mitochondrial alterations in HEK293T cells 
Due to the loss of an intact mitochondrial network, several mitochondrial 
assays were performed to investigate the functionality of the mitochondria. 
We first investigated the amount of oxidative stress. Mitochondria are the 
major source of oxidative stress due to the mitochondrial process of 
oxidative phosphorylation which generates free radicals. ROS was measured 
by DHE staining 12 h post-transfection. A significant difference in the 
amount of oxidative stress was seen in DFNA5-transfected HEK293T. A 
significant increase in oxidative stress from 4.59% to 28.67% DHE positivity 
was observed upon mutDFNA5 transfection compared to wtDFNA5 (p<0.01) 
suggesting oxidative stress mediated by mutDFNA5 (Fig. 4a).  
 
Next, the mitochondrial membrane potential (∆Ψ) was measured to further 
investigate the role of the mitochondria in mutDFNA5-induced cell death. 
Loss of ∆Ψ could suggest opening of the permeability transition pore. To 
measure ∆Ψ, HEK293T cells were stained with TMRM, 12 h post-
transfection, and measured by flow cytometry. Cells were gated on GFP 
positivity and viability and at least 10000 events were recorded. A reduction 
in TMRM fluorescence was observed upon mutDFNA5 transfection 
indicating decreased ∆Ψ supporting mitochondrial permeabilisation (Fig. 
4b).  
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Fig. 4: Mitochondrial alterations induced by mutDFNA5. a. DHE staining measuring 
oxidative stress. Transfected HEK293T cells were stained with 2.5 µg/ml 
dihydroethdium (DHE) and measured by flow cytometry. Significant increase in 
oxidative stress was seen in mutDFNA5 HEK293T cells compared to wtDFNA5. Cells 
were gated on GFP positivity and at least 10000 events were recorded. b. TMRM 
assay measuring the mitochondrial membrane potential (Δψ). Significant decrease of 
the Δψ was seen upon transfection of mutDFNA5. Cells were gated on GFP positivity 
(transfected HEK293T cells) and on viability. ‘Normalised to mode’ means that the % 
of maximum was taken. This is the # of cells in each bin divided by the # of cells in the 
bin that contains the largest number of cells. **: p<0.01.  
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Release of cytochrome c and citrate synthase to the cytosol 
The partial loss of ∆Ψ can initiate the release of several apoptotic factors by 
mitochondrial permeabilisation. One of the main factors to be released 
through mitochondria is cytochrome c. Under normal conditions, 
cytochrome c resides in the mitochondria, but it is released to the cytosol 
upon induction of apoptosis. To verify the cellular location of cytochrome c, 
fractionated protein lysates were collected at different time-points post-
transfection obtaining a cytosolic and mitochondrial protein fraction. The 
presence of cytosolic cytochrome c was determined by western blot using a 
specific cytochrome c antibody. First, the integrity of the mitochondrial 
preparation during fractionation was verified to determine the purity of 
each fraction. Cytosolic GAPDH and mitochondrial VDAC antibodies were 
used as controls for respectively the mitochondria and the cytosol. No VDAC 
and GAPDH was present in respectively the cytosolic and the mitochondrial 
protein lysate, demonstrating a correct fractionation procedure obtaining 
pure protein fractions (Fig. 5a). Therefore, cytosolic cytochrome c would 
support mitochondrial permeabilisation. No increase in cytosolic 
cytochrome c release was seen in mutDFNA5-transfected HEK293T cells at 9 
h, 12 h and 16 h post-transfection (data not shown), but as shown in Fig. 5b, 
increased release of cytochrome c to the cytosol was indeed seen at 20 h 
post-transfection. MutDFNA5-transfected HEK293T cells showed elevated 
cytochrome c levels compared to control and wtDFNA5. Quantification of 
the cytochrome c protein levels in relation to GAPDH, the loading control, 
confirmed the significant increase of cytosolic cytochrome c release 
(p(<0.001) and p(<0.001) compared to respectively control and wtDFNA5) 
(Fig. 5b). This release was six times higher in mutDFNA5 protein samples 
compared to control and wtDFNA5. Cytochrome c however, partially 
remained in the mitochondria suggesting restricted mitochondrial 
permeabilisation (Fig. 5b).  
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Although cytochrome c was released to the mitochondria, no caspase 
cleavage could be detected. Therefore, the mitochondrial integrity was 
further determined by investigating the release of citrate synthase. Citrate 
synthase, a mitochondrial matrix protein, is often used as a marker for intact 
mitochondria as it is retained in the mitochondria during permeabilisation. 
In addition to the release of cytochrome c, 20 h post-transfection increased 
release of citrate synthase to the cytosol was seen in HEK293T cells 
transfected with mutDFNA5 compared to control and wtDFNA5 (Fig. 5c). 
Citrate synthase was still detectable in the mitochondrial fraction, 
suggesting partial disintegration of the mitochondria. This is similar to 
cytochrome c which also partially remained in the mitochondria. Release of 
citrate synthase however, clearly demonstrates loss of intact mitochondria. 
As the VDAC protein was only present in the mitochondrial fraction, the 
release of citrate synthase could not be attributed to an erroneous 
fractionation procedure. As increased release of citrate synthase to the 
cytosol was seen in mutDFNA5 compared to control and wtDFNA5, this 
release is probably induced by mutDFNA5.  
The increase in oxidative stress, the loss of the mitochondrial membrane 
potential and the release of cytochrome c and citrate synthase indeed 
confirm the presence of damaged mitochondria induced by mutDFNA5. Due 
to the lack of caspase cleavage, the release of cytochrome c could be a 
secondary event in the cell death pathway. This release can be due to 
damaged mitochondria, explaining the absence of caspase activation. 
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4.4.5 MutDFNA5-induced cell death is independent of Necrox or 
ferrostatin 
The presence of damaged mitochondria indicates a role for the 
mitochondria in mutDFNA5-induced cell death. Besides apoptosis, other 
forms of PCD are related to the mitochondria and characterised by 
enhanced ROS production. Therefore, we tested two hypotheses to study 
the role of ROS in the caspase-independent mutDFNA5-induced cell death.  
We wondered whether the increased oxidative stress is the result of 
ferroptosis, a specific non-apoptotic, iron-dependent form of cell death 
characterised by enhanced ROS [7].  Furthermore, we also investigated 
whether the oxidative stress could be alleviated by Necrox, a novel class of 
mitochondrial ROS scavengers involved in non-apoptotic cell death [8, 9].   
 
Different concentrations of Necrox were used and their effect on cell 
viability of HEK293T-transfected cell lines was studied. As a positive control 
for mitochondrial ROS production, 500 μM t-BHP, a pro-oxidant compound, 
was used whose toxic effects could be abolished by Necrox. MutDFNA5-
transfected or untransfected HEK293T cells were incubated overnight with 
different concentrations of Necrox. Pretreated HEK293T cells were 
incubated, 16 h post-transfection, with t-BHP for 4 hours as a positive 
control for Necrox. As shown in Fig. 6, addition of 10 μM Necrox did not 
have any major influence on the amount of cell death induced by mutDFNA5 
when compared to untransfected HEK293T cells. Addition of 500 μM t-BHP 
for 4 hours decreased cell viability which could be partially inhibited by 
overnight pretreatment of HEK293T cells with 10 μM Necrox, indicating that 
Necrox is indeed taken up by the HEK293T cells (Fig. 6a). Addition of higher 
Necrox concentrations like 20 μM or 50 μM did also not alter the cell 
viability of mutDFNA5-transfected HEK293T cells (Suppl Fig. 4.1a.).  
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Fig. 6: Role of Necrox and ferrostatin on mutDFNA5 cell viability. a. 10 µM 
Necrox was added overnight for 16 h to mutDFNA5-transfected and 
untransfected HEK293T cells. As a positive control, pretreated HEK293T cells were 
incubated for 4 hours with t-BHP. Cell viability was measured by flow cytometry 
using PI as a cell death marker. b. 10 µM ferrostatin and/or erastin was added 
overnight for 16 h to mutDFNA5-transfected and untransfected HEK293T cells. 
Cell viability was measured the following day by flow cytometry using PI as a cell 
death marker. * denotes a significant difference in cell viability in mutDFNA5 
compared to untransfected HEK293T cells. *: p<0.05; **: p<0.01; ***: p<0.001. t-
BHP, tert-butylhydroperoxide. 
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As the cell viability could not be ameliorated by Necrox, a specific 
mitochondrial ROS scavenger, we wondered whether ferrostatin, a specific 
inhibitor of ferroptosis, could decrease cell death induced by mutDFNA5. 
Ferrostatin-1, a ROS scavenger preventing damage to membrane lipids, can 
inhibit ferroptosis, indicating that lipid peroxidation contributes directly to 
this type of cell death by production of lipid ROS [7, 10]. Erastin was used as 
a positive control for ferroptosis induction. Erastin inhibits the 
cystin/glutamate receptor leading to depletion of glutathion and increase of 
ROS. 
Transfected HEK293T cells were incubated overnight with concentrations of 
ferrostatin and/or erastin and cell viability was measured the following 
morning to determine their role in mutDFNA5-induced cell death. As 
demonstrated in Fig. 6b, addition of 10 μM ferrostatin could not increase 
cell viability of mutDFNA5-transfected HEK293T cells indicating that 
ferroptosis does not play a major role in DFNA5-associated cell death. 
Addition of higher ferrostatin concentrations like 30 μM or 50 μM 
ferrostatin did also not alter the cell viability of mutDFNA5-transfected 
HEK293T cells (Suppl Fig. 4.1b).  
 
The ferrostatin inducer erastin however, did not decrease cell viability of 
untransfected HEK293T cells. This could be due to the fact that erastin was 
originally identified as a component selectively lethal to RAS-mutant cell 
lines and that HEK293T cell lines do not contain a mutation in the RAS 
oncogene  [7]. 
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4.4.6 Autophagy 
As no specific type of cell death could be linked to mutDFNA5, therefore we 
focused on autophagy, an important, pro-survival mechanism maintaining 
cellular homeostasis. Autophagy can function as a redox sensor and can be 
preceded by a decrease in mitochondrial membrane potential. Moreover, 
mitochondrial damage, can suggest mitophagy, a specific autophagic 
process [11]. Under normal circumstances autophagy clears damaged 
mitochondria in order to abolish cell death. Therefore two autophagic 
assays were tested: the effect of 3-methyladenine (3-MA) and the 
expression of LC3. 3-MA is an autophagy inhibitor which mediates class III of 
the PI3K essential for formation of autophagosomes [12]. As a positive 
control for autophagy induction, HEK293T cells were starved in PBS 
pretreated either with or without 10 mM 3-MA for 3-4 hours. Initiation of 
autophagy was confirmed by light microscopy. This clearly demonstrated 
the induction of autophagy as shown by the cell morphology (data not 
shown). Samples were collected to measure the cell viability by flow 
cytometry. Addition of 10 mM 3-MA did not increase the viability in 
mutDFNA5-transfected HEK293T cells as compared to untransfected 
HEK293T cells (Fig. 7a).  
LC3 is a marker for autophagic flux involved in the formation of the 
autophagosomes. Upon induction of autophagy, LC3-I is converted to LC3-II 
indicating autophagosome formation. Total protein lysates of transfected 
HEK293T cells were collected and the LC3 conversion was investigated by 
western blot. LC3-I however was converted to LC3-II (Fig. 7b) but no 
significant differences were seen upon comparison of the control, wtDFNA5 
or mutDFNA5 protein samples (Fig. 7b). Due to lack of proper autophagic 
flux inhibitors like bafilomycin and to the dual specificity and non-
autophagy-related role of 3-MA, a correct interpretation of the LC3-II 
protein is however difficult [12-14]. 
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Fig. 7: Autophagic assays. a. 10 µM 3-MA was added overnight for 16 h to 
mutDFNA5-transfected and untransfected HEK293T cells. Pretreated 
HEK293T cells were incubated for 3-4 hours with PBS as a positive control for 
autophagy induction (data not shown). Cell viability was measured by flow 
cytometry using PI as a cell death marker. b. Western Blot analysis of the LC3 
protein, a marker for autophagic flux, in HEK293T transfected cell lines. 
Conversion of LC3-I to LC3-II was seen in all samples, suggesting no 
differences in autophagy level between mutDFNA5, control and wtDFNA5. * 
denotes a significant difference in cell viability in mutDFNA5 compared to 
untransfected HEK293T cells. ***: p<0.01; 3-MA, 3-methyladenine. 
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4.5 Discussion 
This study investigated the role of DFNA5 in programmed cell death in 
HEK293T cells. As previous research in yeast indicated a link between DFNA5 
and several mitochondrial proteins (see chapter II), we examined the role of 
the mitochondria in human cell lines in more detail. MutDFNA5-mediated 
cell death was indeed related to mitochondrial dysfunction as increased ROS 
production and partial loss of the mitochondrial membrane potential (∆Ψ) 
were observed. Decreased ∆Ψ could indicate mitochondrial 
permeabilisation suggesting a mitochondrial role in mutDFNA5-induced cell 
death. Mitochondrial permeabilisation is a key process of the intrinsic 
apoptotic pathway and although enhanced cytosolic cytochrome c was 
demonstrated upon mutDFNA5 transfection, caspase activation seems to be 
absent as demonstrated by the lack of caspase-3 cleavage. Furthermore, 
release of the matrix citrate synthase, a marker for intact mitochondria [15], 
and the accumulation of damaged mitochondria, visualised by fluorescence 
microscopy, suggested the presence of damaged mitochondria. As the 
cytosolic release of cytochrome c and citrate synthase is limited and both 
are still present in the mitochondria, mitochondrial disintegration seems to 
be partial and does not represent an end-stage in this cell death process. 
Due to the lack of caspase cleavage and the increased release of cytochrome 
c and citrate synthase, it can be concluded that the DFNA5-induced cell 
death is not mediated by mitochondrial permeabilisation, but the presence 
of damaged mitochondria will most likely result in the release of those 
factors. How mutDFNA5 is related to this accumulation of damaged 
mitochondria resulting in mitochondrial collapse remains unknown at this 
moment.  
In addition, the absence of the DNA-laddering pattern suggests the lack of 
specific DNA fragmentation, contrasting the former TUNEL staining [5]. 
TUNEL however, is a very unspecific method to measure DNA 
fragmentation. A smear of DNA, which was slightly visible in mutDFNA5 DNA 
samples, can also give positive TUNEL results. The previous positive TUNEL 
staining experiments might be the result of unspecific, random DNA 
cleavage by nucleases released during the cell death process [5]. Moreover, 
upon re-evaluation of the AnnexinV/PI results, the increase in AnnexinV 
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positive cells was only seen in double stained, AnnexinV/PI cells. Single 
AnnexinV positive cells however were not increased, but only a small 
increase in single PI-stained cells could be observed (data not shown). 
Double stained AnnexinV/PI cells and a small increase in single PI-stained 
cells rather indicate a non-apoptotic form of cell death induced by 
mutDFNA5. Based on these results, we concluded that mutDFNA5 does not 
induce cell death through the caspases-dependent apoptotic pathway. Due 
to these conclusions, we performed some basic cell death assays to 
distinguish between different types of non-apoptotic cell death, namely 
ferroptosis and necroptosis, both independent on caspases and associated 
with enhanced ROS [7, 10, 16, 17]. 
 
Ferroptosis is morphological and biochemical distinct from other forms of 
PCD, such as apoptosis, necrosis or autophagy. Ferroptosis is characterised 
by smaller mitochondria and iron-dependent accumulation of lethal lipid 
ROS. Exploration of the genetic basis of ferroptosis by a custom arrayed 
shRNA library targeting mitochondrial genes identified a role for citrate 
synthase [7]. Citrate synthase is a mitochondrial matrix protein involved in 
mitochondrial fatty acid metabolism [15]. Silencing of citrate synthase 
specifically abolished erastin-induced ferroptosis, suggesting a role for 
citrate synthase and mitochondrial lipid synthesis in ferroptosis [7]. 
Ferroptosis is induced by the depletion of glutathione peroxidase 4, due to 
impaired cystine uptake, abolishing the cellular anti-oxidant response [18]. 
Due to increased ROS production, the mitochondrial collapse and the 
release of citrate synthase, we wondered whether ferroptosis could be 
involved in mutDFNA5-induced cell death. However, addition of ferrostatin, 
a ferroptosis inhibitor [7, 10], did not ameliorate cell viability of mutDFNA5-
transfected HEK293T cells. The ferrostatin inducer erastin however, did not 
decrease cell viability of untransfected HEK293T cells. This could be due to 
the fact that HEK293T cell lines do not contain a mutation in the RAS 
oncogene. Erastin was initially identified as a component selectively lethal to 
RAS-mutant cell lines which could explain these results [7]. Although we are 
currently investigating a RAS mutant tumour cell line determining the 
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efficacy of erastin, the lack of increased viability of mutDFNA5-transfected 
HEK293T cells, makes a role for ferroptosis highly uncertain. 
 
Necroptosis is a non-apoptotic caspase-independent form of cell death 
initiated by death receptors ligands and mediated by the kinase activity of 
RIPK1. RIPK1 can also induce apoptosis by recruiting caspase-8. However, in 
the absence of caspase activity, RIPK1 can mediate necroptosis through its 
kinase domain. Activated RIPK1 forms a complex with MLKL and RIPK3, a 
kinase essential for necroptosis [16, 19, 20]. Necroptosis is characterised by 
enhanced ROS production, no caspase-3 cleavage and TUNEL positivity due 
to plasma membrane rupture [21]. Therefore, we further investigated the 
role of necroptosis by the use of Nec-1s, a specific RIPK1 kinase inhibitor 
able to inhibit necroptosis. Addition of Nec-1s did not have a significant 
effect on cell viability of mutDFNA5-transfected HEK293T cells. Because Nec-
1s was shown to be able to block necroptosis by inhibiting the kinase activity 
of RIPK1, it is believed that RIPK1 is required to activate RIPK3, an essential 
executioner of necroptosis [19, 22, 23] . However, due to the lack of RIPK3 
and MLKL in HEK293T, mutDFNA5 is probably not able to induce necroptosis 
in HEK293T cells, explaining the lack of an effect of the inhibition of RIPK1 by 
Nec-1s. Therefore, a role of necroptosis in mutDFNA5-induced cell death can 
most likely be excluded. 
 
Next to apoptosis, different forms of PCD can be mediated through the 
mitochondria. Mitochondria have different protein quality control 
mechanisms and one of them is mitophagy, a selective form of autophagy. 
Mitophagy is a clearance system mediating degradation of the complete 
mitochondria protein content. Functional mitochondrial impairment and 
permeabilisation can promote mitophagy acting as a quality control process. 
Several neurodegenerative diseases and lysosomal storage disorders have 
been correlated with defective quality control mechanisms and 
dysfunctional mitochondria. These mitochondria are characterised by loss of 
the ∆Ψ and increased ROS production [24]. Moreover, mitochondrial 
dynamics and enhanced mitochondrial fission mediating isolation of 
damaged mitochondria are closely related to mitophagy [25, 26]. Although 
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we investigated the role of LC3 in mutDFNA5-induced cell death, due to the 
lack of proper autophagic inhibitors and the unequal sensitivity of the 
antibody for LC3-II, correct interpretation of the LC3-I/ LC3-II ratio is 
currently difficult. Therefore it could be interesting to repeat the 
experiments with the addition of either bafilomycin A or chloroquine, two 
frequently used autophagic flux inhibitors, to more specifically determine 
the amount of LC3-II and hence the role of autophagy. Additionally, a co-
staining of autophagosomes by LC3-GFP and the mitochondria using a 
specific mitotracker can provide extra information on the role of mitophagy. 
Degradation of the mitochondrial network and accumulation of damaged 
mitochondria described in this study, can indeed point to a correlation with 
mitophagy. Proper turnover of the mitochondria is essential for energy 
homeostasis and deregulation of mitophagy results in accumulation of 
damaged mitochondria. This will ultimately lead to (neuronal) cell death as 
demonstrated in several neurodegenerative diseases [27]. Finally, electron 
microscopy (EM) can also be used as a quantitative identification method for 
autophagic vesicles and the morphology of the mitochondria in more 
particular [28]. Although this has not yet been performed, this is something 
which certainly has to be explored in the future. 
 
In addition to mitophagy, mutDFNA5-associated cell death can also be 
mediated by mitoptosis, programmed destruction of the mitochondria 
which differs from mitophagy. Mitoptosis is characterised by extensive 
mitochondrial fragmentation, does not require extra mitochondrial proteins 
and is caspase independent [29, 30]. Although mitoptosis can stimulate 
mitophagy, mitoptosis can occur in a non-autophagic mode of cell death by 
the formation of mitoptosomes which are secreted into the extracellular 
space [31, 32]. Due to the presence of fragmented mitochondria and the 
lack of caspase cleavage, the presence of mitoptosis is a reasonable 
possibility which has to be further investigated in the future.  
 
In conclusion, DFNA5-induced cell death is characterised by accumulation of 
damaged mitochondria as demonstrated by disintegration of the 
mitochondrial network and the release of several mitochondrial proteins. 
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Despite the observations of dysfunctional mitochondria, their relation to 
mutDFNA5 needs to be further investigated.  
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5 General discussion and future perspectives  
DFNA5 was originally identified as a gene responsible for an autosomal 
dominant non-syndromic form of hearing loss (HL) [1]. Nowadays, eight 
families have been identified with mutations in DFNA5 related to HL. Four of 
these mutations differ at the genomic level, but they all result in the 
skipping of exon 8 leading to an immature truncated protein [1-4]. Besides 
HL, DFNA5 has been associated with several different forms of cancer, such 
as breast, colorectal, gastric and melanoma cancer. Here, DFNA5 is 
epigenetically inactivated by hypermethylation, resulting in enhanced 
tumour growth. Based on this, DFNA5 has been identified as a potential 
tumour suppressor gene [5-7].  
At the beginning of my PhD thesis, the knowledge of the function of DFNA5 
was limited. Previous studies on DFNA5 revealed that transfection of an 
expression construct for the DFNA5 mutation induced a growth defect in 
mammalian cell lines and in fission yeast [8, 9]. The domain responsible for 
cell death induction was assigned to the first globular part of DFNA5, a part 
present both in wtDFNA5 and in mutDFNA5 [9]. Apart from small homology 
domains with Pejvakin and the yeast Mcm10 gene, DFNA5 did not have a 
high degree of homology with other genes, making functional assumptions 
not evident. As this identified growth defect seemed to be at least partially 
conserved among eukaryotes as shown by Gregan et al. [8], further research 
on DFNA5-related cell death mechanisms was started in a yeast model, 
namely Saccharomyces cerevisiae. In a second stage, HEK293T cell lines 
were used as a model. 
5.1 Yeast as a humanised model system for DFNA5 
This project initially mainly focused on apoptosis, as a link to apoptosis was 
previously demonstrated in HEK293T cells [9]. Apoptosis is a complex 
mechanism highly connected with other forms of PCD. A simplified version 
of apoptosis exists in yeast, making the interpretation of results slightly less 
complicated. However, this needs to be taken with caution as biased 
interpretation of data might occur. The first aim of this thesis was to 
generate and evaluate the new DFNA5 yeast model. Transformation of 
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mutDFNA5 in yeast indeed induced a growth defect associated with PCD and 
this toxicity was still confined to the first globular domain as described in 
chapter II. A mixed form of PCD was however present, as both apoptotic and 
necrotic yeast cells accumulated upon mutDFNA5 expression. At first this 
seemed to be in contrast with the human cell line results. The initial 
association of apoptosis with DFNA5 however, turned out to be premature 
as later results pointed to a necrotic form of cell death. The absence of the 
DNA laddering pattern and the increase in double AnnexinV/PI and single PI-
stained cells supports this hypothesis. Furthermore, yeast created the basis 
for future experiments in HEK293T supporting the value of the DFNA5 yeast 
model. Several mitochondria-related proteins associated with DFNA5-
induced cell death were characterised in yeast. Proteins like Fis1, Por1, Aac1 
and Aac3 were identified to mediate the DFNA5-related growth defect. All 
these proteins are related to the mitochondrial dynamics and the 
permeabilisation process. Moreover, in yeast we observed a partial co-
localisation of mutDFNA5 and the mitochondria, and the loss of an intact 
mitochondrial network. The importance of the mitochondria was indeed 
later confirmed in HEK293T cells by the loss of an intact mitochondrial 
network and the release of certain mitochondrial proteins (described in 
chapter IV).  
 
The region responsible for the apoptotic effect was assigned to the first 
globular domain, as previously identified in HEK293T cells [9]. Interestingly, 
the PCD-inducing capacity of this region was also present in yeast cells. 
Substitution of the second, highly conserved, hydrophobic amino acid of this 
domain abolished the cell death-inducing capacity of this N-terminal 
globular domain both in yeast and in HEK293T cells. This confirms the 
relevance of the yeast model.  
 
Based on the conserved role of the mitochondria and the PCD-inducing 
capacity of the first globular domain in mutDFNA5-induced cell death, yeast 
seemed to be a suitable model to investigate DFNA5-related mechanisms. 
However, as this model also has some disadvantages (one major limitation is 
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the lack of the extrinsic apoptotic pathway), these results needed to be 
further validated in human cell lines.  
5.2 MutDFNA5 induces mitochondrial cell death mediated by 
MAPK 
The second part of this thesis was based on the previous yeast results and 
was performed in human cell lines. This part investigated several aspects of 
the mitochondria. Several mitochondrial assays demonstrated altered 
mitochondrial morphology and function induced by mutDFNA5. This was 
shown by fluorescence microscopy and the cytosolic release of both 
cytochrome c and citrate synthase. Furthermore, a transcriptomic analysis 
revealed MAPK activation induced by mutDFNA5. Although mitochondrial 
alteration mediated by MAPK pathways is well known, numerous 
mechanisms are still possible. The most common interference is through the 
BCL2 protein family. Both anti- and pro-apoptotic proteins can respectively 
be inhibited and activated by the JNK proteins. This interference influences 
the critical equilibrium of the BCL2 family tipping the balance to pro-
apoptosis [10, 11].  
 
To investigate the link between the mitochondria and the MAPK pathways, 
it would be interesting to investigate whether either JNK or ERK are localised 
in the mitochondria as mitochondrial translocation of both proteins was 
observed upon cell death induction by other researchers [12-16]. This can be 
either direct, as shown for ERK, which was found associated with 
mitochondrial proteins [17, 18]. It can also be indirect by interaction with 
the OMM, which was demonstrated for JNK [19]. This mitochondrial 
localisation has been associated with the release of several apoptotic 
factors, such as Smac and cytochrome c, and addition of specific JNK 
inhibitors reduced the stress-induced release of Smac and cytochrome c. 
ERK and JNK have also been correlated with oxidative stress and 
mitochondrial dysfunction, two features observed upon mutDFNA5-induced 
cell death. In previous studies, oxidative stress enhanced the 
phosphorylation of either ERK or JNK, followed by reduced ATP production 
and lower respiration [14, 20]. All these findings provide a direct link 
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between MAPK activation and the mitochondrial death machinery. ATP 
depletion also shows that the MAPK pathway can interfere with the 
mitochondrial metabolism, regulating mitochondrial bio-energetics. Altered 
cellular and mitochondrial energetics has a direct effect on mitochondrial 
morphology as shown by diverse studies [21-23]. Alterations in metabolic 
flux, such as elevated glucose levels, free fatty acids or Ca2+ supply, have 
been shown to have a direct effect on ROS production and subsequently on 
mitochondrial morphology. Mitochondrial fragmentation and ROS 
production are hence tightly associated with mitochondrial bio-energetics 
which need to be closely regulated [21, 22, 24, 25]. The determination of the 
ATP level in mutDFNA5-transfected cell lines could therefore give an idea 
about the bio-energetics of the mitochondria. As described in chapter II, 
research in yeast identified two proteins involved in ATP transport, namely 
Aac1 and Aac3. The Aac proteins function as ADP/ATP transporters and 
mediate ATP release to the cytosol under healthy cellular conditions. This 
finding could point to altered ATP levels in mutDFNA5-transformed yeast 
cells.  
5.3 The role of other forms of PCD 
This project initially mainly focused on the investigation of apoptosis as 
previous research pointed in this direction [9]. However, many different 
forms of PCD co-exist and it is often not evident to pinpoint one particular 
form of PCD. Therefore, we reinvestigated the role of apoptosis, as well as 
other forms of PCD. 
Apoptosis is a cellular mechanism that can lead to death of stressed cells 
and can indicate an end-stage in the struggle for life, preceded by other 
processes. Autophagy on the other hand, is often regarded as a pro-survival 
mechanism, trying to prevent cell death by recycling and specifically 
eliminating damaged or superfluous organelles. It elicits an adaptive stress 
response avoiding cell death, or it can result in autophagic cell death 
indicating a link to other forms of PCD. This crosstalk however, is very 
complex and both apoptosis and necrosis, can be preceded, inhibited or 
activated, by autophagy [26, 27].  
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We did not investigate in detail the role of autophagy and preliminary 
experiments studying the role of LC3 were inconclusive. Therefore, it is 
worthwhile to investigate the role of autophagy in more detail, especially at 
earlier time points where autophagy could precede cell death. As autophagy 
is a conserved mechanism among eukaryotes [28, 29], studying the role of 
several Atg genes in DFNA5-transformed yeast cells, could certainly uncover 
interesting findings about the importance of this cellular process.  
Much is still unknown about the crosstalk between PCD and autophagy, but 
several proteins have been identified to play a dual role in for example PCD 
and autophagy. The death-associated protein kinase (DAPK) for example, 
was first identified as a positive mediator of PCD, and later as an activator of 
autophagy [30-32]. DAPK becomes activated by oxidative stress. Activated 
DAPK regulates JNK signalling and is required for caspase-independent 
necrotic cell death [33]. For autophagy, DAPK has been associated with the 
phosphorylation of Vps34, a kinase indispensable for autophagosome 
formation [34].  
This is just one of the many examples which demonstrate the complex 
crosstalk between autophagy and PCD. They both can be induced by 
common stimuli resulting in either a mixed phenotype, or excluding each 
other by mutual inhibition. This complex relationship clearly indicates the 
importance of investigating the role of autophagy in mechanisms related to 
PCD, such as DFNA5.  
 
Additionally, increased ROS production and loss of the mitochondrial 
network can also suggest the presence of mitoptosis or programmed 
destruction of the mitochondria, a mitochondrial suicide mechanism [35, 
36]. This can be mediated by DRP-1, a mitochondrial fission protein inducing 
mitochondrial fragmentation, or through protease inhibitors [37, 38]. During 
mitoptosis, mitochondria appear condensed, followed by swelling, rupture 
of the OMM and mitochondrial fragmentation. Clustering of fragmented 
mitochondria and membrane sequestration will form mitoptotic bodies. 
Inside this mitoptotic body, fragmented mitochondria are further degraded 
and finally released in the extracellular space leading to a non-autophagic-
related mitoptotic cell death [35, 37, 39]. Programmed destruction of the 
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mitochondria can also be followed by activation of selective mitochondrial 
autophagy, known as mitophagy [35, 40]. It has been shown previously that 
mitophagy is induced by dissipation of the ∆ψ and mediated by JNK, linking 
autophagy and MAPK-signalling pathways [38].  
5.4 Role of the ER in mutDFNA5-induced cell death? 
This study revealed a role for the mitochondria and suggested a role for the 
ER in mutDFNA5-induced cell death mechanisms in both model organisms. It 
would therefore be interesting to investigate the connection between those 
two organelles in mutDFNA5-associated cell death and to determine 
whether the GO-identified processes (chapter III), like protein folding, are 
related to ER stress. 
These two organelles are highly interconnected by mitochondria-associated 
membrane channels, mediating mitochondrial supply of metabolites and 
lipids. ER stress has therefore a detrimental effect on mitochondrial 
metabolism and hence the cellular energy status (reviewed in [41, 42]). ER 
stress can induce cell death through the mitochondria and is characterised 
by accumulation of unfolded proteins in the lumen. Unfolded proteins are 
sensed by three different transmembrane proteins, triggering an adaptive 
response [43]. One of the downstream events is the up-regulation of CHOP 
and cleavage of XBP-1, two markers for ER stress. Additionally, an increased 
amount of polyubiquitinated proteins, Ca2+ release through the IP3-ER Ca2+ 
channel and eIF2α phosphorylation, are also typical hallmarks of ER stress 
[44, 45].  
Interestingly, CHOP can be directly induced by activated JNK, implying a link 
between the MAPK pathway and ER stress [46, 47]. JNK is activated by Ask1, 
a kinase involved in the receptor-mediated branch of apoptosis. Upon ER 
stress, Ask1 is recruited by one of the three ER transmembrane protein 
sensors [48]. In addition to CHOP activation, activation of the IRE1α branch 
is also involved in JNK signalling [48, 49]. IRE1α activation by ER stress leads 
to the recruitment of the TRAF adaptor protein leading to JNK activation [50, 
51]. The IRE1α pathway is the only conserved ER stress pathway in yeast and 
can induce cleavage of the XBP-1 (Hac1 in yeast) mRNA [52]. As an 
association with GO pathways related to protein folding and the ER were 
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seen in both model organisms, the investigation of the role of the IRE1α 
pathway could be a good starting point for future research. 
 
Release of Ca2+ from the ER by the IP3-receptor can directly induce 
mitochondrial permeabilisation and the IP3-receptor can be modulated by 
several BCL2 family proteins, providing a link between the mitochondria and 
the ER [53, 54]. Interestingly, cytochrome c released from the mitochondria 
has been shown to bind to the IP3-channel. This can regulate the Ca2+ 
release and amplify the mitochondria-related cell death signal [55]. 
Sustained ER stress can indeed modulate mitochondrial morphology. The 
release of Ca2+ seems to play a prominent role in this process and this is 
often accompanied by mitochondrial fragmentation [41, 56, 57]. However, 
we did not measure the Ca2+ levels in this study. Furthermore, ER stress has 
also been linked to increased oxidative stress which further supports a 
putative role of the ER in mutDFNA5-associated cell death [58].  
 
These data demonstrate a link between the MAPK pathways and the 
induction of mitochondria-related cell death. The investigation of certain ER 
markers, such as CHOP, XBP-1 cleavage or the Ca2+ release by the ER, would 
reveal extra information on the role of the ER in mutDFNA5-induced cell 
death.  
 
But if ER stress would be present, how would it relate to mutDFNA5? The ER 
is responsible for protein folding and protein quality control of roughly one-
quarter of the proteome (proteins of the secretory pathway) [59]. Misfolded 
proteins, leading to ER stress, can either elicit an unfolded protein response 
in order to increase the folding capacity of the ER. Alternatively they can 
initiate an ER-associated degradation (ERAD) pathway, recognizing 
terminally misfolded proteins. Both responses are coordinated and mediate 
each other [60-63]. Different ERAD systems exist both in yeast and human 
cell lines, namely ERAD-M, ERAD-L and ERAD-C responsible for degradation 
of respectively misfolded transmembrane, luminal or cytosolic parts of 
transmembrane proteins of the ER [64, 65]. The presence of a granulated 
expression pattern of mutDFNA5 in HEK293T and in yeast cells, in contrast 
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to an evenly distributed cytoplasmic expression of wtDFNA5, could suggest 
impaired protein folding leading to aggregate formation. Due to the 
association of GO terms-related to the ER and protein folding, this could 
suggest a failure of the protein quality control in the ER. However, as far as 
we known, DFNA5 is a cytoplasmic protein, not located in the ER or any 
other secretory organelle.  
How aggregated mutDFNA5 would mediate ERAD is uncertain at this 
moment, but examples of the requirement of ERAD-C for the degradation of 
non-ER proteins do exist in yeast [66-69]. The role of ERAD-C in yeast 
depends on the presence of a specific degradation sequence in the 
substrate recognised by Doa1, the yeast homologue of TEB4 (MARCH6). 
Doa1 is an E3 ligase mediating the ubiquitination process essential for 
degradation of the misfolded substrates [66, 68]. This degradation is 
dependent on Ubc6 and Ubc7, two ubiquitin-conjugating enzymes [67].  
There is one example of a link between ERAD and cytosolic degradation of a 
non-ER protein in human cell lines [70]. This study demonstrated 
proteasomal degradation of aberrantly located p53 mediated by Synoviolin, 
an ER-resident E3 ubiquitin ligase, under mild ER stress. It remains to be 
investigated whether other ERAD-related components are involved in this 
degradation. This could indicate whether this degradation is indeed related 
to ERAD or if this is due to an additional non-ERAD-related feature of 
Synoviolin.  
5.5 Role of ER stress in the pathology of hearing loss 
Despite the limited knowledge about the correlation of mutDFNA5 with ER 
stress, certain forms of HL have already been correlated with the presence 
of ER stress. The Usher syndrome for example, a hereditary form of hearing 
loss combined with visual impairment, is associated with enhanced ER stress 
that promotes apoptosis. Different Usher-associated proteins of the 
secretory pathway preassemble on the ER before trafficking to Golgi. This 
cooperation is essential to shape the sensory hair cells and stereocilia. 
Mutations in one of these genes lead to protein trafficking defects and 
mislocalisation of several Usher-associated proteins, proteins related to 
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either the Usher type 1 or 2 clinical phenotype. This mislocalisation induces 
ER stress followed by apoptosis of the hair cells [71].  
In addition to the hereditary forms of HL, ototoxicity (HL due to the use of 
pharmaceuticals such as aminoglycoside antibiotics and platinum-based 
chemotherapeutics) was also shown to be correlated with ER stress-
dependent pathways. Certain pain relievers, contributing to tinnitus and 
progressive bilateral sensorineural HL, were shown to induce ROS 
overproduction, altered ER morphology and changes in ER stress markers, 
such as CHOP [72]. The role of the ER however, remains to be elucidated in 
DFNA5-related cell death mechanisms.  
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V. Supplementary Material  
V.1 Supplementary Material Chapter II 
Table 2.1: Strain list 
Strain Genotype Reference/Source 
   
BY 4741 Mata his3∆1 leu2∆0 met15∆0 ura3∆0 [20] 
aac1∆ BY4741YMR056c::kanMX EUROSCARF 
aac3∆ BY4741YBR085w::kanMX4 EUROSCARF 
aif1∆ BY4741YNR074c::kanMX4 EUROSCARF 
dnm1∆  BY4741YLL001w::kanMX4 EUROSCARF 
fis1∆ BY4741YIL065c::kanMX4 EUROSCARF 
mca1∆  BY4741YOR197w::kanMX4 EUROSCARF 
mdv1∆  BY4741YJL112w::kanMX4 EUROSCARF 
nma111∆ BY4741YNL123w::kanMX4 EUROSCARF 
nuc1∆ BY4741YJL208c::kanMX4 EUROSCARF 
por1∆ BY4741YNL055c::kanMX4 EUROSCARF 
por2∆ BY4741YIL114c::kanMX4 EUROSCARF 
rny1∆ BY4741YPL123c::kanMX4 EUROSCARF 
snl1∆ BY4741YIL016w::kanMX4 EUROSCARF 
tdh2∆ BY4741YJR009c::kanMX4 EUROSCARF 
tdh3∆ BY4741YGR192c::kanMX4 EUROSCARF 
tim18∆  BY4741YOR297c::kanMX4 EUROSCARF 
ymr074c∆ BY4741YMR074c::kanMX4 EUROSCARF 
ysp1∆ BY4741YHR155w::kanMX4 EUROSCARF 
 
 
 xxii 
 
Tabl  Table 2.2: Primer pairs   
Construct Forward primer Reverse primer 
   
wtDFNA5-HA  
 
TATATATATAGAATTCATGTTTGCCAAAGCAACCA
GGAATT 
GACCGGTGGATCCCGTGAATGTTCTCTGCCTAAAGC 
mutDFNA5-HA 
  
TATATATATAGAATTCATGTTTGCCAAAGCAACCA
GGAATT 
GACCGGTGGATCCCGAGGTTGGGTCTTCAAGATCAG 
wtDFNA5-EGFP 
  
TATATATATAGAATTCATGTTTGCCAAAGCAACCA
GGAATT 
TATATATAGTCGACGCTTGTACAGCTCGTCCATGCC 
mutDFNA5-EGFP 
  
TATATATATAGAATTCATGTTTGCCAAAGCAACCA
GGAATT 
TATATATAGTCGACGCTTGTACAGCTCGTCCATGCC 
DFNA5 domain A 
  
TATATATATAGAATTCATGTTTGCCAAAGCAACCA
GGAATT 
CGGTGGATCCCGGTCCAGGTAGACAGAGTCAAT 
DFNA5 domain B 
  
AAGCTTCGAATTCTGGCCACCATGGACCCCCTGGT
CTTTCGAGAG 
GACCGGTGGATCCCGTGAATGTTCTCTGCCTAAAGC 
HCA-F2R mutant* 
 
GAGCTCAAGCTTCGAATTCTGATGCGTGCCAAAG
CAACCAGG 
CCTGGTTGCTTTGGCACGCATCAGAATTCGAAGCTTGAGC
TCG 
HCA-A3R mutant* 
 
CGAGCTCAAGCTTCGAATTCTGATGTTTCGTAAAG
CAACCAGG 
CCTGGTTGCTTTACGAAACATCAGAATTCGAAGCTTGAGC
TCG 
Restriction sites used for cloning are underlined 
*=site-directed mutagenesis primers 
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Table 2.3: Quantification of growth*  
Strain Function T½ 
Control 
T½ wtDFNA5 T½ 
mutDFNA5 
∆T½ 
wtDFNA5-
Control 
∆T½ 
mutDFNA5-
Control 
%∆T½ 
mutDFNA5-
wtDFNA5 
BY4741 (HA-tagged) 19.83 ± 0.52 22.83 ± 0.26 31.38 ± 0.48 3.00 ± 0.24 11.54 ± 0.32 100.00 ± 1.42 
BY4741 (EGFP-tagged)  20.30 ± 1.15 24.90 ± 2.61 35.88 ± 3.54 4.60 ± 1.27 15.58 ± 1.84  128.49 ± 8.60 
aac1∆ Mitochondrial ADP/ATP Carrier 31.30 ± 1.20 28.13 ± 5.36 31.08 ± 1.36 -3.18 ± 2.73 -0.22 ± 0.77 34.63 ± 11.17 
aac3∆ Mitochondrial ADP/ATP Carrier 24.70 ± 0.45 27.00 ± 0.82 29.40 ± 1.67 2.30 ± 0.45 4.70 ± 0.77 28.10 ± 3.37 
aif1∆ Mitochondrial Apoptosis inducing 
factor 
19.60 ± 0.22 23.13 ± 0.25 33.00 ± 0.82 3.53 ± 0.16 13.40 ± 0.42 115.61 ± 1.76 
dnm1∆ Dynamin-related GTPase,  
mitochondrial fission 
20.20 ± 0.27 22.33 ± 1.61 31.50 ± 2.38 2.13 ± 0.94 11.30 ± 1.20 107.32 ± 6.07 
fis1∆ Mitochondrial membrane fission 26.70 ± 1.10 34.38 ± 1.80 48.67 ± 1.15 7.68 ± 1.02 21.97 ± 0.83 167.32 ± 5.26 
mca1∆ Putative cysteine protease,  
metacaspase 
21.80 ± 0.27 24.30 ± 0.45 34.50 ± 2.27 2.50 ± 0.23 12.70 ± 1.14 119.41 ± 4.54 
mdv1∆ Dmn1 adaptor protein, 
mitochondrial fission 
20.40 ± 1.34 24.38 ± 0.25 31.90 ± 2.01 3.98 ± 0.61 11.50 ± 1.08 88.10 ± 4.66 
nma111∆ Omi1/HtrA2 Orthologue, Serine 
protease  
20.00 ± 0.00 23.67 ± 0.58 31.25 ± 2.22 3.67 ± 0.33 11.25 ± 1.11 88.78 ± 4.82 
nuc1∆ Mitochondrial nuclease, Endo G 
orthologue  
22.38 ± 2.14 24.10 ± 0.55 33.67 ± 0.58 1.73 ± 1.10 11.29 ± 1.12 112.00 ± 6.54 
por1∆ Mitochondrial porin, VDAC 
homologue 
20.50 ± 1.50 25.40 ± 0.65 40.00 ± 1.38 4.90 ± 0.91 19.50 ± 1.03 170.93 ± 5.53 
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Table 2.3 continued: Quantification of growth*  
Strain Function T½ 
Control 
T½ wtDFNA5 T½ 
mutDFNA5 
∆T½ 
wtDFNA5-
Control 
∆T½ 
mutDFNA5-
Control 
%∆T½ mutDFNA5-
wtDFNA5 
por2∆ Putative mitochondrial porin,  
VDAC homologue 
21.20 ± 0.45 23.90 ± 0.42 31.30 ± 2.49 2.70 ± 0.27 10.10 ± 1.13 86.63 ± 4.31 
rny1∆ Ribonuclease from yeast 20.90 ± 0.55 22.80 ± 0.57 33.90 ± 2.13 1.90 ± 0.35 13.00 ± 0.98 129.95 ± 3.87 
snl1∆ Suppressor of nup116-C lethal, 
Bag-1 homologue 
18.60 ± 0.89 20.38 ± 0.25 28.00 ± 0.00 1.78 ± 0.42 9.40 ± 0.40 89.27 ± 2.33 
tdh2∆ Triose-phosphate 
dehydrogenase 
20.13 ± 0.25 23.00 ± 0.50 31.00 ± 1.54 2.88 ± 0.31 10.88 ± 0.70 93.66 ± 3.07 
tdh3∆ Triose-phosphate 
dehydrogenase 
22.00 ± 0.00 23.88 ± 0.25 35.50 ± 1.00 1.88 ± 0.13 13.50 ± 0.50 136.10 ± 2.13 
tim18∆ Translocase of the inner 
mitochondrial membrane 
21.40 ± 0.42 25.50 ± 0.50 33.50 ± 0;58 4.10 ± 0.34 12.10 ± 0.34 93.66 ± 1.96 
ymr074c∆ Protein with homology to 
human PDCD5 
20.75 ± 0.50 23.70 ± 0.57 29.00 ± 3.32 2.95 ± 0.36 8.25 ± 1.50 62.05 ± 6.03 
ysp∆ Yeast suicide protein 20.00 ± 0.00 23.40 ± 1.39 34.10 ± 1.95 3.40 ± 0.62 14.10 ± 0.87 125.27 ± 4.18 
T½: time to reach half maximal optical density (hours) 
∆T½: difference in time to reach half maximal optical density (hours) 
*Values are expressed as mean  standard deviation. 
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V.2 Supplementary Material Chapter III 
 
Table 3.1: Primer sequences for RT-PCR 
Gene Fw_sequence Rv_sequence 
   
TM7SF2 TCT ACA TGA AGG CGC AGG TAG C AGT CGT AAA TCG GAT TGC CTG AG 
UCP2 TCT CCC AAT GTT GCT CGT AAT GCC AAG TGG CAA GGG AGG TCA TCT GTC 
VPS33B TGT GGA TCT GCT GAG CAT GGA AC TCC AAC GCT GAT CTC CTT CCA G 
FOSB GAG AGC TGG TAG TTA GTA GCA TGT GA AAT TCC AAT AAT GAA CCC AAT AGA TTA 
EGR1 GCA CCT GAC CGC AGA GTC TT AGT GGT TTG GCT GGG GTA ACT 
   
HMBS_HHG GGC AAT GCG GCT GCA A GGG TAC CCA CGC GAA TCA C 
GAPDH_HHG TGC ACC ACC AAC TGC TTA GC GGC ATG GAC TGT GGT CAT GAG 
RPL13A_HHG CCT GGA GTT TTC TTT CCA GAG TTG AGA ACC TCT GTG TAT TTG 
UBC_HHG GCA CTG GTT TTC TTT CCA GAG CAC GAA GAT CTG CAT TGT TCA 
YWHAZ_HHG ACT TTT GGT ACA TTG TGG CTT CCG CCA GGA CAA ACC AGT AT 
HHG: housekeeping genes used for normalisation 
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Table 3.2: Condensed list of all the GO annotations significantly associated with the up-regulated genes at the post-diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     GO:0016676 19 6 <0,00 oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor 
GO:0016675 19 6 <0,00 oxidoreductase activity, acting on a heme group of donors 
GO:0004129 19 6 <0,00 Cytochrome c oxidase activity 
GO:0015002 19 6 <0,00 heme-copper terminal oxidase activity 
GO:0015078 68 9 <0,00 hydrogen ion transmembrane transporter activity 
GO:0015077 86 9 <0,00 monovalent inorganic cation transmembrane transporter activity 
… … … … … 
GO:0009055 33 5 0,01 electron carrier activity 
GO:0009313 18 4 0,01 oligosaccharide catabolic process 
GO:0045333 108 8 0,01 cellular respiration 
GO:0009060 85 7 0,01 aerobic respiration 
GO:0005985 8 3 0,01 sucrose metabolic process 
GO:0005987 8 3 0,01 sucrose catabolic process 
GO:0000025 2 2 0,01 maltose catabolic process 
… … … … … 
GO:0008645 24 4 0,01 hexose transport 
GO:0046906 24 4 0,01 tetrapyrrole binding 
GO:0015749 24 4 0,01 monosaccharide transport 
GO:0008324 170 9 0,02 cation transmembrane transporter activity 
GO:0005746 27 4 0,02 mitochondrial respiratory chain 
GO:0015926 27 4 0,02 glucosidase activity 
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Table 3.2 continued: Condensed list of all the GO annotations significantly associated with the up-regulated genes at the post-
diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     GO:0006123 12 3 0,02 mitochondrial electron transport, cytochrome c to oxygen 
GO:0005751 12 3 0,02 mitochondrial respiratory chain complex IV 
GO:0045277 12 3 0,02 respiratory chain complex IV 
GO:0042773 28 4 0,02 ATP synthesis coupled electron transport 
GO:0042775 28 4 0,02 mitochondrial ATP synthesis coupled electron transport 
GO:0006119 29 4 0,02 oxidative phosphorylation 
GO:0000023 13 3 0,02 maltose metabolic process 
GO:0005215 443 15 0,02 transporter activity 
GO:0022857 349 13 0,02 transmembrane transporter activity 
GO:0005984 30 4 0,02 disaccharide metabolic process 
GO:0022904 30 4 0,02 respiratory electron transport chain 
GO:0022900 31 4 0,02 electron transport chain 
GO:0070469 32 4 0,02 respiratory chain 
GO:0022891 314 12 0,02 substrate-specific transmembrane transporter activity 
GO:0005353 15 3 0,02 fructose transmembrane transporter activity 
GO:0015578 15 3 0,02 mannose transmembrane transporter activity 
… … … … … 
GO:0015146 4 2 0,02 pentose transmembrane transporter activity 
… … … … … 
GO:0015145 17 3 0,03 monosaccharide transmembrane transporter activity 
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Table 3.2 continued: Condensed list of all the GO annotations significantly associated with the up-regulated genes at the post-
diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     GO:0044455 166 8 0,03 mitochondrial membrane part 
GO:0005506 38 4 0,03 iron ion binding 
GO:0044724 95 6 0,03 single-organism carbohydrate catabolic process 
GO:0044275 39 4 0,03 cellular carbohydrate catabolic process 
… … … … … 
GO:0051119 20 3 0,04 sugar transmembrane transporter activity 
GO:0008643 43 4 0,04 carbohydrate transport 
GO:0016052 105 6 0,04 carbohydrate catabolic process 
GO:0009311 44 4 0,04 oligosaccharide metabolic process 
 Population term: the number of genes in the whole yeast population set (5640 genes) that are annotated to the GO term in question. Study 
term: the number of genes in the study set that is annotated to the GO term in question. The study set contained 75 significantly up-regulated 
genes with a log (FC) < 1.5. WtDFNA5 transformed yeast cells were used as a reference. GO-enriched terms related to mitochondria are 
indicated in red, to transporter activity in blue and GO terms related to energy metabolism in green. Adj.p.value, p-value adjusted for multiple 
hypothesis testing. ‘… ‘denotes a gap in the list due to space restriction. 
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Table 3.3: List of all the GO annotations significantly associated with the down-regulated genes at the post-diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     
GO:0006007 52 10 <0,00 glucose catabolic process 
GO:0019320 59 10 <0,00 hexose catabolic process 
GO:0046365 65 10 <0,00 monosaccharide catabolic process 
GO:0006096 32 8 <0,00 glycolysis 
GO:0044724 95 10 <0,00 single-organism carbohydrate catabolic process 
GO:0006006 98 10 <0,00 glucose metabolic process 
GO:0016052 105 10 <0,00 carbohydrate catabolic process 
GO:0006094 32 7 <0,00 gluconeogenesis 
GO:0019319 33 7 <0,00 hexose biosynthetic process 
GO:0046364 34 7 <0,00 monosaccharide biosynthetic process 
GO:0019318 115 10 <0,00 hexose metabolic process 
GO:0005996 121 10 <0,00 monosaccharide metabolic process 
GO:0006091 189 9 <0,00 generation of precursor metabolites and energy 
GO:0016051 97 7 <0,00 carbohydrate biosynthetic process 
GO:0005886 454 13 <0,00 plasma membrane 
GO:0005975 343 11 <0,00 carbohydrate metabolic process 
GO:0044723 298 10 <0,00 single-organism carbohydrate metabolic process 
GO:0044445 235 9 <0,00 cytosolic part 
GO:0016861 8 3 <0,00 intramolecular oxidoreductase activity, interconverting aldoses and ketoses 
GO:0005829 531 12 <0.01 cytosol 
GO:0022626 168 7 <0.01 cytosolic ribosome 
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Table 3.3 continued: List of all the GO annotations significantly associated with the down-regulated genes at the post-diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     
GO:0006098 15 3 <0.01 pentose-phosphate shunt 
GO:0071944 650 13 <0.01 cell periphery 
GO:0004365 3 2 <0.01 glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity 
GO:0044712 491 11 <0.01 single-organism catabolic process 
GO:0006740 19 3 0.01 NADPH regeneration 
GO:0016860 20 3 0.01 intramolecular oxidoreductase activity 
GO:0046496 50 4 0.01 nicotinamide nucleotide metabolic process 
GO:0019362 51 4 0.01 pyridine nucleotide metabolic process 
GO:0003735 214 7 0.01 structural constituent of ribosome 
GO:0006739 22 3 0.01 NADP metabolic process 
GO:0051287 25 3 0.01 NAD binding 
GO:0044391 229 7 0.01 ribosomal subunit 
GO:0045903 6 2 0.01 positive regulation of translational fidelity 
GO:0072524 62 4 0.01 pyridine-containing compound metabolic process 
GO:0006733 65 4 0.01 oxidoreduction coenzyme metabolic process 
GO:1901576 1945 22 0.02 organic substance biosynthetic process 
GO:0044711 817 13 0.02 single-organism biosynthetic process 
GO:0009058 1973 22 0.02 biosynthetic process 
GO:0006732 144 5 0.04 coenzyme metabolic process 
GO:1901575 777 12 0.04 organic substance catabolic process 
GO:0022625 89 4 0.04 cytosolic large ribosomal subunit 
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Table 3.3 continued: List of all the GO annotations significantly associated with the down-regulated genes at the post-diauxic shift 
ID Pop.term Study.term adj.P.Val  Name 
     
GO:0006090 13 2 0.05 pyruvate metabolic process 
Population term: the number of genes in the yeast population set (5640 yeast genes) that are annotated to the GO term in question. Study 
term: the number of genes in the study set that is annotated to the GO term in question. The study set contained 36 significantly down-
regulated genes with a log (FC) < 1.5. WtDFNA5 transformed yeast cells were used as a reference. GO-enriched terms related to translation are 
indicated in red. Adj.p.value, p-value adjusted for multiple hypothesis testing. 
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Table 3.4: Condensed list of GO annotations significantly associated with mutDFNA5 genes down-regulated in stationary phase  
ID Pop.term Study.term adj.P.Val Name 
     
… … … … … 
GO:0006696 29 13 <0.01 ergosterol biosynthetic process 
GO:0044108 29 13 <0.01 cellular alcohol biosynthetic process 
GO:0016129 29 13 <0.01 phytosteroid biosynthetic process 
GO:0046165 81 23 <0.01 alcohol biosynthetic process 
GO:0006694 39 15 <0.01 steroid biosynthetic process 
GO:0016126 39 15 <0.01 sterol biosynthetic process 
GO:0071704 3529 388 <0.01 organic substance metabolic process 
GO:1901617 89 24 <0.01 organic hydroxy compound biosynthetic process 
GO:0008202 50 17 <0.01 steroid metabolic process 
GO:0016125 50 17 <0.01 sterol metabolic process 
GO:0008204 31 13 <0.01 ergosterol metabolic process 
GO:0016128 31 13 <0.01 phytosteroid metabolic process 
GO:0009277 97 25 <0.01 fungal-type cell wall 
… … … … … 
GO:0090502 47 15 <0.01 RNA phosphodiester bond hydrolysis, endonucleolytic 
GO:0006629 308 52 <0.01 lipid metabolic process 
GO:0005829 531 79 <0.01 cytosol 
GO:0006633 33 12 <0.01 fatty acid biosynthetic process 
GO:0009987 4554 471 <0.01 cellular process 
… … … … … 
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Table 3.4 continued: Condensed list of GO annotations significantly associated with mutDFNA5 genes down-regulated in stationary phase 
ID Pop.term Study.term adj.P.Val  Name 
     
GO:0034641 2046 239 <0.01 cellular nitrogen compound metabolic process 
GO:0005783 478 72 <0.01 endoplasmic reticulum 
GO:1901070 6 5 <0.01 guanosine-containing compound biosynthetic process 
GO:0046037 6 5 <0.01 GMP metabolic process 
GO:0044432 379 60 <0.01 endoplasmic reticulum part 
… … … … … 
GO:1901137 223 40 <0.01 carbohydrate derivative biosynthetic process 
GO:0042175 366 58 <0.01 nuclear outer membrane-endoplasmic reticulum membrane network 
GO:0006753 310 51 <0.01 nucleoside phosphate metabolic process 
… … … … … 
GO:0005789 353 56 <0.01 endoplasmic reticulum membrane 
GO:0030497 4 4 <0.01 fatty acid elongation 
GO:0006725 1974 230 <0.01 cellular aromatic compound metabolic process 
… … … … … 
GO:0072599 38 12 <0.01 establishment of protein localization to endoplasmic reticulum 
GO:0045047 38 12 <0.01 protein targeting to ER 
GO:1901135 411 62 <0.01 carbohydrate derivative metabolic process 
GO:0005844 33 11 <0.01 polysome 
GO:0006913 173 32 <0.01 nucleocytoplasmic transport 
GO:0022618 144 28 0.01 ribonucleoprotein complex assembly 
GO:0006066 130 26 0.01 alcohol metabolic process 
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Table 3.4 continued: Condensed list of GO annotations significantly associated with mutDFNA5 genes down-regulated in stationary phase 
ID Pop.term Study.term adj.P.Val  Name 
     
… … … … … 
GO:0043001 11 6 0.01 Golgi to plasma membrane protein transport 
GO:0046365 65 16 0.01 monosaccharide catabolic process 
… … … … … 
GO:0072659 17 7 0.01 protein localization to plasma membrane 
GO:0090002 17 7 0.01 establishment of protein localization to plasma membrane 
… … … … … 
GO:0004312 9 5 0.02 fatty acid synthase activity 
GO:0009147 9 5 0.02 pyrimidine nucleoside triphosphate metabolic process 
GO:0019319 33 10 0.02 hexose biosynthetic process 
GO:0070972 45 12 0.02 protein localization to endoplasmic reticulum 
Population term: the number of genes in the yeast population set (5640 yeast genes) that are annotated to the GO term in question. Study 
term: The numbers of genes in the study set that are annotated to the GO term in question. The study set contained 541 significantly up-
regulated genes with a log (FC) < 1.5. MutDFNA5-transformed yeast cells in exponential phase were used as a reference. The first 50 GO terms 
were left out, as they were all related to ribosomal processes and similar to wtDFNA5 down-regulated processes. GO terms related to lipid 
metabolism are indicated in red, GO terms associated to the endoplasmic reticulum/protein transport are indicated in green. ‘… ‘denotes a gap 
in the list due to space restriction. Adj.p.value, p-value adjusted for multiple hypothesis testing. 
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Table 3.5: Condensed list of GO annotations significantly associated with wtDFNA5 genes down-regulated in stationary phase  
ID Pop.term Study.term adj.P.Val  Name 
     
… … … … … 
GO:0005856 239 34 <0.01 Cytoskeleton 
GO:0031974 1070 98 <0.01 membrane-enclosed lumen 
GO:0008610 187 29 <0.01 lipid biosynthetic process 
GO:0022613 427 50 <0.01 ribonucleoprotein complex biogenesis 
GO:0044430 224 32 <0.01 cytoskeletal part 
GO:0000226 106 20 <0.01 microtubule cytoskeleton organization 
GO:0005874 64 15 <0.01 Microtubule 
GO:0005935 166 26 <0.01 cellular bud neck 
GO:0071944 650 66 <0.01 cell periphery 
GO:0048610 406 47 <0.01 cellular process involved in reproduction 
GO:0000922 82 17 <0.01 spindle pole 
GO:0022414 254 34 <0.01 reproductive process 
GO:0005828 6 5 <0.01 kinetochore microtubule 
GO:0005815 75 16 <0.01 microtubule organizing center 
GO:0005816 75 16 <0.01 spindle pole body 
GO:0044764 122 21 <0.01 multi-organism cellular process 
GO:1901617 89 17 <0.01 organic hydroxy compound biosynthetic process 
GO:0005880 7 5 <0.01 nuclear microtubule 
GO:0032040 48 12 <0.01 small-subunit processome 
GO:0046165 81 16 <0.01 alcohol biosynthetic process 
GO:0005788 16 7 <0.01 endoplasmic reticulum lumen 
GO:0034660 423 46 <0.01 ncRNA metabolic process 
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Table 3.5 continued: Condensed list of GO annotations significantly associated with wtDFNA5 genes down-regulated in stationary phase  
ID Pop.term Study.term adj.P.Val  Name 
     
GO:0044085 1017 89 <0.01 cellular component biogenesis 
GO:0019953 219 29 <0.01 sexual reproduction 
GO:0044703 219 29 <0.01 multi-organism reproductive process 
GO:0005200 29 9 <0.01 structural constituent of cytoskeleton 
GO:0005876 23 8 <0.01 spindle microtubule 
GO:0007051 44 11 <0.01 spindle organization 
GO:0007052 38 10 <0.01 mitotic spindle organization 
GO:0044452 71 14 <0.01 nucleolar part 
GO:0071840 2122 158 <0.01 cellular component organization or biogenesis 
GO:0007010 232 29 <0.01 cytoskeleton organization 
GO:0016538 26 8 <0.01 cyclin-dependent protein serine/threonine kinase regulator activity 
GO:0044815 20 7 <0.01 DNA packaging complex 
GO:0000027 34 9 <0.01 ribosomal large subunit assembly 
GO:0000462 95 16 <0.01 
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 
LSU-rRNA) 
GO:0044450 15 6 <0.01 microtubule organizing center part 
Population term: the number of genes in the yeast population set (5640 yeast genes) that are annotated to the GO term in question. Study 
term: The numbers of genes in the study set that are annotated to the GO term in question. The study set contained 331 significantly up-
regulated genes with a log (FC) < 1.5. WtDFNA5-transformed yeast cells in exponential phase were used as a reference. First 40 GO terms were 
left out, as they were all related to ribosomal processes and similar to mutDFNA5 down-regulated processes. GO terms related to 
cytoskeleton/microtubuli are indicated in red. Adj.p.value, p-value adjusted for multiple hypothesis testing. ‘… ‘denotes a gap in the list due to 
space restriction. 
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Table 3.6: List of biological GO annotations significantly associated with mutDFNA5 genes up-regulated in HEK293T cells 
Biological GO term Pop.term Study.term adj.P.Val  Name 
       
GO:0007275 4169 45 <0.01 multicellular organismal development 
GO:0032502 4721 47 <0.01 developmental process 
GO:0044767 4669 46 <0.01 single-organism developmental process 
GO:0032501 5653 50 <0.01 multicellular organismal process 
GO:0044707 5444 49 <0.01 single-multicellular organism process 
GO:0051591 86 8 <0.01 response to cAMP 
GO:0048856 4195 41 <0.01 anatomical structure development 
GO:0048513 2587 31 <0.01 organ development 
GO:0048731 3621 37 <0.01 system development 
GO:0050794 7865 56 <0.01 regulation of cellular process 
GO:0048523 3017 33 <0.01 negative regulation of cellular process 
GO:0046683 114 8 <0.01 response to organophosphorus 
GO:0009888 1395 22 <0.01 tissue development 
GO:0080090 4512 41 <0.01 regulation of primary metabolic process 
GO:0048585 948 18 <0.01 negative regulation of response to stimulus 
GO:0050789 8324 57 <0.01 regulation of biological process 
GO:0048519 3313 34 <0.01 negative regulation of biological process 
GO:0014074 129 8 <0.01 response to purine-containing compound 
GO:0009893 2193 27 <0.01 positive regulation of metabolic process 
GO:0010604 1992 25 <0.01 positive regulation of macromolecule metabolic process 
GO:0060255 4267 38 <0.01 regulation of macromolecule metabolic process 
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Table 3.6 continued: List of biological GO annotations significantly associated with mutDFNA5 genes up-regulated in HEK293T cells 
Biological GO term Pop.term Study.term adj.P.Val  Name 
       
GO:0043407 65 6 <0.01 negative regulation of MAP kinase activity 
GO:1902532 287 10 <0.01 negative regulation of intracellular signal transduction 
GO:0010605 1464 21 <0.01 negative regulation of macromolecule metabolic process 
GO:0043409 111 7 <0.01 negative regulation of MAPK cascade 
GO:0006469 166 8 <0.01 negative regulation of protein kinase activity 
GO:0031325 2083 25 <0.01 positive regulation of cellular metabolic process 
GO:0065007 8823 57 <0.01 biological regulation 
GO:0031323 4611 39 <0.01 regulation of cellular metabolic process 
Population term: the number of genes in the human population set (26640 human genes) that are annotated to the GO term in question. Study 
term: the number of genes in the study set that is annotated to the GO term in question. The study set contained 79 significantly up-regulated 
genes with a log (FC) < 0.5. WtDFNA5-transfected HEK293T cells were used as a reference. GO terms related to the cAMP response and the 
MAPK pathway are indicated in red. Adj.p.value, p-value adjusted for multiple hypothesis testing. 
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Table 3.7: List of biological GO annotations significantly associated with mutDFNA5 genes down-regulated in HEK293T cells  
Biological GO term  Pop.term Study.term adj.P.Val  Name 
     
GO:0006986 134 5 <0.01 response to unfolded protein 
GO:0035966 142 5 <0.01 response to topologically incorrect protein 
Population term: the number of genes in the human population set (26640 human genes) that are annotated to the GO term in question. Study 
term: the number of genes in the study set that is annotated to the GO term in question. The study set contained 50 significantly up-regulated 
genes with a log (FC) < 0.5. WtDFNA5-transfected HEK293T cells were used as a reference.  Adj.p.value, p-value adjusted for multiple hypothesis 
testing. 
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V.3 Supplementary Material Chapter IV 
 
 
 
 
 
Suppl. Fig. 4.1: Role of Necrox and ferrostatin on mutDFNA5 cell viability. a. 20 
µM or 50 µM Necrox was added overnight for 16 h to mutDFNA5 transfected and 
untransfected HEK293T cells. Cell viability was measured the following day by 
flow cytometry using PI as a cell death marker. b. 30 µM or 50 µM ferrostatin 
and/or erastin (positive control) was added overnight for 16 h to mutDFNA5 
transfected and untransfected HEK293T cells. Cell viability was measured the 
following day by flow cytometry using PI as a cell death marker. * denotes a 
significant difference in cell viability in mutDFNA5 compared to untransfected 
HEK293T cells. ***: p<0.001. 
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VI. Dankwoord 
Vijf jaar, een hele periode waarin ik hoogtes en dieptes heb gekend, en een 
hoofdstuk dat nu afgesloten wordt. Gedurende deze periode heb ik vele 
nieuwe mensen ontmoet die het mogelijk maakten om dit project tot een 
goed einde te brengen. 
 
Bij deze zou ik graag Prof. Guy Van Camp bedanken om mij de kans te geven 
om een doctoraatsproject te starten. Na een korte en boeiende 
masterstage, begon ik met plezier hier te werken. Mede dankzij uw inzet en 
enthousiasme is alles op zijn pootjes terecht gekomen. 
 
Ook Prof. Joris Winderickx verdient een bedanking voor de steun en het 
advies gedurende mijn eerste doctoraatsjaren. Uw inbreng, nieuwe ideeën 
en ijver voor de wetenschap hebben mij de afgelopen jaren veel bijgeleerd.  
 
Anne, jij bent ongetwijfeld de persoon aan wie ik het meeste te danken heb 
tijdens mijn doctoraat. Vooral in de laatste maanden heb ik enorm veel 
steun aan u gehad, zowel in het labowerk als op persoonlijk vlak. In drukke 
periodes was jij er altijd om een tandje bij te steken of om een luisterend 
oor te bieden voor mijn (vele) frustraties. Je grappige verhalen over je zonen 
zorgden ook steeds voor een vrolijke noot  waar ik met plezier aan terug 
denk. Bedankt! Ken, zonder jou was ik nooit begonnnen aan dit project, en 
als één van de enige DFNA5-kenners in het lab kon ik ook steeds bij jou 
terecht met mijn vragen. Dank u voor de goede opmerkingen en inbreng bij 
het schrijven van de thesis.  
 
De afgelopen vijf jaar heb ik met veel interessante mensen mogen 
samenwerken. Mijn collega’s in Leuven om mee te beginnen. Al was het in 
het begin niet evident om als Antwerpenaar aan de slag te gaan in Leuven, ik 
heb er enorm graag gewerkt. Bedankt Erwin, Ruben en Vanessa om me in 
mijn eerste jaren bij te staan met advies, het kritisch bekijken van mijn 
resultaten en verbeteren. Vanessa, veel geluk met je prille gezinnetje. Erwin, 
een grappige, oprecht geïnteresseerde collega waar ik graag mee heb 
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samengewerkt. Tine, ik leef met je mee in uw laatste, ongetwijfeld zware 
doctoraatsjaar. Laat het niet aan je hart komen, maar met jouw 
relativeringsvermogen en optimisme komt dit zeker goed. Tobias en 
Mathias, nog veel succes gewenst met de laatste jaren en het schrijven. 
Katrien, jij ook veel succes gewenst met verdere loopbaan. Joëlle, Cathy en 
Catherina (al heb ik niet echt met je kunnen samenwerken, jij bent 
ongetwijfeld een aanwinst voor het labo), voor het reilen en zeilen van de FB 
groep, van de administratie tot het in goede banen leiden van de 
labcleanings en voor de kleurrijke babbels. 
 
Mijn collega’s in Antwerpen wil ik uiteraard ook niet vergeten. Speciaal dank 
aan mijn bureau-collega’s, waar er altijd een prettig gezellige sfeer hing. Ik 
wil mij eerst excuseren voor de laatste maanden, waar ik misschien niet 
altijd de meest aangename collega was, die met de glimlach kwam werken. 
Maar, jullie aanwezigheid, bereidheid tot luisteren naar mijn klaagzang en 
jullie grappige avonturen heb ik steeds zeer geapprecieerd. De 
geheimzinnige lachjes van Nele, de herkenbare IWT- /huisstress van Ellen, 
laat-avond babbels met Dorien, het aanstekelijk enthousiasme en de 
kleurrijke verhalen van Lieselot, de hilarische discussies over vrouwen- en 
mannenzaken met Timon, en Igor, die de lekkerste kaastaart kan maken. 
Het zijn slechts een aantal herinneringen om aan te tonen dat wij echt een 
TOP bureau hadden, waar wonder boven wonder ook echt goed gewerkt 
kan worden. Een goede combinatie van plezier en werk, ik zal jullie zeker 
missen. 
 
Ook de andere (DOOF)collega’s verdienen een woordje van dank. Manou, ik 
ben er zeker van dat jij een fantastische mama zal worden, en ik wens jou 
nog geweldig veel succes met je doctoraat. Al zal dit zeker niet altijd volgens 
plan lopen, het komt zeker in orde met jouw inzet en talent. Hanne, 
Mathias, en Marieke, de laatste doof- of oncocollega’s, geniet er nog van. Ik 
ben ervan overtuigd dat jullie dit zeer goed zullen doen. 
Al de andere collega’s, Dorien S, Gerarda, Liesbeth, Ilse, Ilse, Nikhita, Gretl, 
Evi, Eveline, Céline, Sien, Geert, Jeanette, Sofie M, bedankt voor de leuke 
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babbels tussendoor, de gezellige middagpauzes en de oprechte interesse en 
steun naar het einde toe.  
Yves, Jonathan en Jasmijn, ik ben heel blij dat we toch nog met elkaar 
proberen af te spreken. Ik herinner me nog de vele leuke momenten tijdens 
de pauzes op de unief. Yves, zeker in de laatste maanden, heb ik veel aan 
jouw kennis en hulp gehad in Gent. Ook jij nog veel succes en moed in de 
laatste maanden. 
 
Mijn vriedinnen, voor de mentale steun, begrip, het vragen naar ‘met-wat-
ben-jij-nu-juist-bezig?’, en voor al die andere leuke momenten die de 
minder leuke draagbaar maken. Ik ben ervan overtuigd dat we nog vele 
leuke avonturen met elkaar gaan beleven.  
 
Mama, papa, voor wie ik de laatste maanden niet veel tijd heb gehad, maar 
bij wie ik steeds terecht kon, ik heb enorm veel aan jullie te danken. 
Telefoontjes op geregelde tijdstippen om mij moed in te spreken, de kansen 
die jullie mij boden. Zonder jullie was dit zeker niet mogelijk geweest. 
Bedankt ook voor het organiseren van de receptie om jullie te nemen.  
Veerle en Karolien, de twee beste zussen die ik me kan wensen. Mentale 
steun is zeker niet onbelangrijk, en jullie zorgen voor een leuke afleiding op 
geregelde tijdstippen. We moeten toch echt eens werk maken van de 
maandelijkse brunch-/ lunchplannen, want op deze manier gaat dit er nooit 
van komen. In de toekomst heeft mijn agenda alvast meer tijd voor jullie. 
 
Tom, zonder jou was dit ongetwijfeld niet gelukt. Op momenten wanneer ik 
het écht niet meer zag zitten was jij degene die me opbeurde en weer in 
mezelf deed geloven. Dank u voor je onvoorwaardelijke steun. Eindelijk 
kunnen we de periode van doctoreren achter ons laten en samen een nieuw 
hoofdstuk beginnen. Door je handigheid, inzicht, oprechte interesse (nog 
nooit een man gekend die zo goed luisterde ) en overheerlijke 
kookkunsten geniet ik van elke dag die we samen doorbrengen. Ik zie je 
enorm graag! 
